
| (State or other jurisdiction of incorporation or organization) | (I.R.S. Employer Identification No.) | (Registrant’s telephone number, including area code) | ||||||||||||||||||
(Address of principal executive offices, including Zip Code) | ||||||||||||||||||||
Securities registered pursuant to Section 12(b) of the Act: | Trading Symbol(s) | Name of exchange on which registered | ||||||
| Title of each class | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of Fixed-to-Floating Rate | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of 4.875% | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of 4.250% | ||||||||
| Depositary Shares, each representing 1/1,000th interest in a share of 6.500% | ||||||||
Depositary Shares, each representing 1/1,000th interest in a share of 6.625% | ||||||||
| of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto) | ||||||||
| of Morgan Stanley Finance LLC (and Registrant’s guarantee with respect thereto) | ||||||||
| ☒ | Accelerated filer | ☐ | Non-accelerated filer | ☐ | Smaller reporting company | Emerging growth company | |||||||||||||||||||||||
| ANNUAL REPORT ON FORM 10-K | ![]() | ||||
For the year ended December 31, 2025 | |||||
| Table of Contents | Part | Item | Page | ||||||||
| I | 1 | ||||||||||
| 1A | |||||||||||
1C | |||||||||||
| II | 7 | ||||||||||
| 7A | |||||||||||
| 8 | |||||||||||
Report of Independent Registered Public Accounting Firm (PCAOB ID No. | |||||||||||
| Table of Contents | Part | Item | Page | ||||||||
| 9 | |||||||||||
| 9A | |||||||||||
| 9B | |||||||||||
| 9C | |||||||||||
| I | 1B | ||||||||||
| 2 | |||||||||||
| 3 | |||||||||||
| 4 | |||||||||||
| II | 5 | ||||||||||
| III | 10 | ||||||||||
| 11 | |||||||||||
| 12 | |||||||||||
| 13 | |||||||||||
| 14 | |||||||||||
| IV | 15 | ||||||||||
| 16 | |||||||||||
5 | December 2025 Form 10-K | |||||||
| December 2025 Form 10-K | 6 | |||||||
7 | December 2025 Form 10-K | |||||||
| December 2025 Form 10-K | 8 | |||||||
9 | December 2025 Form 10-K | |||||||
| December 2025 Form 10-K | 10 | |||||||
11 | December 2025 Form 10-K | |||||||
| Category | Metric | At December 31, 2025 | |||||||||
| Employees | Employees by geography (thousands) | Americas | 54 | ||||||||
Asia | 19 | ||||||||||
| EMEA | 10 | ||||||||||
| Culture | Employee engagement1 | % Proud to work at Morgan Stanley | 93 | % | |||||||
Employee Representation | Global gender representation | % Women | 40 | % | |||||||
% Women officer2 | 30 | % | |||||||||
| U.S. ethnic diversity representation | % Ethnically diverse3 | 36 | % | ||||||||
% Ethnically diverse officer2,3 | 29 | % | |||||||||
| Retention | Voluntary attrition in 2025 | % Global | 9 | % | |||||||
| Tenure | Management Committee average length of service (years) | 25 | |||||||||
| All employees average length of service (years) | 7 | ||||||||||
| Compensation | Compensation and benefits | Total compensation and benefits expense in 2025 (millions) | $ | 29,216 | |||||||
| December 2025 Form 10-K | 12 | |||||||
13 | December 2025 Form 10-K | |||||||
| December 2025 Form 10-K | 14 | |||||||
15 | December 2025 Form 10-K | |||||||
| December 2025 Form 10-K | 16 | |||||||
17 | December 2025 Form 10-K | |||||||
| December 2025 Form 10-K | 18 | |||||||
19 | December 2025 Form 10-K | |||||||
| December 2025 Form 10-K | 20 | |||||||
21 | December 2025 Form 10-K | |||||||
| December 2025 Form 10-K | 22 | |||||||
23 | December 2025 Form 10-K | |||||||
| December 2025 Form 10-K | 24 | |||||||
25 | December 2025 Form 10-K | |||||||
| December 2025 Form 10-K | 26 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||



27 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||



| December 2025 Form 10-K | 28 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||

$ in millions, except per share data | 2025 | 2024 | 2023 | ||||||||
| Consolidated results | |||||||||||
| Net revenues | $ | 70,645 | $ | 61,761 | $ | 54,143 | |||||
| Earnings applicable to Morgan Stanley common shareholders | $ | 16,249 | $ | 12,800 | $ | 8,530 | |||||
| Earnings per diluted common share | $ | 10.21 | $ | 7.95 | $ | 5.18 | |||||
| Consolidated financial measures | |||||||||||
Expense efficiency ratio1 | 68 | % | 71 | % | 77 | % | |||||
ROE2 | 16.6 | % | 14.0 | % | 9.4 | % | |||||
ROTCE2,3 | 21.6 | % | 18.8 | % | 12.8 | % | |||||
Pre-tax margin4 | 31 | % | 28 | % | 22 | % | |||||
| Effective tax rate | 22.5 | % | 23.1 | % | 21.9 | % | |||||
Pre-tax margin by segment4 | |||||||||||
| Institutional Securities | 34 | % | 31 | % | 19 | % | |||||
| Wealth Management | 29 | % | 27 | % | 25 | % | |||||
| Investment Management | 23 | % | 19 | % | 16 | % | |||||
$ in millions, except per share data, worldwide employees and client assets | At December 31, 2025 | At December 31, 2024 | ||||||
Average liquidity resources for three months ended5 | $ | 385,884 | $ | 345,440 | ||||
Loans6 | $ | 289,038 | $ | 246,814 | ||||
| Total assets | $ | 1,420,270 | $ | 1,215,071 | ||||
| Deposits | $ | 415,523 | $ | 376,007 | ||||
| Borrowings | $ | 348,935 | $ | 288,819 | ||||
Common equity | $ | 101,882 | $ | 94,761 | ||||
Tangible common equity3 | $ | 79,147 | $ | 71,604 | ||||
| Common shares outstanding | 1,583 | 1,607 | ||||||
Book value per common share7 | $ | 64.37 | $ | 58.98 | ||||
Tangible book value per common share3,7 | $ | 50.00 | $ | 44.57 | ||||
| Worldwide employees (in thousands) | 83 | 80 | ||||||
Client assets8 (in billions) | $ | 9,276 | $ | 7,860 | ||||
Capital ratios9 | ||||||||
| Common Equity Tier 1 capital—Standardized | 15.0 | % | 15.9 | % | ||||
| Tier 1 capital—Standardized | 16.8 | % | 18.0 | % | ||||
| Common Equity Tier 1 capital—Advanced | 16.2 | % | 15.7 | % | ||||
| Tier 1 capital—Advanced | 18.0 | % | 17.8 | % | ||||
| Tier 1 leverage | 6.7 | % | 6.9 | % | ||||
| SLR | 5.4 | % | 5.6 | % | ||||
29 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
$ in millions | 2025 | 2024 | 2023 | ||||||||
| Net revenues | $ | 70,645 | $ | 61,761 | $ | 54,143 | |||||
Adjustment for mark-to-market losses (gains) on DCP1 | (471) | (363) | (434) | ||||||||
| Adjusted Net revenues—non-GAAP | $ | 70,174 | $ | 61,398 | $ | 53,709 | |||||
| Compensation expense | $ | 29,216 | $ | 26,178 | $ | 24,558 | |||||
Adjustment for mark-to-market gains (losses) on DCP1 | (764) | (672) | (668) | ||||||||
| Adjusted Compensation expense—non-GAAP | $ | 28,452 | $ | 25,506 | $ | 23,890 | |||||
| Wealth Management Net revenues | $ | 31,754 | $ | 28,420 | $ | 26,268 | |||||
Adjustment for mark-to-market losses (gains) on DCP1 | (348) | (239) | (282) | ||||||||
| Adjusted Wealth Management Net revenues—non-GAAP | $ | 31,406 | $ | 28,181 | $ | 25,986 | |||||
| Wealth Management Compensation expense | $ | 16,950 | $ | 15,207 | $ | 13,972 | |||||
Adjustment for mark-to-market gains (losses) on DCP1 | (535) | (431) | (412) | ||||||||
| Adjusted Wealth Management Compensation expense—non-GAAP | $ | 16,415 | $ | 14,776 | $ | 13,560 | |||||
| At December 31, | |||||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Tangible equity | |||||||||||
Common equity | $ | 101,882 | $ | 94,761 | $ | 90,288 | |||||
| Less: Goodwill and net intangible assets | (22,735) | (23,157) | (23,761) | ||||||||
Tangible common equity—non-GAAP | $ | 79,147 | $ | 71,604 | $ | 66,527 | |||||
| Average Monthly Balance | |||||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Tangible equity | |||||||||||
Common equity | $ | 98,046 | $ | 91,699 | $ | 90,819 | |||||
| Less: Goodwill and net intangible assets | (22,922) | (23,482) | (24,013) | ||||||||
Tangible common equity—non-GAAP | $ | 75,124 | $ | 68,217 | $ | 66,806 | |||||
| $ in billions | 2025 | 2024 | 2023 | ||||||||
Average common equity1 | |||||||||||
| Institutional Securities | $ | 48.4 | $ | 45.0 | $ | 45.6 | |||||
| Wealth Management | 29.4 | 29.1 | 28.8 | ||||||||
| Investment Management | 10.6 | 10.8 | 10.4 | ||||||||
ROE2 | |||||||||||
| Institutional Securities | 17 | % | 14 | % | 7 | % | |||||
| Wealth Management | 24 | % | 20 | % | 17 | % | |||||
| Investment Management | 11 | % | 8 | % | 6 | % | |||||
Average tangible common equity1 | |||||||||||
| Institutional Securities | $ | 48.0 | $ | 44.6 | $ | 45.2 | |||||
| Wealth Management | 16.3 | 15.5 | 14.8 | ||||||||
| Investment Management | 1.0 | 1.1 | 0.7 | ||||||||
ROTCE2 | |||||||||||
| Institutional Securities | 17 | % | 14 | % | 7 | % | |||||
| Wealth Management | 43 | % | 37 | % | 33 | % | |||||
| Investment Management | 111 | % | 76 | % | 88 | % | |||||
| December 2025 Form 10-K | 30 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
31 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| December 2025 Form 10-K | 32 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
33 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| % Change | |||||||||||||||||
| $ in millions | 2025 | 2024 | 2023 | 2025 | 2024 | ||||||||||||
| Revenues | |||||||||||||||||
| Advisory | $ | 2,888 | $ | 2,378 | $ | 2,244 | 21 | % | 6 | % | |||||||
| Equity | 1,965 | 1,599 | 889 | 23 | % | 80 | % | ||||||||||
Fixed Income | 2,766 | 2,193 | 1,445 | 26 | % | 52 | % | ||||||||||
| Total Underwriting | 4,731 | 3,792 | 2,334 | 25 | % | 62 | % | ||||||||||
Total Investment Banking | 7,619 | 6,170 | 4,578 | 23 | % | 35 | % | ||||||||||
| Equity | 15,631 | 12,230 | 9,986 | 28 | % | 22 | % | ||||||||||
Fixed Income | 8,716 | 8,418 | 7,673 | 4 | % | 10 | % | ||||||||||
| Other | 1,114 | 1,262 | 823 | (12) | % | 53 | % | ||||||||||
| Net revenues | 33,080 | 28,080 | 23,060 | 18 | % | 22 | % | ||||||||||
| Provision for credit losses | 302 | 202 | 401 | 50 | % | (50) | % | ||||||||||
| Compensation and benefits | 9,785 | 8,669 | 8,369 | 13 | % | 4 | % | ||||||||||
| Non-compensation expenses | 11,756 | 10,460 | 9,814 | 12 | % | 7 | % | ||||||||||
| Total non-interest expenses | 21,541 | 19,129 | 18,183 | 13 | % | 5 | % | ||||||||||
| Income before provision for income taxes | 11,237 | 8,749 | 4,476 | 28 | % | 95 | % | ||||||||||
| Provision for income taxes | 2,430 | 1,947 | 884 | 25 | % | 120 | % | ||||||||||
| Net income | 8,807 | 6,802 | 3,592 | 29 | % | 89 | % | ||||||||||
| Net income applicable to noncontrolling interests | 157 | 136 | 139 | 15 | % | (2) | % | ||||||||||
| Net income applicable to Morgan Stanley | $ | 8,650 | $ | 6,666 | $ | 3,453 | 30 | % | 93 | % | |||||||
| $ in billions | 2025 | 2024 | 2023 | ||||||||
Completed mergers and acquisitions1 | $ | 756 | $ | 655 | $ | 677 | |||||
Equity and equity-related offerings2, 3 | 79 | 63 | 32 | ||||||||
Fixed Income offerings2, 4 | 414 | 326 | 236 | ||||||||
| 2025 | |||||||||||||||||
| $ in millions | Trading | Fees1 | Net Interest2 | All Other3 | Total | ||||||||||||
| Financing | $ | 9,714 | $ | 635 | $ | (2,543) | $ | 4 | $ | 7,810 | |||||||
| Execution services | 4,790 | 2,992 | (396) | 435 | 7,821 | ||||||||||||
| Total Equity | $ | 14,504 | $ | 3,627 | $ | (2,939) | $ | 439 | $ | 15,631 | |||||||
| Total Fixed Income | $ | 7,440 | $ | 428 | $ | 494 | $ | 354 | $ | 8,716 | |||||||
| 2024 | |||||||||||||||||
| $ in millions | Trading | Fees1 | Net Interest2 | All Other3 | Total | ||||||||||||
| Financing | $ | 8,135 | $ | 566 | $ | (2,840) | $ | 17 | $ | 5,878 | |||||||
| Execution services | 3,702 | 2,591 | (291) | 350 | 6,352 | ||||||||||||
| Total Equity | $ | 11,837 | $ | 3,157 | $ | (3,131) | $ | 367 | $ | 12,230 | |||||||
Total Fixed Income | $ | 8,464 | $ | 394 | $ | (730) | $ | 290 | $ | 8,418 | |||||||
| 2023 | |||||||||||||||||
| $ in millions | Trading | Fees1 | Net Interest2 | All Other3 | Total | ||||||||||||
| Financing | $ | 7,206 | $ | 524 | $ | (2,886) | $ | 66 | $ | 4,910 | |||||||
| Execution services | 2,919 | 2,235 | (190) | 112 | 5,076 | ||||||||||||
| Total Equity | $ | 10,125 | $ | 2,759 | $ | (3,076) | $ | 178 | $ | 9,986 | |||||||
Total Fixed Income | $ | 7,848 | $ | 375 | $ | (975) | $ | 425 | $ | 7,673 | |||||||
| December 2025 Form 10-K | 34 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
35 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| % Change | |||||||||||||||||
| $ in millions | 2025 | 2024 | 2023 | 2025 | 2024 | ||||||||||||
| Revenues | |||||||||||||||||
| Asset management | $ | 18,627 | $ | 16,501 | $ | 14,019 | 13 | % | 18 | % | |||||||
Transactional1 | 4,588 | 3,864 | 3,556 | 19 | % | 9 | % | ||||||||||
| Net interest | 7,911 | 7,313 | 8,118 | 8 | % | (10) | % | ||||||||||
Other2 | 628 | 742 | 575 | (15) | % | 29 | % | ||||||||||
| Net revenues | 31,754 | 28,420 | 26,268 | 12 | % | 8 | % | ||||||||||
| Provision for credit losses | 47 | 62 | 131 | (24) | % | (53) | % | ||||||||||
| Compensation and benefits | 16,950 | 15,207 | 13,972 | 11 | % | 9 | % | ||||||||||
| Non-compensation expenses | 5,464 | 5,411 | 5,635 | 1 | % | (4) | % | ||||||||||
| Total non-interest expenses | 22,414 | 20,618 | 19,607 | 9 | % | 5 | % | ||||||||||
| Income before provision for income taxes | 9,293 | 7,740 | 6,530 | 20 | % | 19 | % | ||||||||||
| Provision for income taxes | 2,163 | 1,852 | 1,508 | 17 | % | 23 | % | ||||||||||
| Net income applicable to Morgan Stanley | $ | 7,130 | $ | 5,888 | $ | 5,022 | 21 | % | 17 | % | |||||||
| $ in billions | At December 31, 2025 | At December 31, 2024 | ||||||
Total client assets1 | $ | 7,381 | $ | 6,194 | ||||
| U.S. Bank Subsidiary loans | $ | 181 | $ | 160 | ||||
Margin and other lending2 | $ | 31 | $ | 28 | ||||
Deposits3 | $ | 408 | $ | 370 | ||||
Annualized weighted average cost of deposits4 | ||||||||
| Period end | 2.51% | 2.73% | ||||||
| Period average | 2.76% | 3.05% | ||||||
| 2025 | 2024 | 2023 | |||||||||
Net new assets | $ | 356.3 | $ | 251.7 | $ | 282.3 | |||||
| $ in billions | At December 31, 2025 | At December 31, 2024 | ||||||
Advisor-led client assets1 | $ | 5,715 | $ | 4,758 | ||||
Fee-based client assets2 | $ | 2,753 | $ | 2,347 | ||||
Fee-based client assets as a percentage of advisor-led client assets | 48% | 49% | ||||||
| 2025 | 2024 | 2023 | |||||||||
Fee-based asset flows3 | $ | 160.1 | $ | 123.1 | $ | 109.2 | |||||
| At December 31, 2025 | At December 31, 2024 | |||||||
Self-directed assets (in billions)1 | $ | 1,667 | $ | 1,437 | ||||
Self-directed households (in millions)2 | 8.5 | 8.3 | ||||||
| 2025 | 2024 | 2023 | |||||||||
Daily average revenue trades (“DARTs”) (in thousands)3 | 1,029 | 837 | 759 | ||||||||
| At December 31, 2025 | At December 31, 2024 | |||||||
Workplace unvested assets (in billions)2 | $ | 534 | $ | 475 | ||||
Number of participants (in millions)3, 4 | 6.5 | 6.6 | ||||||
| December 2025 Form 10-K | 36 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| $ in billions | At December 31, 2024 | Inflows1 | Outflows2 | Market Impact3 | At December 31, 2025 | ||||||||||||
Separately managed4 | $ | 719 | $ | 91 | $ | (39) | $ | 62 | $ | 833 | |||||||
| Unified managed | 613 | 145 | (66) | 68 | 760 | ||||||||||||
| Advisor | 207 | 36 | (37) | 23 | 229 | ||||||||||||
| Portfolio manager | 750 | 126 | (95) | 80 | 861 | ||||||||||||
| Subtotal | $ | 2,289 | $ | 398 | $ | (237) | $ | 233 | $ | 2,683 | |||||||
| Cash management | 58 | 56 | (44) | — | 70 | ||||||||||||
| Total fee-based client assets | $ | 2,347 | $ | 454 | $ | (281) | $ | 233 | $ | 2,753 | |||||||
| $ in billions | At December 31, 2023 | Inflows1 | Outflows2 | Market Impact3 | At December 31, 2024 | ||||||||||||
Separately managed4 | $ | 589 | $ | 69 | $ | (38) | $ | 99 | $ | 719 | |||||||
| Unified managed | 501 | 120 | (56) | 48 | 613 | ||||||||||||
| Advisor | 188 | 31 | (35) | 23 | 207 | ||||||||||||
| Portfolio manager | 645 | 120 | (88) | 73 | 750 | ||||||||||||
| Subtotal | $ | 1,923 | $ | 340 | $ | (217) | $ | 243 | $ | 2,289 | |||||||
| Cash management | 60 | 57 | (59) | — | 58 | ||||||||||||
| Total fee-based client assets | $ | 1,983 | $ | 397 | $ | (276) | $ | 243 | $ | 2,347 | |||||||
| $ in billions | At December 31, 2022 | Inflows1 | Outflows2 | Market Impact3 | At December 31, 2023 | ||||||||||||
Separately managed4 | $ | 501 | $ | 70 | $ | (23) | $ | 41 | $ | 589 | |||||||
| Unified managed | 408 | 96 | (56) | 53 | 501 | ||||||||||||
| Advisor | 167 | 29 | (32) | 24 | 188 | ||||||||||||
| Portfolio manager | 552 | 98 | (73) | 68 | 645 | ||||||||||||
| Subtotal | $ | 1,628 | $ | 293 | $ | (184) | $ | 186 | $ | 1,923 | |||||||
| Cash management | 50 | 60 | (50) | — | 60 | ||||||||||||
| Total fee-based client assets | $ | 1,678 | $ | 353 | $ | (234) | $ | 186 | $ | 1,983 | |||||||
| Fee rate in bps | 2025 | 2024 | 2023 | ||||||||
| Separately managed | 12 | 12 | 12 | ||||||||
| Unified managed | 90 | 91 | 92 | ||||||||
| Advisor | 78 | 79 | 80 | ||||||||
| Portfolio manager | 88 | 89 | 91 | ||||||||
| Subtotal | 64 | 65 | 65 | ||||||||
| Cash management | 6 | 6 | 6 | ||||||||
| Total fee-based client assets | 63 | 63 | 64 | ||||||||
37 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| December 2025 Form 10-K | 38 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| % Change | |||||||||||||||||
| $ in millions | 2025 | 2024 | 2023 | 2025 | 2024 | ||||||||||||
| Revenues | |||||||||||||||||
Asset management and related fees | $ | 6,068 | $ | 5,627 | $ | 5,231 | 8 | % | 8 | % | |||||||
Performance-based income and other1 | 457 | 234 | 139 | 95 | % | 68 | % | ||||||||||
| Net revenues | 6,525 | 5,861 | 5,370 | 11 | % | 9 | % | ||||||||||
| Compensation and benefits | 2,481 | 2,302 | 2,217 | 8 | % | 4 | % | ||||||||||
| Non-compensation expenses | 2,566 | 2,422 | 2,311 | 6 | % | 5 | % | ||||||||||
| Total non-interest expenses | 5,047 | 4,724 | 4,528 | 7 | % | 4 | % | ||||||||||
| Income before provision for income taxes | 1,478 | 1,137 | 842 | 30 | % | 35 | % | ||||||||||
| Provision for income taxes | 349 | 275 | 199 | 27 | % | 38 | % | ||||||||||
| Net income | 1,129 | 862 | 643 | 31 | % | 34 | % | ||||||||||
Net income applicable to noncontrolling interests | 7 | 3 | 4 | 133 | % | (25) | % | ||||||||||
Net income applicable to Morgan Stanley | $ | 1,122 | $ | 859 | $ | 639 | 31 | % | 34 | % | |||||||
| $ in billions | At Dec 31, 2024 | Inflows1 | Outflows2 | Market Impact3 | Other4 | At Dec 31, 2025 | ||||||||||||||
| Equity | $ | 312 | $ | 45 | $ | (67) | $ | 26 | $ | (2) | $ | 314 | ||||||||
Fixed Income | 192 | 89 | (59) | 12 | — | 234 | ||||||||||||||
Alternatives and Solutions6 | 593 | 159 | (120) | 76 | (5) | 703 | ||||||||||||||
Long-Term AUM | $ | 1,097 | $ | 293 | $ | (246) | $ | 114 | $ | (7) | $ | 1,251 | ||||||||
| Liquidity and Overlay Services | 569 | 2,721 | (2,661) | 26 | (11) | 644 | ||||||||||||||
| Total | $ | 1,666 | $ | 3,014 | $ | (2,907) | $ | 140 | $ | (18) | $ | 1,895 | ||||||||
| $ in billions | At Dec 31, 2023 | Inflows1 | Outflows2 | Market Impact3 | Other4 | At Dec 31, 2024 | ||||||||||||||
| Equity | $ | 295 | $ | 44 | $ | (66) | $ | 49 | $ | (10) | $ | 312 | ||||||||
Fixed Income | 171 | 69 | (49) | 7 | (6) | 192 | ||||||||||||||
Alternatives and Solutions6 | 508 | 140 | (108) | 62 | (9) | 593 | ||||||||||||||
Long-Term AUM | $ | 974 | $ | 253 | $ | (223) | $ | 118 | $ | (25) | $ | 1,097 | ||||||||
| Liquidity and Overlay Services | 485 | 2,349 | (2,268) | 20 | (17) | 569 | ||||||||||||||
| Total | $ | 1,459 | $ | 2,602 | $ | (2,491) | $ | 138 | $ | (42) | $ | 1,666 | ||||||||
| $ in billions | At Dec 31, 2022 | Inflows1 | Outflows2 | Market Impact3 | Other4,5 | At Dec 31, 2023 | ||||||||||||||
| Equity | $ | 259 | $ | 40 | $ | (57) | $ | 57 | $ | (4) | $ | 295 | ||||||||
| Fixed Income | 173 | 56 | (62) | 11 | (7) | 171 | ||||||||||||||
Alternatives and Solutions6 | 431 | 108 | (91) | 57 | 3 | 508 | ||||||||||||||
| Long-Term AUM | $ | 863 | $ | 204 | $ | (210) | $ | 125 | $ | (8) | $ | 974 | ||||||||
| Liquidity and Overlay Services | 442 | 2,282 | (2,244) | 20 | (15) | 485 | ||||||||||||||
| Total | $ | 1,305 | $ | 2,486 | $ | (2,454) | $ | 145 | $ | (23) | $ | 1,459 | ||||||||
39 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| $ in billions | 2025 | 2024 | 2023 | ||||||||
| Equity | $ | 318 | $ | 305 | $ | 279 | |||||
| Fixed income | 212 | 180 | 170 | ||||||||
| Alternatives and Solutions | 640 | 557 | 466 | ||||||||
Long-term AUM subtotal | 1,170 | 1,042 | 915 | ||||||||
| Liquidity and Overlay Services | 572 | 498 | 464 | ||||||||
Total | $ | 1,742 | $ | 1,540 | $ | 1,379 | |||||
| Fee rate in bps | 2025 | 2024 | 2023 | ||||||||
| Equity | 69 | 71 | 71 | ||||||||
| Fixed income | 36 | 36 | 35 | ||||||||
| Alternatives and Solutions | 27 | 28 | 32 | ||||||||
Long-term AUM | 40 | 42 | 44 | ||||||||
| Liquidity and Overlay Services | 12 | 12 | 13 | ||||||||
Total | 31 | 32 | 34 | ||||||||
| December 2025 Form 10-K | 40 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| $ in billions | At December 31, 2025 | At December 31, 2024 | ||||||
Investment securities | ||||||||
| Available-for-sale at fair value | $ | 88.4 | $ | 76.5 | ||||
| Held-to-maturity | 44.2 | 47.8 | ||||||
| Total Investment securities | $ | 132.6 | $ | 124.3 | ||||
Wealth Management loans2 | ||||||||
| Residential real estate | $ | 72.3 | $ | 66.6 | ||||
Securities-based lending and Other3 | 108.9 | 92.9 | ||||||
Total Wealth Management loans | $ | 181.2 | $ | 159.5 | ||||
Institutional Securities loans2 | ||||||||
| Corporate | $ | 8.4 | $ | 7.1 | ||||
| Secured lending facilities | 67.2 | 50.2 | ||||||
| Commercial and Residential real estate | 11.2 | 10.5 | ||||||
| Securities-based lending and Other | 9.0 | 5.6 | ||||||
Total Institutional Securities loans | $ | 95.8 | $ | 73.4 | ||||
Total assets | $ | 487.3 | $ | 434.8 | ||||
Deposits4 | $ | 408.1 | $ | 369.7 | ||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Deferred cash-based awards | $ | 950 | $ | 770 | $ | 693 | |||||
| Return on referenced investments | 764 | 672 | 668 | ||||||||
| Total recognized in compensation expense | $ | 1,714 | $ | 1,442 | $ | 1,361 | |||||
41 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Institutional Securities | $ | 155 | $ | 150 | $ | 162 | |||||
| Wealth Management | 1,382 | 1,100 | 984 | ||||||||
| Investment Management | 177 | 192 | 215 | ||||||||
| Total recognized in compensation expense | $ | 1,714 | $ | 1,442 | $ | 1,361 | |||||
| $ in millions | |||||
Award liabilities at December 31, 20252, 3 | $ | 6,423 | |||
Fully vested amounts to be distributed by the end of February 20264 | (701) | ||||
Unrecognized portion of prior awards at December 31, 20253 | 1,928 | ||||
2025 performance year awards granted in 20263 | 446 | ||||
Total5 | $ | 8,096 | |||
| $ in millions | |||||
| Estimated to be recognized in: | |||||
2026 | $ | 679 | |||
| 2027 | 475 | ||||
| Thereafter | 1,220 | ||||
| Total | $ | 2,374 | |||
| December 2025 Form 10-K | 42 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
43 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| December 2025 Form 10-K | 44 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
45 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| December 2025 Form 10-K | 46 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| At December 31, 2025 | ||||||||||||||
| $ in millions | IS | WM | IM | Total | ||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 81,228 | $ | 30,426 | $ | 41 | $ | 111,695 | ||||||
| Trading assets at fair value | 410,573 | 12,428 | 5,275 | 428,276 | ||||||||||
| Investment securities | 34,111 | 129,445 | — | 163,556 | ||||||||||
| Securities purchased under agreements to resell | 106,728 | 13,515 | — | 120,243 | ||||||||||
| Securities borrowed | 150,902 | 1,006 | — | 151,908 | ||||||||||
| Customer and other receivables | 71,645 | 41,447 | 1,628 | 114,720 | ||||||||||
Loans1 | 96,850 | 181,241 | 3 | 278,094 | ||||||||||
Goodwill | 437 | 10,199 | 6,090 | 16,726 | ||||||||||
Intangible assets | 21 | 2,607 | 3,382 | 6,010 | ||||||||||
Other assets2 | 17,058 | 10,703 | 1,281 | 29,042 | ||||||||||
| Total assets | $ | 969,553 | $ | 433,017 | $ | 17,700 | $ | 1,420,270 | ||||||
| At December 31, 2024 | ||||||||||||||
| $ in millions | IS | WM | IM | Total | ||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | 74,079 | $ | 31,072 | $ | 235 | $ | 105,386 | ||||||
| Trading assets at fair value | 320,003 | 6,915 | 4,966 | 331,884 | ||||||||||
| Investment securities | 38,096 | 121,583 | — | 159,679 | ||||||||||
| Securities purchased under agreements to resell | 100,404 | 18,161 | — | 118,565 | ||||||||||
| Securities borrowed | 121,901 | 1,958 | — | 123,859 | ||||||||||
| Customer and other receivables | 47,321 | 37,196 | 1,641 | 86,158 | ||||||||||
Loans1 | 78,607 | 159,542 | 4 | 238,153 | ||||||||||
Goodwill | 435 | 10,190 | 6,081 | 16,706 | ||||||||||
Intangible assets | 27 | 2,939 | 3,487 | 6,453 | ||||||||||
Other assets2 | 15,735 | 11,292 | 1,201 | 28,228 | ||||||||||
| Total assets | $ | 796,608 | $ | 400,848 | $ | 17,615 | $ | 1,215,071 | ||||||
47 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | December 31, 2025 | September 30, 2025 | ||||||
| Cash deposits with central banks | $ | 67,334 | $ | 56,629 | ||||
Unencumbered HQLA securities1: | ||||||||
| U.S. government obligations | 186,200 | 189,861 | ||||||
| U.S. agency and agency mortgage-backed securities | 89,737 | 82,958 | ||||||
Non-U.S. sovereign obligations2 | 34,790 | 30,629 | ||||||
| Other investment grade securities | 358 | 321 | ||||||
Total HQLA1 | $ | 378,419 | $ | 360,398 | ||||
| Cash deposits with banks (non-HQLA) | 7,465 | 7,692 | ||||||
| Total Liquidity Resources | $ | 385,884 | $ | 368,090 | ||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | December 31, 2025 | September 30, 2025 | ||||||
| Non-Bank legal entities | ||||||||
| U.S.: | ||||||||
| Parent Company | $ | 91,181 | $ | 90,626 | ||||
| Non-Parent Company | 58,795 | 55,786 | ||||||
| Total U.S. | 149,976 | 146,412 | ||||||
| Non-U.S. | 77,770 | 70,173 | ||||||
| Total Non-Bank legal entities | 227,746 | 216,585 | ||||||
| Bank legal entities | ||||||||
| U.S. | 150,428 | 145,349 | ||||||
| Non-U.S. | 7,710 | 6,156 | ||||||
| Total Bank legal entities | 158,138 | 151,505 | ||||||
| Total Liquidity Resources | $ | 385,884 | $ | 368,090 | ||||
| December 2025 Form 10-K | 48 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | December 31, 2025 | September 30, 2025 | ||||||
Eligible HQLA | ||||||||
| Cash deposits with central banks | $ | 62,425 | $ | 51,867 | ||||
Securities1 | 232,693 | 234,905 | ||||||
Total Eligible HQLA | $ | 295,118 | $ | 286,772 | ||||
| Net cash outflows | $ | 219,706 | $ | 222,223 | ||||
| LCR | 134 | % | 129 | % | ||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | December 31, 2025 | September 30, 2025 | ||||||
Available stable funding | $ | 698,728 | $ | 678,009 | ||||
| Required stable funding | 577,403 | 565,048 | ||||||
| NSFR | 121 | % | 120 | % | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Securities purchased under agreements to resell and Securities borrowed | $ | 272,151 | $ | 242,424 | ||||
| Securities sold under agreements to repurchase and Securities loaned | $ | 95,849 | $ | 65,293 | ||||
Securities received as collateral1 | $ | 2,449 | $ | 9,625 | ||||
| Average Daily Balance Three Months Ended | ||||||||
| $ in millions | December 31, 2025 | December 31, 2024 | ||||||
| Securities purchased under agreements to resell and Securities borrowed | $ | 255,202 | $ | 250,354 | ||||
| Securities sold under agreements to repurchase and Securities loaned | $ | 90,397 | $ | 74,949 | ||||
49 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Savings and demand deposits: | ||||||||
Brokerage sweep deposits1 | $ | 145,237 | $ | 142,550 | ||||
| Savings and other | 170,646 | 157,348 | ||||||
| Total Savings and demand deposits | 315,883 | 299,898 | ||||||
Time deposits2 | 99,640 | 76,109 | ||||||
Total3 | $ | 415,523 | $ | 376,007 | ||||
| $ in millions | Parent Company | Subsidiaries | Total | ||||||||
| Original maturities of one year or less | $ | — | $ | 7,254 | $ | 7,254 | |||||
| Original maturities greater than one year | |||||||||||
| 2026 | $ | 11,568 | $ | 14,667 | $ | 26,235 | |||||
| 2027 | 22,066 | 17,551 | 39,617 | ||||||||
| 2028 | 16,080 | 28,682 | 44,762 | ||||||||
| 2029 | 23,549 | 12,961 | 36,510 | ||||||||
| 2030 | 16,080 | 14,840 | 30,920 | ||||||||
| Thereafter | 110,985 | 52,652 | 163,637 | ||||||||
| Total greater than one year | $ | 200,328 | $ | 141,353 | $ | 341,681 | |||||
| Total | $ | 200,328 | $ | 148,607 | $ | 348,935 | |||||
| Parent Company | |||||||||||
| Short-Term Debt | Long-Term Debt | Rating Outlook | |||||||||
| DBRS, Inc. | R-1 (middle) | AA (low) | Stable | ||||||||
| Fitch Ratings, Inc. | F1 | A+ | Stable | ||||||||
| Moody’s Investors Service, Inc. | P-1 | A1 | Stable | ||||||||
| Rating and Investment Information, Inc. | a-1 | A+ | Stable | ||||||||
| S&P Global Ratings | A-2 | A- | Stable | ||||||||
| MSBNA | |||||||||||
| Short-Term Debt | Long-Term Debt | Rating Outlook | |||||||||
| Fitch Ratings, Inc. | F1+ | AA- | Stable | ||||||||
| Moody’s Investors Service, Inc. | P-1 | Aa3 | Stable | ||||||||
| S&P Global Ratings | A-1 | A+ | Stable | ||||||||
| MSPBNA | |||||||||||
| Short-Term Debt | Long-Term Debt | Rating Outlook | |||||||||
| Fitch Ratings, Inc. | F1+ | AA- | Stable | ||||||||
| Moody’s Investors Service, Inc. | P-1 | Aa3 | Stable | ||||||||
| S&P Global Ratings | A-1 | A+ | Stable | ||||||||
| December 2025 Form 10-K | 50 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| in millions, except for per share data | 2025 | 2024 | 2023 | ||||||||
| Number of shares | 32 | 33 | 62 | ||||||||
| Average price per share | $ | 141.33 | $ | 99.16 | $ | 85.35 | |||||
| Total | $ | 4,585 | $ | 3,250 | $ | 5,300 | |||||
| Announcement date | January 15, 2026 | ||||
| Amount per share | $1.00 | ||||
| Date paid | February 13, 2026 | ||||
| Shareholders of record as of | January 30, 2026 | ||||
51 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| At December 31, 2025 | At December 31, 2024 | At December 31, 2025 and December 31, 2024 | |||||||||
| Standardized | Standardized | Advanced | |||||||||
| Capital buffers | |||||||||||
| Fixed 2.5% buffer | —% | —% | 2.5% | ||||||||
SCB1 | 4.3% | 6.0% | N/A | ||||||||
G-SIB capital surcharge2 | 3.0% | 3.0% | 3.0% | ||||||||
CCyB3 | —% | —% | —% | ||||||||
| Capital conservation buffer requirement | 7.3% | 9.0% | 5.5% | ||||||||
| Regulatory Minimum | At December 31, 2025 | At December 31, 2024 | At December 31, 2025 and December 31, 2024 | |||||||||||
| Standardized | Standardized | Advanced | ||||||||||||
Required ratios1 | ||||||||||||||
CET1 capital ratio | 4.5 | % | 11.8% | 13.5% | 10.0% | |||||||||
| Tier 1 capital ratio | 6.0 | % | 13.3% | 15.0% | 11.5% | |||||||||
| Total capital ratio | 8.0 | % | 15.3% | 17.0% | 13.5% | |||||||||
| December 2025 Form 10-K | 52 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Standardized | Advanced | ||||||||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | At December 31, 2025 | At December 31, 2024 | |||||||||||||
Risk-based capital | |||||||||||||||||
| CET1 capital | $ | 83,153 | $ | 75,095 | $ | 83,153 | $ | 75,095 | |||||||||
| Tier 1 capital | 92,728 | 84,790 | 92,728 | 84,790 | |||||||||||||
| Total capital | 103,449 | 95,567 | 102,680 | 94,846 | |||||||||||||
| Total RWA | 552,515 | 471,834 | 514,158 | 477,331 | |||||||||||||
Risk-based capital ratios | |||||||||||||||||
| CET1 capital | 15.0 | % | 15.9 | % | 16.2 | % | 15.7 | % | |||||||||
| Tier 1 capital | 16.8 | % | 18.0 | % | 18.0 | % | 17.8 | % | |||||||||
| Total capital | 18.7 | % | 20.3 | % | 20.0 | % | 19.9 | % | |||||||||
Required ratios1 | |||||||||||||||||
| CET1 capital | 11.8 | % | 13.5 | % | 10.0 | % | 10.0 | % | |||||||||
| Tier 1 capital | 13.3 | % | 15.0 | % | 11.5 | % | 11.5 | % | |||||||||
| Total capital | 15.3 | % | 17.0 | % | 13.5 | % | 13.5 | % | |||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
Leverage-based capital | ||||||||
Adjusted average assets1 | $ | 1,383,314 | $ | 1,223,779 | ||||
Supplementary leverage exposure2 | 1,717,775 | 1,517,687 | ||||||
Leverage-based capital ratios | ||||||||
| Tier 1 leverage | 6.7 | % | 6.9 | % | ||||
| SLR | 5.4 | % | 5.6 | % | ||||
Required ratios3 | ||||||||
| Tier 1 leverage | 4.0 | % | 4.0 | % | ||||
| SLR | 5.0 | % | 5.0 | % | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | Change | ||||||||
CET1 capital | |||||||||||
Common shareholders’ equity | $ | 101,882 | $ | 94,761 | $ | 7,121 | |||||
| Regulatory adjustments and deductions: | |||||||||||
| Net goodwill | (16,373) | (16,354) | (19) | ||||||||
| Net intangible assets | (4,663) | (5,003) | 340 | ||||||||
Impact of CECL transition | — | 62 | (61) | ||||||||
Other adjustments and deductions1 | 2,307 | 1,629 | 678 | ||||||||
Total CET1 capital | $ | 83,153 | $ | 75,095 | $ | 8,058 | |||||
| Additional Tier 1 capital | |||||||||||
| Preferred stock | $ | 9,750 | $ | 9,750 | $ | — | |||||
| Noncontrolling interests | 823 | 807 | 16 | ||||||||
| Additional Tier 1 capital | $ | 10,573 | $ | 10,557 | $ | 16 | |||||
| Deduction for investments in covered funds | (998) | (862) | (136) | ||||||||
| Total Tier 1 capital | $ | 92,728 | $ | 84,790 | $ | 7,938 | |||||
| Standardized Tier 2 capital | |||||||||||
| Subordinated debt | $ | 8,380 | $ | 8,851 | $ | (471) | |||||
| Eligible ACL | 2,411 | 2,065 | 346 | ||||||||
| Other adjustments and deductions | (70) | (139) | 69 | ||||||||
| Total Standardized Tier 2 capital | $ | 10,721 | $ | 10,777 | $ | (56) | |||||
| Total Standardized capital | $ | 103,449 | $ | 95,567 | $ | 7,882 | |||||
| Advanced Tier 2 capital | |||||||||||
| Subordinated debt | $ | 8,380 | $ | 8,851 | $ | (471) | |||||
| Eligible credit reserves | 1,642 | 1,344 | 298 | ||||||||
| Other adjustments and deductions | (70) | (139) | 69 | ||||||||
| Total Advanced Tier 2 capital | $ | 9,952 | $ | 10,056 | $ | (104) | |||||
| Total Advanced capital | $ | 102,680 | $ | 94,846 | $ | 7,834 | |||||
53 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| $ in millions | Standardized | Advanced | ||||||
| Credit risk RWA | ||||||||
| Balance at December 31, 2024 | $ | 417,982 | $ | 316,429 | ||||
| Change related to the following items: | ||||||||
| Derivatives | 21,522 | 15,259 | ||||||
| Securities financing transactions | 22,249 | 4,593 | ||||||
| Investment securities | (718) | (1,289) | ||||||
| Commitments, guarantees and loans | 22,203 | 5,565 | ||||||
| Equity investments | 4,029 | 4,538 | ||||||
| Other credit risk | 5,939 | 4,835 | ||||||
| Total change in credit risk RWA | $ | 75,224 | $ | 33,501 | ||||
| Balance at December 31, 2025 | $ | 493,206 | $ | 349,930 | ||||
| Market risk RWA | ||||||||
| Balance at December 31, 2024 | $ | 53,852 | $ | 54,322 | ||||
| Change related to the following items: | ||||||||
| Regulatory VaR | 2,637 | 2,637 | ||||||
| Regulatory stressed VaR | 526 | 526 | ||||||
| Incremental risk charge | (2,114) | (2,114) | ||||||
| Comprehensive risk measure | (6) | (434) | ||||||
| Specific risk | 4,414 | 4,408 | ||||||
| Total change in market risk RWA | $ | 5,457 | $ | 5,023 | ||||
| Balance at December 31, 2025 | $ | 59,309 | $ | 59,345 | ||||
| Operational risk RWA | ||||||||
| Balance at December 31, 2024 | N/A | $ | 106,580 | |||||
| Change in operational risk RWA | N/A | (1,697) | ||||||
| Balance at December 31, 2025 | N/A | $ | 104,883 | |||||
| Total RWA | $ | 552,515 | $ | 514,158 | ||||
| December 2025 Form 10-K | 54 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| Actual Amount/Ratio | ||||||||||||||
| $ in millions | Regulatory Minimum | Required Ratio1 | At December 31, 2025 | At December 31, 2024 | ||||||||||
External TLAC2 | $ | 284,259 | $ | 266,146 | ||||||||||
| External TLAC as a % of RWA | 18.0 | % | 21.5 | % | 51.4 | % | 55.8 | % | ||||||
| External TLAC as a % of leverage exposure | 7.5 | % | 9.5 | % | 16.5 | % | 17.5 | % | ||||||
Eligible LTD3 | $ | 181,401 | $ | 169,690 | ||||||||||
| Eligible LTD as a % of RWA | 9.0 | % | 9.0 | % | 32.8 | % | 35.5 | % | ||||||
| Eligible LTD as a % of leverage exposure | 4.5 | % | 4.5 | % | 10.6 | % | 11.2 | % | ||||||
55 | December 2025 Form 10-K | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
| $ in billions | 2025 | 2024 | 2023 | ||||||||
| Institutional Securities | $ | 48.4 | $ | 45.0 | $ | 45.6 | |||||
Wealth Management | 29.4 | 29.1 | 28.8 | ||||||||
Investment Management | 10.6 | 10.8 | 10.4 | ||||||||
| Parent | 9.6 | 6.8 | 6.0 | ||||||||
| Total | $ | 98.0 | $ | 91.7 | $ | 90.8 | |||||
| December 2025 Form 10-K | 56 | |||||||
| Management’s Discussion and Analysis | ![]() | ||||
57 | December 2025 Form 10-K | |||||||

| December 2025 Form 10-K | 58 | |||||||
| Risk Disclosures | ![]() | ||||
59 | December 2025 Form 10-K | |||||||
| Risk Disclosures | ![]() | ||||
| December 2025 Form 10-K | 60 | |||||||
| Risk Disclosures | ![]() | ||||
61 | December 2025 Form 10-K | |||||||
| Risk Disclosures | ![]() | ||||
| December 2025 Form 10-K | 62 | |||||||
| Risk Disclosures | ![]() | ||||
| 2025 | ||||||||||||||
| $ in millions | Period End | Average | High1 | Low1 | ||||||||||
| Interest rate and credit spread | $ | 27 | $ | 30 | $ | 43 | $ | 20 | ||||||
| Equity price | 27 | 30 | 44 | 17 | ||||||||||
| Foreign exchange rate | 7 | 12 | 22 | 6 | ||||||||||
| Commodity price | 13 | 16 | 27 | 11 | ||||||||||
Less: Diversification benefit2 | (36) | (39) | N/A | N/A | ||||||||||
| Primary Risk Categories | $ | 38 | $ | 49 | $ | 63 | $ | 34 | ||||||
| Credit Portfolio | 14 | 18 | 23 | 13 | ||||||||||
Less: Diversification benefit2 | (8) | (15) | N/A | N/A | ||||||||||
| Total Management VaR | $ | 44 | $ | 52 | $ | 64 | $ | 38 | ||||||
| 2024 | ||||||||||||||
| $ in millions | Period End | Average | High1 | Low1 | ||||||||||
| Interest rate and credit spread | $ | 23 | $ | 31 | $ | 52 | $ | 19 | ||||||
| Equity price | 21 | 23 | 39 | 17 | ||||||||||
| Foreign exchange rate | 10 | 10 | 15 | 6 | ||||||||||
| Commodity price | 18 | 15 | 23 | 10 | ||||||||||
Less: Diversification benefit2 | (37) | (37) | N/A | N/A | ||||||||||
| Primary Risk Categories | $ | 35 | $ | 42 | $ | 59 | $ | 32 | ||||||
| Credit Portfolio | 20 | 24 | 26 | 20 | ||||||||||
Less: Diversification benefit2 | (16) | (17) | N/A | N/A | ||||||||||
| Total Management VaR | $ | 39 | $ | 49 | $ | 66 | $ | 39 | ||||||
63 | December 2025 Form 10-K | |||||||
| Risk Disclosures | ![]() | ||||


| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Derivatives | $ | 6 | $ | 6 | ||||
| Borrowings carried at fair value | 59 | 49 | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Basis point change | ||||||||
+200 | $ | 410 | $ | 699 | ||||
| +100 | 209 | 350 | ||||||
| -100 | (244) | (371) | ||||||
-200 | (542) | (803) | ||||||
| December 2025 Form 10-K | 64 | |||||||
| Risk Disclosures | ![]() | ||||
| Loss from 10% Decline | ||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
Investments related to Investment Management activities | $ | 629 | $ | 571 | ||||
| Other investments: | ||||||||
| MUMSS | 129 | 122 | ||||||
| Other Firm investments | 493 | 463 | ||||||
65 | December 2025 Form 10-K | |||||||
| Risk Disclosures | ![]() | ||||
| At December 31, 2025 | ||||||||||||||
| $ in millions | HFI | HFS | FVO1 | Total | ||||||||||
| Institutional Securities: | ||||||||||||||
| Corporate | $ | 7,277 | $ | 7,202 | $ | — | $ | 14,479 | ||||||
| Secured lending facilities | 69,149 | 1,817 | — | 70,966 | ||||||||||
| Commercial and Residential real estate | 8,039 | 320 | 3,949 | 12,308 | ||||||||||
| Securities-based lending and Other | 3,780 | 30 | 6,904 | 10,714 | ||||||||||
| Total Institutional Securities | 88,245 | 9,369 | 10,853 | 108,467 | ||||||||||
| Wealth Management: | ||||||||||||||
| Residential real estate | 72,403 | 5 | — | 72,408 | ||||||||||
| Securities-based lending and Other | 109,201 | — | — | 109,201 | ||||||||||
| Total Wealth Management | 181,604 | 5 | — | 181,609 | ||||||||||
Total Investment Management2 | 3 | — | 91 | 94 | ||||||||||
Total loans | 269,852 | 9,374 | 10,944 | 290,170 | ||||||||||
| ACL | (1,132) | (1,132) | ||||||||||||
| Total loans, net of ACL | $ | 268,720 | $ | 9,374 | $ | 10,944 | $ | 289,038 | ||||||
Lending commitments3 | $ | 166,989 | $ | 41,445 | $ | 732 | $ | 209,166 | ||||||
| Total exposure | $ | 435,709 | $ | 50,819 | $ | 11,676 | $ | 498,204 | ||||||
| December 2025 Form 10-K | 66 | |||||||
| Risk Disclosures | ![]() | ||||
| At December 31, 2024 | ||||||||||||||
| $ in millions | HFI | HFS | FVO1 | Total | ||||||||||
| Institutional Securities: | ||||||||||||||
| Corporate | $ | 6,889 | $ | 9,183 | $ | — | $ | 16,072 | ||||||
| Secured lending facilities | 48,842 | 2,507 | — | 51,349 | ||||||||||
| Commercial and Residential real estate | 8,412 | 628 | 2,420 | 11,460 | ||||||||||
| Securities-based lending and Other | 2,876 | — | 6,041 | 8,917 | ||||||||||
| Total Institutional Securities | 67,019 | 12,318 | 8,461 | 87,798 | ||||||||||
| Wealth Management: | ||||||||||||||
| Residential real estate | 66,738 | — | — | 66,738 | ||||||||||
| Securities-based lending and Other | 93,139 | 1 | — | 93,140 | ||||||||||
| Total Wealth Management | 159,877 | 1 | — | 159,878 | ||||||||||
Total Investment Management2 | 4 | — | 200 | 204 | ||||||||||
Total loans | 226,900 | 12,319 | 8,661 | 247,880 | ||||||||||
| ACL | (1,066) | (1,066) | ||||||||||||
| Total loans, net of ACL | $ | 225,834 | $ | 12,319 | $ | 8,661 | $ | 246,814 | ||||||
Lending commitments3 | $ | 148,818 | $ | 26,955 | $ | 758 | $ | 176,531 | ||||||
| Total exposure | $ | 374,652 | $ | 39,274 | $ | 9,419 | $ | 423,345 | ||||||
| $ in millions | 2025 | ||||
| ACL—Loans | |||||
| Beginning balance | $ | 1,066 | |||
| Gross charge-offs | (214) | ||||
| Recoveries | 22 | ||||
Net (charge-offs)/recoveries | (192) | ||||
| Provision for credit losses | 230 | ||||
| Other | 28 | ||||
| Ending balance | $ | 1,132 | |||
ACL—Lending commitments | |||||
| Beginning balance | $ | 656 | |||
| Provision for credit losses | 119 | ||||
| Other | 23 | ||||
| Ending balance | $ | 798 | |||
| Total ending balance | $ | 1,930 | |||
| Year Ended December 31, 2025 | |||||||||||
| $ in millions | IS | WM | Total | ||||||||
| Loans | $ | 185 | $ | 45 | $ | 230 | |||||
| Lending commitments | 117 | 2 | 119 | ||||||||
| Total | $ | 302 | $ | 47 | $ | 349 | |||||
| 4Q 2026 | 4Q 2027 | |||||||
| Year-over-year growth rate | 1.8 | % | 2.1 | % | ||||
67 | December 2025 Form 10-K | |||||||
| Risk Disclosures | ![]() | ||||
| At December 31, 2025 | At December 31, 2024 | |||||||||||||
| IS | WM | IS | WM | |||||||||||
| Accrual | 99.2 | % | 99.8 | % | 99.2 | % | 99.7 | % | ||||||
Nonaccrual1 | 0.8 | % | 0.2 | % | 0.8 | % | 0.3 | % | ||||||
| Year Ended December 31, | ||||||||||||||||||||||||||
| 2025 | 2024 | 2023 | ||||||||||||||||||||||||
| $ in millions | Net Charge-off Ratio1 | Average Loans | Net Charge-off Ratio1 | Average Loans | Net Charge-off Ratio1 | Average Loans | ||||||||||||||||||||
| Corporate | 0.31% | $7,727 | 0.57% | $6,895 | 0.47% | $7,062 | ||||||||||||||||||||
Secured Lending Facilities | —% | 57,913 | 0.03% | 43,158 | —% | 37,702 | ||||||||||||||||||||
Commercial Real Estate | 1.82% | 8,280 | 1.87% | 8,620 | 1.50% | 8,590 | ||||||||||||||||||||
Residential Real Estate | —% | 69,225 | —% | 63,204 | —% | 57,177 | ||||||||||||||||||||
SBL and Other | 0.02% | 103,660 | 0.03% | 91,221 | —% | 91,126 | ||||||||||||||||||||
| Total | 0.08% | $246,805 | 0.11% | $213,098 | 0.08% | $201,657 | ||||||||||||||||||||
| At December 31, 2025 | |||||||||||||||||
| Contractual Years to Maturity | |||||||||||||||||
| $ in millions | < 1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
| Loans | |||||||||||||||||
| AA | $ | 2 | $ | 163 | $ | — | $ | — | $ | 165 | |||||||
| A | 989 | 1,159 | 158 | — | 2,306 | ||||||||||||
| BBB | 3,872 | 17,798 | 967 | 429 | 23,066 | ||||||||||||
| BB | 9,948 | 40,450 | 2,668 | 413 | 53,479 | ||||||||||||
| Other NIG | 5,288 | 12,931 | 3,965 | 153 | 22,337 | ||||||||||||
Unrated2 | 212 | 1,587 | 955 | 3,596 | 6,350 | ||||||||||||
| Total loans, net of ACL | 20,311 | 74,088 | 8,713 | 4,591 | 107,703 | ||||||||||||
| Lending commitments | |||||||||||||||||
| AAA | — | 75 | — | — | 75 | ||||||||||||
| AA | 3,795 | 5,024 | 275 | — | 9,094 | ||||||||||||
| A | 11,952 | 29,626 | 983 | — | 42,561 | ||||||||||||
| BBB | 9,721 | 61,325 | 2,138 | 148 | 73,332 | ||||||||||||
| BB | 2,676 | 30,373 | 3,492 | 1,551 | 38,092 | ||||||||||||
| Other NIG | 868 | 21,087 | 3,651 | 3 | 25,609 | ||||||||||||
Unrated2 | 20 | 88 | 8 | 1 | 117 | ||||||||||||
Total lending commitments | 29,032 | 147,598 | 10,547 | 1,703 | 188,880 | ||||||||||||
| Total exposure | $ | 49,343 | $ | 221,686 | $ | 19,260 | $ | 6,294 | $ | 296,583 | |||||||
| At December 31, 2024 | |||||||||||||||||
| Contractual Years to Maturity | |||||||||||||||||
| $ in millions | < 1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
| Loans | |||||||||||||||||
| AA | $ | 3 | $ | 575 | $ | 187 | $ | — | $ | 765 | |||||||
| A | 894 | 588 | 164 | — | 1,646 | ||||||||||||
| BBB | 5,165 | 13,185 | 91 | 124 | 18,565 | ||||||||||||
| BB | 11,235 | 24,467 | 2,592 | 358 | 38,652 | ||||||||||||
| Other NIG | 8,520 | 12,776 | 1,673 | 145 | 23,114 | ||||||||||||
Unrated2 | 227 | 1,176 | 420 | 2,503 | 4,326 | ||||||||||||
| Total loans, net of ACL | 26,044 | 52,767 | 5,127 | 3,130 | 87,068 | ||||||||||||
| Lending commitments | |||||||||||||||||
| AAA | — | 75 | — | — | 75 | ||||||||||||
| AA | 2,560 | 4,285 | 88 | — | 6,933 | ||||||||||||
| A | 8,226 | 21,372 | 1,091 | — | 30,689 | ||||||||||||
| BBB | 10,135 | 54,752 | 1,507 | 146 | 66,540 | ||||||||||||
| BB | 3,174 | 23,239 | 3,062 | 941 | 30,416 | ||||||||||||
| Other NIG | 1,074 | 17,436 | 3,956 | 2 | 22,468 | ||||||||||||
Unrated2 | 14 | 93 | 33 | — | 140 | ||||||||||||
Total lending commitments | 25,183 | 121,252 | 9,737 | 1,089 | 157,261 | ||||||||||||
| Total exposure | $ | 51,227 | $ | 174,019 | $ | 14,864 | $ | 4,219 | $ | 244,329 | |||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
Industry | ||||||||
| Financials | $ | 83,193 | $ | 68,512 | ||||
| Real estate | 50,923 | 40,041 | ||||||
| Healthcare | 21,725 | 15,455 | ||||||
| Communications Services | 21,292 | 20,425 | ||||||
| Industrials | 20,952 | 20,024 | ||||||
| Information Technology | 17,252 | 15,666 | ||||||
| Consumer staples | 16,851 | 12,098 | ||||||
| Consumer discretionary | 15,504 | 14,699 | ||||||
| Utilities | 13,828 | 11,755 | ||||||
| Energy | 12,946 | 9,036 | ||||||
| Materials | 9,689 | 7,378 | ||||||
| Insurance | 7,443 | 6,812 | ||||||
| Other | 4,985 | 2,428 | ||||||
| Total exposure | $ | 296,583 | $ | 244,329 | ||||
| December 2025 Form 10-K | 68 | |||||||
| Risk Disclosures | ![]() | ||||
| At December 31, 2025 | |||||||||||
| $ in millions | Loans | Lending Commitments | Total | ||||||||
| Corporate | $ | 7,277 | $ | 119,390 | $ | 126,667 | |||||
| Secured lending facilities | 69,149 | 26,947 | 96,096 | ||||||||
| Commercial real estate | 8,039 | 353 | 8,392 | ||||||||
Securities-based lending and Other | 3,780 | 938 | 4,718 | ||||||||
| Total, before ACL | $ | 88,245 | $ | 147,628 | $ | 235,873 | |||||
| ACL | $ | (764) | $ | (780) | $ | (1,544) | |||||
| At December 31, 2024 | |||||||||||
| $ in millions | Loans | Lending Commitments | Total | ||||||||
| Corporate | $ | 6,889 | $ | 105,824 | $ | 112,713 | |||||
| Secured lending facilities | 48,842 | 20,971 | 69,813 | ||||||||
| Commercial real estate | 8,412 | 1,249 | 9,661 | ||||||||
Securities-based lending and Other | 2,876 | 1,504 | 4,380 | ||||||||
| Total, before ACL | $ | 67,019 | $ | 129,548 | $ | 196,567 | |||||
| ACL | $ | (730) | $ | (640) | $ | (1,370) | |||||
| At December 31, 2025 | At December 31, 2024 | ||||||||||||||||||||||
| $ in millions | Loans1 | LC1 | Total | Loans1 | LC1 | Total | |||||||||||||||||
EMEA | $ | 4,320 | $ | 184 | $ | 4,504 | $ | 3,806 | $ | 522 | $ | 4,328 | |||||||||||
Americas | 4,116 | 202 | 4,318 | 5,066 | 820 | 5,886 | |||||||||||||||||
| Asia | 466 | 15 | 481 | 467 | 13 | 480 | |||||||||||||||||
Total | $ | 8,902 | $ | 401 | $ | 9,303 | $ | 9,339 | $ | 1,355 | $ | 10,694 | |||||||||||
| At December 31, 2025 | At December 31, 2024 | ||||||||||||||||||||||
| $ in millions | Loans1 | LC1 | Total | Loans1 | LC1 | Total | |||||||||||||||||
| Industrial | $ | 3,603 | $ | 118 | $ | 3,721 | $ | 2,610 | $ | 125 | $ | 2,735 | |||||||||||
| Office | 2,143 | 132 | 2,275 | 2,846 | 109 | 2,955 | |||||||||||||||||
| Multifamily | 1,729 | 96 | 1,825 | 2,042 | 80 | 2,122 | |||||||||||||||||
| Hotel | 867 | 51 | 918 | 736 | 70 | 806 | |||||||||||||||||
| Retail | 560 | 4 | 564 | 1,105 | 971 | 2,076 | |||||||||||||||||
Total | $ | 8,902 | $ | 401 | $ | 9,303 | $ | 9,339 | $ | 1,355 | $ | 10,694 | |||||||||||
69 | December 2025 Form 10-K | |||||||
| Risk Disclosures | ![]() | ||||
Year Ended December 31, 2025 | |||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | SBL and Other | Total | ||||||||||||
| ACL—Loans | |||||||||||||||||
Beginning balance | $ | 200 | $ | 140 | $ | 373 | $ | 17 | $ | 730 | |||||||
Gross charge-offs | (24) | — | (173) | — | (197) | ||||||||||||
Recoveries | — | — | 22 | — | 22 | ||||||||||||
Net (charge-offs)/recoveries | (24) | — | (151) | — | (175) | ||||||||||||
Provision (release) | 75 | 59 | 47 | 4 | 185 | ||||||||||||
| Other | 9 | 2 | 14 | (1) | 24 | ||||||||||||
| Ending balance | $ | 260 | $ | 201 | $ | 283 | $ | 20 | $ | 764 | |||||||
ACL—Lending commitments | |||||||||||||||||
Beginning balance | $ | 507 | $ | 88 | $ | 40 | $ | 5 | $ | 640 | |||||||
Provision (release) | 101 | 46 | (28) | (2) | 117 | ||||||||||||
| Other | 17 | 3 | — | 3 | 23 | ||||||||||||
Ending balance | $ | 625 | $ | 137 | $ | 12 | $ | 6 | $ | 780 | |||||||
| Total ending balance | $ | 885 | $ | 338 | $ | 295 | $ | 26 | $ | 1,544 | |||||||
| At December 31, 2025 | At December 31, 2024 | |||||||
| Corporate | 3.6 | % | 2.9 | % | ||||
| Secured lending facilities | 0.3 | % | 0.3 | % | ||||
| Commercial real estate | 3.5 | % | 4.4 | % | ||||
| Securities-based lending and Other | 0.5 | % | 0.6 | % | ||||
| Total Institutional Securities loans | 0.9 | % | 1.1 | % | ||||
| At December 31, 2025 | |||||||||||||||||
| Contractual Years to Maturity | |||||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
Securities-based lending and Other | $ | 96,959 | $ | 11,210 | $ | 654 | $ | 137 | $ | 108,960 | |||||||
Residential real estate | 1 | 116 | 989 | 71,175 | 72,281 | ||||||||||||
| Total loans, net of ACL | $ | 96,960 | $ | 11,326 | $ | 1,643 | $ | 71,312 | $ | 181,241 | |||||||
| Lending commitments | 16,907 | 2,889 | 66 | 424 | 20,286 | ||||||||||||
| Total exposure | $ | 113,867 | $ | 14,215 | $ | 1,709 | $ | 71,736 | $ | 201,527 | |||||||
| At December 31, 2024 | |||||||||||||||||
| Contractual Years to Maturity | |||||||||||||||||
| $ in millions | <1 | 1-5 | 5-15 | >15 | Total | ||||||||||||
Securities-based lending and Other | $ | 82,788 | $ | 8,944 | $ | 1,024 | $ | 145 | $ | 92,901 | |||||||
Residential real estate | 1 | 111 | 1,106 | 65,423 | 66,641 | ||||||||||||
| Total loans, net of ACL | $ | 82,789 | $ | 9,055 | $ | 2,130 | $ | 65,568 | $ | 159,542 | |||||||
| Lending commitments | 16,318 | 2,523 | 43 | 386 | 19,270 | ||||||||||||
| Total exposure | $ | 99,107 | $ | 11,578 | $ | 2,173 | $ | 65,954 | $ | 178,812 | |||||||
| At December 31, 2025 | At December 31, 2024 | ||||||||||||||||||||||
| $ in millions | Loans1 | LC1 | Total exposure | Loans1 | LC1 | Total exposure | |||||||||||||||||
| Retail | $ | 2,306 | $ | — | $ | 2,306 | $ | 2,293 | $ | — | $ | 2,293 | |||||||||||
| Office | 2,136 | 1 | 2,137 | 1,951 | 11 | 1,962 | |||||||||||||||||
| Multifamily | 1,701 | 197 | 1,898 | 1,928 | 261 | 2,189 | |||||||||||||||||
| Industrial | 437 | — | 437 | 456 | — | 456 | |||||||||||||||||
| Hotel | 385 | — | 385 | 442 | — | 442 | |||||||||||||||||
| Other | 311 | — | 311 | 309 | — | 309 | |||||||||||||||||
Total | $ | 7,276 | $ | 198 | $ | 7,474 | $ | 7,379 | $ | 272 | $ | 7,651 | |||||||||||
| December 2025 Form 10-K | 70 | |||||||
| Risk Disclosures | ![]() | ||||
Year Ended December 31, 2025 | |||||||||||
| $ in millions | Residential Real Estate | SBL and Other | Total | ||||||||
| ACL—Loans | |||||||||||
| Beginning balance | $ | 97 | $ | 239 | $ | 336 | |||||
| Gross charge-offs | — | (17) | (17) | ||||||||
Provision (release) | 30 | 15 | 45 | ||||||||
| Other | — | 4 | 4 | ||||||||
| Ending balance | $ | 127 | $ | 241 | $ | 368 | |||||
ACL—Lending commitments | |||||||||||
| Beginning balance | $ | 4 | $ | 12 | $ | 16 | |||||
Provision (release) | 1 | 1 | 2 | ||||||||
| Ending balance | $ | 5 | $ | 13 | $ | 18 | |||||
| Total ending balance | $ | 132 | $ | 254 | $ | 386 | |||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Institutional Securities | $ | 52,657 | $ | 27,612 | ||||
| Wealth Management | 31,214 | 28,270 | ||||||
| Total | $ | 83,871 | $ | 55,882 | ||||
| At December 31, 2025 | ||||||||||||||||||||
Counterparty Credit Rating1 | ||||||||||||||||||||
| $ in millions | AAA | AA | A | BBB | NIG | Total | ||||||||||||||
| Less than 1 year | $ | 969 | $ | 12,406 | $ | 41,750 | $ | 19,551 | $ | 10,930 | $ | 85,606 | ||||||||
| 1-3 years | 485 | 5,978 | 16,718 | 9,879 | 7,556 | 40,616 | ||||||||||||||
| 3-5 years | 676 | 6,324 | 9,408 | 7,288 | 3,223 | 26,919 | ||||||||||||||
| Over 5 years | 3,124 | 23,497 | 52,600 | 28,599 | 7,471 | 115,291 | ||||||||||||||
| Total, gross | $ | 5,254 | $ | 48,205 | $ | 120,476 | $ | 65,317 | $ | 29,180 | $ | 268,432 | ||||||||
Counterparty netting | (3,041) | (39,093) | (90,919) | (46,335) | (16,243) | (195,631) | ||||||||||||||
| Cash and securities collateral | (2,114) | (7,346) | (25,473) | (13,043) | (5,669) | (53,645) | ||||||||||||||
| Total, net | $ | 99 | $ | 1,766 | $ | 4,084 | $ | 5,939 | $ | 7,268 | $ | 19,156 | ||||||||
At December 31, 2024 | ||||||||||||||||||||
Counterparty Credit Rating1 | ||||||||||||||||||||
| $ in millions | AAA | AA | A | BBB | NIG | Total | ||||||||||||||
| Less than 1 year | $ | 1,711 | $ | 17,625 | $ | 50,643 | $ | 22,643 | $ | 9,793 | $ | 102,415 | ||||||||
| 1-3 years | 541 | 6,249 | 19,068 | 10,248 | 6,095 | 42,201 | ||||||||||||||
| 3-5 years | 973 | 7,308 | 9,821 | 5,631 | 3,750 | 27,483 | ||||||||||||||
| Over 5 years | 3,330 | 25,406 | 49,469 | 28,206 | 6,398 | 112,809 | ||||||||||||||
| Total, gross | $ | 6,555 | $ | 56,588 | $ | 129,001 | $ | 66,728 | $ | 26,036 | $ | 284,908 | ||||||||
| Counterparty netting | (3,320) | (44,604) | (98,598) | (47,132) | (14,691) | (208,345) | ||||||||||||||
| Cash and securities collateral | (2,559) | (10,632) | (25,568) | (13,729) | (5,558) | (58,046) | ||||||||||||||
| Total, net | $ | 676 | $ | 1,352 | $ | 4,835 | $ | 5,867 | $ | 5,787 | $ | 18,517 | ||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Industry | ||||||||
| Financials | $ | 7,233 | $ | 5,678 | ||||
| Utilities | 3,626 | 3,733 | ||||||
| Industrials | 1,251 | 1,315 | ||||||
| Consumer discretionary | 1,174 | 1,046 | ||||||
| Materials | 804 | 409 | ||||||
| Energy | 756 | 987 | ||||||
| Communications Services | 719 | 914 | ||||||
| Regional governments | 637 | 799 | ||||||
| Healthcare | 618 | 353 | ||||||
| Consumer staples | 541 | 734 | ||||||
| Sovereign governments | 325 | 683 | ||||||
| Real estate | 301 | 91 | ||||||
| Information technology | 230 | 634 | ||||||
| Insurance | 159 | 207 | ||||||
| Not-for-profit organizations | 98 | 94 | ||||||
| Other | 684 | 840 | ||||||
| Total | $ | 19,156 | $ | 18,517 | ||||
71 | December 2025 Form 10-K | |||||||
| Risk Disclosures | ![]() | ||||
| December 2025 Form 10-K | 72 | |||||||
| Risk Disclosures | ![]() | ||||
| At December 31, 2025 | |||||||||||||||||
| $ in millions | United Kingdom | France | Germany | Japan | Brazil | ||||||||||||
| Sovereign | |||||||||||||||||
Net inventory1 | $ | 727 | $ | 5,222 | $ | 1,576 | $ | 2,372 | $ | 5,756 | |||||||
Net counterparty exposure2 | 19 | 2 | 73 | 41 | — | ||||||||||||
| Exposure before hedges | 746 | 5,224 | 1,649 | 2,413 | 5,756 | ||||||||||||
Hedges3 | (21) | (61) | (148) | (144) | (167) | ||||||||||||
| Net exposure | $ | 725 | $ | 5,163 | $ | 1,501 | $ | 2,269 | $ | 5,589 | |||||||
| Non-sovereign | |||||||||||||||||
Net inventory1 | $ | 1,255 | $ | 837 | $ | 174 | $ | 516 | $ | 129 | |||||||
Net counterparty exposure2 | 7,688 | 3,354 | 3,228 | 3,687 | 385 | ||||||||||||
Loans | 13,015 | 425 | 2,657 | 880 | 233 | ||||||||||||
Lending commitments | 10,375 | 4,756 | 6,893 | 284 | 435 | ||||||||||||
Exposure before hedges | 32,333 | 9,372 | 12,952 | 5,367 | 1,182 | ||||||||||||
Hedges3 | (1,749) | (1,506) | (1,559) | (354) | (91) | ||||||||||||
Net exposure | $ | 30,584 | $ | 7,866 | $ | 11,393 | $ | 5,013 | $ | 1,091 | |||||||
| Total net exposure | $ | 31,309 | $ | 13,029 | $ | 12,894 | $ | 7,282 | $ | 6,680 | |||||||
| $ in millions | Australia | Korea | Spain | Netherlands | Canada | ||||||||||||
| Sovereign | |||||||||||||||||
Net inventory1 | $ | 146 | $ | 2,457 | $ | 593 | $ | 322 | $ | 231 | |||||||
Net counterparty exposure2 | 16 | 332 | — | — | 13 | ||||||||||||
Exposure before hedges | 162 | 2,789 | 593 | 322 | 244 | ||||||||||||
Hedges3 | — | (35) | (8) | (12) | — | ||||||||||||
Net exposure | $ | 162 | $ | 2,754 | $ | 585 | $ | 310 | $ | 244 | |||||||
| Non-sovereign | |||||||||||||||||
Net inventory1 | $ | 366 | $ | 175 | $ | 469 | $ | 565 | $ | 776 | |||||||
Net counterparty exposure2 | 745 | 849 | 438 | 711 | 787 | ||||||||||||
Loans | 1,685 | — | 1,477 | 1,105 | 136 | ||||||||||||
Lending commitments | 1,453 | 150 | 917 | 1,078 | 1,749 | ||||||||||||
Exposure before hedges | 4,249 | 1,174 | 3,301 | 3,459 | 3,448 | ||||||||||||
Hedges3 | (416) | (30) | (233) | (143) | (123) | ||||||||||||
Net exposure | $ | 3,833 | $ | 1,144 | $ | 3,068 | $ | 3,316 | $ | 3,325 | |||||||
| Total net exposure | $ | 3,995 | $ | 3,898 | $ | 3,653 | $ | 3,626 | $ | 3,569 | |||||||
73 | December 2025 Form 10-K | |||||||
| Risk Disclosures | ![]() | ||||
| December 2025 Form 10-K | 74 | |||||||
| Risk Disclosures | ![]() | ||||
75 | December 2025 Form 10-K | |||||||
| Risk Disclosures | ![]() | ||||
| December 2025 Form 10-K | 76 | |||||||
| Risk Disclosures | ![]() | ||||
77 | December 2025 Form 10-K | |||||||
| December 2025 Form 10-K | 78 | |||||||
79 | December 2025 Form 10-K | |||||||
| Consolidated Income Statement | ![]() | ||||
| in millions, except per share data | 2025 | 2024 | 2023 | ||||||||
| Revenues | |||||||||||
| Investment banking | $ | $ | $ | ||||||||
| Trading | |||||||||||
| Investments | |||||||||||
| Commissions and fees | |||||||||||
| Asset management | |||||||||||
| Other | |||||||||||
| Total non-interest revenues | |||||||||||
Interest income1 | |||||||||||
Interest expense1 | |||||||||||
| Net interest | |||||||||||
| Net revenues | |||||||||||
| Provision for credit losses | |||||||||||
| Non-interest expenses | |||||||||||
| Compensation and benefits | |||||||||||
| Brokerage, clearing and exchange fees | |||||||||||
| Information processing and communications | |||||||||||
| Professional services | |||||||||||
| Occupancy and equipment | |||||||||||
| Marketing and business development | |||||||||||
| Other | |||||||||||
| Total non-interest expenses | |||||||||||
| Income before provision for income taxes | |||||||||||
| Provision for income taxes | |||||||||||
| Net income | $ | $ | $ | ||||||||
| Net income applicable to noncontrolling interests | |||||||||||
| Net income applicable to Morgan Stanley | $ | $ | $ | ||||||||
| Preferred stock dividends | |||||||||||
| Earnings applicable to Morgan Stanley common shareholders | $ | $ | $ | ||||||||
| Earnings per common share | |||||||||||
| Basic | $ | $ | $ | ||||||||
| Diluted | |||||||||||
| Average common shares outstanding | |||||||||||
| Basic | |||||||||||
| Diluted | |||||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Net income | $ | $ | $ | ||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||
| Foreign currency translation adjustments | ( | ( | |||||||||
| Change in net unrealized gains (losses) on available-for-sale securities | |||||||||||
| Pension and other | ( | ||||||||||
| Change in net debt valuation adjustment | ( | ( | ( | ||||||||
| Net change in cash flow hedges | ( | ||||||||||
| Total other comprehensive income (loss) | $ | $ | ( | $ | ( | ||||||
| Comprehensive income | $ | $ | $ | ||||||||
| Net income applicable to noncontrolling interests | |||||||||||
| Other comprehensive income (loss) applicable to noncontrolling interests | ( | ( | ( | ||||||||
| Comprehensive income applicable to Morgan Stanley | $ | $ | $ | ||||||||
| December 2025 Form 10-K | 80 | See Notes to Consolidated Financial Statements | ||||||
| Consolidated Balance Sheet | ![]() | ||||
| $ in millions, except share data | At December 31, 2025 | At December 31, 2024 | ||||||
| Assets | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
Trading assets at fair value ($ | ||||||||
Investment securities: | ||||||||
Available-for-sale at fair value (amortized cost of $ | ||||||||
Held-to-maturity (fair value of $ | ||||||||
Securities purchased under agreements to resell (includes $ | ||||||||
| Securities borrowed | ||||||||
| Customer and other receivables | ||||||||
| Loans: | ||||||||
Held for investment (net of allowance for credit losses of $ | ||||||||
| Held for sale | ||||||||
| Goodwill | ||||||||
Intangible assets (net of accumulated amortization of $ | ||||||||
| Other assets | ||||||||
| Total assets | $ | $ | ||||||
| Liabilities | ||||||||
Deposits (includes $ | $ | $ | ||||||
| Trading liabilities at fair value | ||||||||
Securities sold under agreements to repurchase (includes $ | ||||||||
| Securities loaned | ||||||||
Other secured financings (includes $ | ||||||||
| Customer and other payables | ||||||||
| Other liabilities and accrued expenses | ||||||||
Borrowings (includes $ | ||||||||
| Total liabilities | ||||||||
| Commitments and contingent liabilities (see Note 14) | ||||||||
| Equity | ||||||||
| Morgan Stanley shareholders’ equity: | ||||||||
| Preferred stock | ||||||||
Common stock, $ | ||||||||
Shares authorized: | ||||||||
| Additional paid-in capital | ||||||||
| Retained earnings | ||||||||
| Employee stock trusts | ||||||||
| Accumulated other comprehensive income (loss) | ( | ( | ||||||
Common stock held in treasury at cost, $ | ( | ( | ||||||
| Common stock issued to employee stock trusts | ( | ( | ||||||
| Total Morgan Stanley shareholders’ equity | ||||||||
| Noncontrolling interests | ||||||||
| Total equity | ||||||||
| Total liabilities and equity | $ | $ | ||||||
| See Notes to Consolidated Financial Statements | 81 | December 2025 Form 10-K | ||||||
| Consolidated Statement of Changes in Total Equity | ![]() | ||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
Preferred stock | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Issuance of preferred stock | |||||||||||
| Ending balance | |||||||||||
Common stock | |||||||||||
| Beginning and ending balance | |||||||||||
Additional paid-in capital | |||||||||||
| Beginning balance | |||||||||||
| Share-based award activity | |||||||||||
| Issuance of preferred stock | ( | ||||||||||
| Ending balance | |||||||||||
Retained earnings | |||||||||||
| Beginning balance | |||||||||||
Cumulative adjustment related to the adoption of accounting standard update1 | ( | ||||||||||
| Net income applicable to Morgan Stanley | |||||||||||
Preferred stock dividends2 | ( | ( | ( | ||||||||
Common stock dividends2 | ( | ( | ( | ||||||||
| Other net increases (decreases) | ( | ( | |||||||||
| Ending balance | |||||||||||
Employee stock trusts | |||||||||||
| Beginning balance | |||||||||||
| Share-based award activity | ( | ||||||||||
| Ending balance | |||||||||||
Accumulated other comprehensive income (loss) | |||||||||||
| Beginning balance | ( | ( | ( | ||||||||
| Net change in Accumulated other comprehensive income (loss) | ( | ( | |||||||||
| Ending balance | ( | ( | ( | ||||||||
Common stock held in treasury at cost | |||||||||||
| Beginning balance | ( | ( | ( | ||||||||
| Share-based award activity | |||||||||||
| Repurchases of common stock and employee tax withholdings | ( | ( | ( | ||||||||
| Ending balance | ( | ( | ( | ||||||||
Common stock issued to employee stock trusts | |||||||||||
| Beginning balance | ( | ( | ( | ||||||||
| Share-based award activity | ( | ( | |||||||||
| Ending balance | ( | ( | ( | ||||||||
Noncontrolling interests | |||||||||||
| Beginning balance | |||||||||||
| Net income applicable to noncontrolling interests | |||||||||||
| Net change in Accumulated other comprehensive income (loss) applicable to noncontrolling interests | ( | ( | ( | ||||||||
| Other net increases (decreases) | ( | ( | ( | ||||||||
| Ending balance | |||||||||||
Total equity | $ | $ | $ | ||||||||
| December 2025 Form 10-K | 82 | See Notes to Consolidated Financial Statements | ||||||
| Consolidated Cash Flow Statement | ![]() | ||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Cash flows from operating activities | |||||||||||
| Net income | $ | $ | $ | ||||||||
| Adjustments to reconcile net income to net cash provided by (used for) operating activities: | |||||||||||
| Deferred income taxes | ( | ||||||||||
| Stock-based compensation expense | |||||||||||
| Depreciation and amortization | |||||||||||
| Provision for credit losses | |||||||||||
| Other operating adjustments | |||||||||||
| Changes in assets and liabilities: | |||||||||||
| Trading assets, net of Trading liabilities | ( | ( | |||||||||
| Securities borrowed | ( | ( | |||||||||
| Securities loaned | ( | ||||||||||
| Customer and other receivables and other assets | ( | ( | |||||||||
| Customer and other payables and other liabilities | ( | ( | |||||||||
| Securities purchased under agreements to resell | ( | ( | |||||||||
| Securities sold under agreements to repurchase | ( | ||||||||||
| Net cash provided by (used for) operating activities | ( | ( | |||||||||
| Cash flows from investing activities | |||||||||||
| Proceeds from (payments for): | |||||||||||
| Other assets—Premises, equipment and software | ( | ( | ( | ||||||||
| Changes in loans, net | ( | ( | ( | ||||||||
| AFS securities: | |||||||||||
| Purchases | ( | ( | ( | ||||||||
| Proceeds from sales | |||||||||||
| Proceeds from paydowns and maturities | |||||||||||
| HTM securities: | |||||||||||
| Purchases | ( | ||||||||||
| Proceeds from paydowns and maturities | |||||||||||
| Other investing activities | ( | ( | ( | ||||||||
| Net cash provided by (used for) investing activities | ( | ( | ( | ||||||||
| Cash flows from financing activities | |||||||||||
| Net proceeds from (payments for): | |||||||||||
| Other secured financings | |||||||||||
| Deposits | ( | ||||||||||
| Issuance of preferred stock, net of issuance costs | |||||||||||
| Proceeds from issuance of Borrowings | |||||||||||
| Payments for: | |||||||||||
| Borrowings | ( | ( | ( | ||||||||
| Repurchases of common stock and employee tax withholdings | ( | ( | ( | ||||||||
| Cash dividends | ( | ( | ( | ||||||||
| Other financing activities | ( | ( | |||||||||
| Net cash provided by (used for) financing activities | ( | ||||||||||
| Effect of exchange rate changes on cash and cash equivalents | ( | ||||||||||
| Net increase (decrease) in cash and cash equivalents | ( | ||||||||||
| Cash and cash equivalents, at beginning of period | |||||||||||
| Cash and cash equivalents, at end of period | $ | $ | $ | ||||||||
| Supplemental Disclosure of Cash Flow Information | |||||||||||
| Cash payments for: | |||||||||||
| Interest | $ | $ | $ | ||||||||
| Income taxes, net of refunds | |||||||||||
| See Notes to Consolidated Financial Statements | 83 | December 2025 Form 10-K | ||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| December 2025 Form 10-K | 84 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
85 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| December 2025 Form 10-K | 86 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
87 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| December 2025 Form 10-K | 88 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
89 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| ACL | Provision for Credit Losses | |||||||
| AFS securities | Contra investment securities | Other revenue | ||||||
| December 2025 Form 10-K | 90 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
91 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| ACL | Provision for Credit Losses | |||||||
| Held for investment loans | Contra asset | Provision for credit losses | ||||||
Other instruments measured at amortized cost (e.g., HTM securities and customer and other receivables) | Contra asset | Other revenues | ||||||
| Employee loans | Contra asset | Compensation and benefits expenses | ||||||
| Held for investment lending commitments | Other liabilities and accrued expenses | Provision for credit losses | ||||||
Other off-balance sheet instruments (e.g., certain guarantees) | Other liabilities and accrued expenses | Other expenses | ||||||
| December 2025 Form 10-K | 92 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| in years | Estimated Useful Life | ||||
| Buildings | |||||
| Leasehold improvements—Building | term of lease to | ||||
| Leasehold improvements—Other | term of lease to | ||||
| Furniture and fixtures | |||||
| Computer and communications equipment | |||||
| Power generation assets | |||||
| Capitalized software costs | |||||
93 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| December 2025 Form 10-K | 94 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Cash and due from banks | $ | $ | ||||||
| Interest bearing deposits with banks | ||||||||
| Total Cash and cash equivalents | $ | $ | ||||||
| Restricted cash | $ | $ | ||||||
95 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | |||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Netting1 | Total | ||||||||||||
| Assets at fair value | |||||||||||||||||
| Trading assets: | |||||||||||||||||
| U.S. Treasury and agency securities | $ | $ | $ | $ | — | $ | |||||||||||
| Other sovereign government obligations | — | ||||||||||||||||
| State and municipal securities | — | ||||||||||||||||
| MABS | — | ||||||||||||||||
Loans and lending commitments2 | — | ||||||||||||||||
| Corporate and other debt | — | ||||||||||||||||
Corporate equities3,5 | — | ||||||||||||||||
| Derivative and other contracts: | |||||||||||||||||
| Interest rate | — | ||||||||||||||||
| Credit | — | ||||||||||||||||
| Foreign exchange | — | ||||||||||||||||
| Equity | — | ||||||||||||||||
| Commodity and other | — | ||||||||||||||||
Netting1 | ( | ( | ( | ( | ( | ||||||||||||
| Total derivative and other contracts | ( | ||||||||||||||||
Investments4,5 | — | ||||||||||||||||
| Physical commodities | — | ||||||||||||||||
Total trading assets4 | ( | ||||||||||||||||
| Investment securities —AFS | — | ||||||||||||||||
| Total assets at fair value | $ | $ | $ | $ | ( | $ | |||||||||||
| At December 31, 2025 | |||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Netting1 | Total | ||||||||||||
| Liabilities at fair value | |||||||||||||||||
| Deposits | $ | $ | $ | $ | — | $ | |||||||||||
| Trading liabilities: | |||||||||||||||||
| U.S. Treasury and agency securities | — | ||||||||||||||||
| Other sovereign government obligations | — | ||||||||||||||||
| Corporate and other debt | — | ||||||||||||||||
Corporate equities3 | — | ||||||||||||||||
| Derivative and other contracts: | |||||||||||||||||
| Interest rate | — | ||||||||||||||||
| Credit | — | ||||||||||||||||
| Foreign exchange | — | ||||||||||||||||
| Equity | — | ||||||||||||||||
| Commodity and other | — | ||||||||||||||||
Netting1 | ( | ( | ( | ( | ( | ||||||||||||
| Total derivative and other contracts | ( | ||||||||||||||||
| Total trading liabilities | ( | ||||||||||||||||
| Securities sold under agreements to repurchase | — | ||||||||||||||||
| Other secured financings | — | ||||||||||||||||
| Borrowings | — | ||||||||||||||||
| Total liabilities at fair value | $ | $ | $ | $ | ( | $ | |||||||||||
| At December 31, 2024 | |||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Netting1 | Total | ||||||||||||
| Assets at fair value | |||||||||||||||||
| Trading assets: | |||||||||||||||||
| U.S. Treasury and agency securities | $ | $ | $ | $ | — | $ | |||||||||||
| Other sovereign government obligations | — | ||||||||||||||||
| State and municipal securities | — | ||||||||||||||||
| MABS | — | ||||||||||||||||
Loans and lending commitments2 | — | ||||||||||||||||
| Corporate and other debt | — | ||||||||||||||||
Corporate equities3,5 | — | ||||||||||||||||
| Derivative and other contracts: | |||||||||||||||||
| Interest rate | — | ||||||||||||||||
| Credit | — | ||||||||||||||||
| Foreign exchange | — | ||||||||||||||||
| Equity | — | ||||||||||||||||
| Commodity and other | — | ||||||||||||||||
Netting1 | ( | ( | ( | ( | ( | ||||||||||||
| Total derivative and other contracts | ( | ||||||||||||||||
Investments4,5 | — | ||||||||||||||||
| Physical commodities | — | ||||||||||||||||
Total trading assets4 | ( | ||||||||||||||||
| Investment securities —AFS | — | ||||||||||||||||
| Total assets at fair value | $ | $ | $ | $ | ( | $ | |||||||||||
| December 2025 Form 10-K | 96 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2024 | |||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Netting1 | Total | ||||||||||||
| Liabilities at fair value | |||||||||||||||||
| Deposits | $ | $ | $ | $ | — | $ | |||||||||||
| Trading liabilities: | |||||||||||||||||
| U.S. Treasury and agency securities | — | ||||||||||||||||
| Other sovereign government obligations | — | ||||||||||||||||
| Corporate and other debt | — | ||||||||||||||||
Corporate equities3 | — | ||||||||||||||||
| Derivative and other contracts: | |||||||||||||||||
| Interest rate | — | ||||||||||||||||
| Credit | — | ||||||||||||||||
| Foreign exchange | — | ||||||||||||||||
| Equity | — | ||||||||||||||||
| Commodity and other | — | ||||||||||||||||
Netting1 | ( | ( | ( | ( | ( | ||||||||||||
| Total derivative and other contracts | ( | ||||||||||||||||
| Total trading liabilities | ( | ||||||||||||||||
| Securities sold under agreements to repurchase | — | ||||||||||||||||
| Other secured financings | — | ||||||||||||||||
| Borrowings | — | ||||||||||||||||
| Total liabilities at fair value | $ | $ | $ | $ | ( | $ | |||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Commercial real estate | $ | $ | ||||||
| Residential real estate | ||||||||
| Securities-based lending and Other loans | ||||||||
| Total | $ | $ | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
Customer and other receivables (payables), net | $ | $ | ||||||
97 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| December 2025 Form 10-K | 98 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
99 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| December 2025 Form 10-K | 100 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| U.S. Treasury and agency securities | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Sales | ( | ||||||||||
| Net transfers | ( | ||||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized gains (losses) | $ | $ | $ | ||||||||
| Other sovereign government obligations | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized gains (losses) | ( | ( | |||||||||
| Purchases | |||||||||||
| Sales | ( | ( | |||||||||
| Net transfers | ( | ( | |||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized gains (losses) | $ | ( | $ | ( | $ | ||||||
| State and municipal securities | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Purchases | |||||||||||
| Sales | ( | ( | |||||||||
| Net transfers | ( | ( | |||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized gains (losses) | $ | $ | $ | ||||||||
| MABS | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized gains (losses) | ( | ||||||||||
| Purchases | |||||||||||
| Sales | ( | ( | ( | ||||||||
| Net transfers | ( | ||||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized gains (losses) | $ | $ | ( | $ | ( | ||||||
| Loans and lending commitments | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized gains (losses) | ( | ( | ( | ||||||||
| Purchases and originations | |||||||||||
| Sales | ( | ( | ( | ||||||||
| Settlements | ( | ( | |||||||||
Net transfers | ( | ||||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized gains (losses) | $ | $ | ( | $ | ( | ||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Corporate and other debt | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized gains (losses) | ( | ( | |||||||||
| Purchases and originations | |||||||||||
| Sales | ( | ( | ( | ||||||||
| Settlements | ( | ( | |||||||||
Net transfers | ( | ( | ( | ||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized gains (losses) | $ | $ | $ | ( | |||||||
| Corporate equities | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized gains (losses) | ( | ( | |||||||||
| Purchases | |||||||||||
| Sales | ( | ( | ( | ||||||||
| Net transfers | |||||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized gains (losses) | $ | $ | ( | $ | |||||||
| Investments | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized gains (losses) | |||||||||||
| Purchases | |||||||||||
| Sales | ( | ( | ( | ||||||||
| Net transfers | ( | ||||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized gains (losses) | $ | $ | ( | $ | |||||||
| Investment securities—AFS | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Sales | ( | ||||||||||
Net transfers | ( | ||||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized gains (losses) | $ | $ | $ | ||||||||
| Net derivatives: Interest rate | |||||||||||
| Beginning balance | $ | ( | $ | ( | $ | ( | |||||
| Realized and unrealized gains (losses) | ( | ( | |||||||||
| Purchases | |||||||||||
| Issuances | ( | ( | ( | ||||||||
| Settlements | ( | ||||||||||
| Net transfers | |||||||||||
| Ending balance | $ | ( | $ | ( | $ | ( | |||||
| Unrealized gains (losses) | $ | ( | $ | ( | $ | ( | |||||
| Net derivatives: Credit | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized gains (losses) | ( | ( | |||||||||
| Issuances | ( | ||||||||||
| Settlements | ( | ||||||||||
| Net transfers | ( | ||||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized gains (losses) | $ | ( | $ | ( | $ | ||||||
| Net derivatives: Foreign exchange | |||||||||||
| Beginning balance | $ | $ | ( | $ | |||||||
| Realized and unrealized gains (losses) | ( | ||||||||||
| Purchases | |||||||||||
| Issuances | ( | ( | |||||||||
| Settlements | ( | ( | ( | ||||||||
| Net transfers | ( | ( | |||||||||
| Ending balance | $ | $ | $ | ( | |||||||
| Unrealized gains (losses) | $ | $ | $ | ( | |||||||
101 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Net derivatives: Equity | |||||||||||
| Beginning balance | $ | ( | $ | ( | $ | ( | |||||
| Realized and unrealized gains (losses) | ( | ( | |||||||||
| Purchases | |||||||||||
| Issuances | ( | ( | ( | ||||||||
| Settlements | |||||||||||
Net transfers | ( | ||||||||||
| Ending balance | $ | ( | $ | ( | $ | ( | |||||
| Unrealized gains (losses) | $ | ( | $ | $ | ( | ||||||
| Net derivatives: Commodity and other | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized gains (losses) | ( | ||||||||||
| Purchases | |||||||||||
| Issuances | ( | ( | ( | ||||||||
| Settlements | ( | ( | |||||||||
| Net transfers | ( | ||||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized gains (losses) | $ | $ | ( | $ | |||||||
| Deposits | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized losses (gains) | |||||||||||
| Issuances | |||||||||||
| Settlements | ( | ||||||||||
| Net transfers | ( | ( | |||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized losses (gains) | $ | $ | $ | ||||||||
| Nonderivative trading liabilities | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized losses (gains) | ( | ( | |||||||||
| Purchases | ( | ( | ( | ||||||||
| Sales | |||||||||||
| Net transfers | ( | ( | |||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized losses (gains) | $ | ( | $ | ( | $ | ||||||
| Securities sold under agreements to repurchase | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized losses (gains) | ( | ||||||||||
| Issuances | |||||||||||
| Settlements | ( | ||||||||||
| Net transfers | ( | ||||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized losses (gains) | $ | $ | ( | $ | |||||||
| Other secured financings | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized losses (gains) | ( | ( | |||||||||
| Sales | ( | ( | |||||||||
| Issuances | |||||||||||
| Settlements | ( | ( | ( | ||||||||
| Net transfers | |||||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized losses (gains) | $ | ( | $ | ( | $ | ||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Borrowings | |||||||||||
| Beginning balance | $ | $ | $ | ||||||||
| Realized and unrealized losses (gains) | |||||||||||
| Issuances | |||||||||||
| Settlements | ( | ( | ( | ||||||||
Net transfers | ( | ( | ( | ||||||||
| Ending balance | $ | $ | $ | ||||||||
| Unrealized losses (gains) | $ | $ | $ | ||||||||
Balance / Range (Average1) | ||||||||
$ in millions, except inputs | At December 31, 2025 | At December 31, 2024 | ||||||
| Assets at Fair Value on a Recurring Basis | ||||||||
| Other sovereign government obligations | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Bond price | ||||||||
| MABS | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Bond price | ||||||||
Loans and lending commitments | $ | $ | ||||||
| Margin loan model: | ||||||||
| Margin loan rate | N/M | |||||||
| Comparable pricing: | ||||||||
| Loan price | ||||||||
Corporate and other debt | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Bond price | ||||||||
| Discounted cash flow: | ||||||||
| Loss given default | ||||||||
| December 2025 Form 10-K | 102 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
Balance / Range (Average1) | ||||||||
$ in millions, except inputs | At December 31, 2025 | At December 31, 2024 | ||||||
| Corporate equities | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Equity price | ||||||||
| Investments | $ | $ | ||||||
| Discounted cash flow: | ||||||||
| WACC | ||||||||
| Exit multiple | ||||||||
| Market approach: | ||||||||
| EBITDA multiple | ||||||||
| Comparable pricing: | ||||||||
| Equity price | ||||||||
| Net derivative and other contracts: | ||||||||
| Interest rate | $ | ( | $ | ( | ||||
| Option model: | ||||||||
| IR volatility skew | ||||||||
| IR curve correlation | ||||||||
| Bond volatility | ||||||||
Inflation volatility | ||||||||
| Credit | $ | $ | ||||||
| Credit default swap model: | ||||||||
| Cash-synthetic basis | ||||||||
| Bond price | ||||||||
| Credit spread | ||||||||
| Funding spread | ||||||||
Foreign exchange2 | $ | $ | ||||||
| Option model: | ||||||||
| IR curve | - | |||||||
| Foreign exchange volatility skew | N/M | |||||||
| Contingency probability | ||||||||
Equity2 | $ | ( | $ | ( | ||||
| Option model: | ||||||||
| Equity volatility | ||||||||
| Equity volatility skew | - | - | ||||||
| Equity correlation | ||||||||
| FX correlation | - | - | ||||||
| IR correlation | ( | N/M | ||||||
| Commodity and other | $ | $ | ||||||
| Option model: | ||||||||
| Forward power price | $ | $ | ||||||
| Commodity volatility | ||||||||
| Cross-commodity correlation | ||||||||
| Liabilities at Fair Value on a Recurring Basis | ||||||||
Corporate and other debt | $ | N/M | ||||||
| Comparable pricing: | ||||||||
| Bond price | N/M | |||||||
| Securities sold under agreements to repurchase | $ | $ | ||||||
| Discounted cash flow: | ||||||||
| Funding spread | ||||||||
| Other secured financings | $ | $ | ||||||
| Comparable pricing: | ||||||||
| Loan price | ||||||||
Balance / Range (Average1) | ||||||||
$ in millions, except inputs | At December 31, 2025 | At December 31, 2024 | ||||||
| Borrowings | $ | $ | ||||||
| Option model: | ||||||||
| Equity volatility | ||||||||
| Equity volatility skew | - | - | ||||||
| Equity correlation | ||||||||
| Equity - FX correlation | - | - | ||||||
| Credit default swap model: | ||||||||
| Credit spread | ||||||||
| Discounted cash flow: | ||||||||
| Loss given default | ||||||||
| Nonrecurring Fair Value Measurement | ||||||||
| Loans | $ | $ | ||||||
| Corporate loan model: | ||||||||
| Credit spread | ||||||||
| Comparable pricing: | ||||||||
| Loan price | ||||||||
| Warehouse model: | ||||||||
| Credit spread | ||||||||
103 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | At December 31, 2024 | |||||||||||||
| $ in millions | Carrying Value | Commitment | Carrying Value | Commitment | ||||||||||
| Private equity and other | $ | $ | $ | $ | ||||||||||
| Real estate | ||||||||||||||
| Hedge | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| December 2025 Form 10-K | 104 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| Carrying Value at December 31, 2025 | ||||||||
| $ in millions | Private Equity and Other | Real Estate | ||||||
| Less than 5 years | $ | $ | ||||||
| 5-10 years | ||||||||
| Over 10 years | ||||||||
| Total | $ | $ | ||||||
| At December 31, 2025 | |||||||||||
| $ in millions | Level 2 | Level 31 | Total | ||||||||
| Assets | |||||||||||
| Loans | $ | $ | $ | ||||||||
| Other assets—Other investments | |||||||||||
| Other assets—ROU assets | |||||||||||
| Total | $ | $ | $ | ||||||||
| Liabilities | |||||||||||
| Other liabilities and accrued expenses—Lending commitments | $ | $ | $ | ||||||||
| Total | $ | $ | $ | ||||||||
| At December 31, 2024 | |||||||||||
| $ in millions | Level 2 | Level 31 | Total | ||||||||
| Assets | |||||||||||
| Loans | $ | $ | $ | ||||||||
| Other assets—Other investments | |||||||||||
| Other assets—ROU assets | |||||||||||
| Total | $ | $ | $ | ||||||||
| Liabilities | |||||||||||
| Other liabilities and accrued expenses—Lending commitments | $ | $ | $ | ||||||||
| Total | $ | $ | $ | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Assets | |||||||||||
Loans2 | $ | ( | $ | ( | $ | ( | |||||
Other assets—Other investments3 | ( | ( | ( | ||||||||
Other assets—Premises, equipment and software4 | ( | ( | ( | ||||||||
Other assets—ROU assets5 | ( | ( | ( | ||||||||
| Total | $ | ( | $ | ( | $ | ( | |||||
| Liabilities | |||||||||||
Other liabilities and accrued expenses—Lending commitments2 | $ | $ | $ | ||||||||
| Total | $ | $ | $ | ||||||||
105 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | |||||||||||||||||
| Carrying Value | Fair Value | ||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Financial assets | |||||||||||||||||
| Cash and cash equivalents | $ | $ | $ | $ | $ | ||||||||||||
| Investment securities—HTM | |||||||||||||||||
Securities purchased under agreements to resell | |||||||||||||||||
| Securities borrowed | |||||||||||||||||
| Customer and other receivables | |||||||||||||||||
Loans1: | |||||||||||||||||
Held for investment | |||||||||||||||||
Held for sale | |||||||||||||||||
| Other assets | |||||||||||||||||
| Financial liabilities | |||||||||||||||||
| Deposits | $ | $ | $ | $ | $ | ||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||
| Securities loaned | |||||||||||||||||
| Other secured financings | |||||||||||||||||
| Customer and other payables | |||||||||||||||||
| Borrowings | |||||||||||||||||
| Commitment Amount | |||||||||||||||||
Lending commitments2 | $ | $ | $ | $ | $ | ||||||||||||
| At December 31, 2024 | |||||||||||||||||
| Carrying Value | Fair Value | ||||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Total | |||||||||||||
| Financial assets | |||||||||||||||||
| Cash and cash equivalents | $ | $ | $ | $ | $ | ||||||||||||
| Investment securities—HTM | |||||||||||||||||
Securities purchased under agreements to resell | |||||||||||||||||
| Securities borrowed | |||||||||||||||||
| Customer and other receivables | |||||||||||||||||
Loans1: | |||||||||||||||||
| Held for investment | |||||||||||||||||
Held for sale | |||||||||||||||||
| Other assets | |||||||||||||||||
| Financial liabilities | |||||||||||||||||
| Deposits | $ | $ | $ | $ | $ | ||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||
| Securities loaned | |||||||||||||||||
| Other secured financings | |||||||||||||||||
| Customer and other payables | |||||||||||||||||
| Borrowings | |||||||||||||||||
| Commitment Amount | |||||||||||||||||
Lending commitments2 | $ | $ | $ | $ | $ | ||||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Business Unit Responsible for Risk Management | ||||||||
| Equity | $ | $ | ||||||
| Interest rates | ||||||||
| Commodities | ||||||||
| Credit | ||||||||
| Foreign exchange | ||||||||
| Total | $ | $ | ||||||
| $ in millions | Trading Revenues | Interest Expense | Net Revenues1 | ||||||||
| 2025 | |||||||||||
| Borrowings | $ | ( | $ | $ | ( | ||||||
| Deposits | ( | ( | |||||||||
| 2024 | |||||||||||
| Borrowings | ( | ( | |||||||||
| Deposits | ( | ( | |||||||||
| 2023 | |||||||||||
| Borrowings | ( | ( | |||||||||
| $ in millions | Trading Revenues | OCI | ||||||
| 2025 | ||||||||
Loans and other receivables1 | $ | ( | $ | |||||
| Lending commitments | ( | |||||||
| Deposits | ||||||||
| Borrowings | ( | ( | ||||||
| 2024 | ||||||||
Loans and other receivables1 | $ | ( | $ | |||||
| Lending commitments | ( | |||||||
| Deposits | ( | |||||||
| Borrowings | ( | ( | ||||||
| 2023 | ||||||||
Loans and other receivables1 | $ | ( | $ | |||||
| Lending commitments | ||||||||
| Deposits | ||||||||
| Borrowings | ( | ( | ||||||
| December 2025 Form 10-K | 106 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Cumulative pre-tax DVA gain (loss) recognized in AOCI | $ | ( | $ | ( | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
Loans and other receivables2 | $ | $ | ||||||
Nonaccrual loans2 | ||||||||
Borrowings3 | ||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Nonaccrual loans | $ | $ | ||||||
Nonaccrual loans 90 or more days past due | $ | $ | ||||||
Assets at December 31, 2025 | ||||||||||||||
| $ in millions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Amounts offset | ||||||||||||||
| Counterparty netting | ( | ( | ( | ( | ||||||||||
| Cash collateral netting | ( | ( | ( | |||||||||||
| Total in Trading assets | $ | $ | $ | $ | ||||||||||
Amounts not offset1 | ||||||||||||||
| Financial instruments collateral | ( | ( | ||||||||||||
| Net amounts | $ | $ | $ | $ | ||||||||||
Amounts for which master netting or collateral agreements are not in place or may not be legally enforceable, included in Net amounts | $ | |||||||||||||
Liabilities at December 31, 2025 | ||||||||||||||
| $ in millions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Amounts offset | ||||||||||||||
| Counterparty netting | ( | ( | ( | ( | ||||||||||
| Cash collateral netting | ( | ( | ( | |||||||||||
| $ | $ | $ | $ | |||||||||||
Amounts not offset1 | ||||||||||||||
| Financial instruments collateral | ( | ( | ( | ( | ||||||||||
| Net amounts | $ | $ | $ | $ | ||||||||||
Amounts for which master netting or collateral agreements are not in place or may not be legally enforceable, included in Net amounts | $ | |||||||||||||
107 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
Assets at December 31, 2024 | ||||||||||||||
| $ in millions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Amounts offset | ||||||||||||||
| Counterparty netting | ( | ( | ( | ( | ||||||||||
| Cash collateral netting | ( | ( | ( | |||||||||||
| Total in Trading assets | $ | $ | $ | $ | ||||||||||
Amounts not offset1 | ||||||||||||||
| Financial instruments collateral | ( | ( | ||||||||||||
| Net amounts | $ | $ | $ | $ | ||||||||||
Amounts for which master netting or collateral agreements are not in place or may not be legally enforceable, included in Net amounts | $ | |||||||||||||
Liabilities at December 31, 2024 | ||||||||||||||
| $ in millions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| Amounts offset | ||||||||||||||
| Counterparty netting | ( | ( | ( | ( | ||||||||||
| Cash collateral netting | ( | ( | ( | |||||||||||
| $ | $ | $ | $ | |||||||||||
Amounts not offset1 | ||||||||||||||
| Financial instruments collateral | ( | ( | ( | |||||||||||
| Net amounts | $ | $ | $ | $ | ||||||||||
Amounts for which master netting or collateral agreements are not in place or may not be legally enforceable, included in Net amounts | $ | |||||||||||||
Assets at December 31, 2025 | ||||||||||||||
| $ in billions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
Liabilities at December 31, 2025 | ||||||||||||||
| $ in billions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
Assets at December 31, 2024 | ||||||||||||||
| $ in billions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| December 2025 Form 10-K | 108 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
Liabilities at December 31, 2024 | ||||||||||||||
| $ in billions | Bilateral OTC | Cleared OTC | Exchange- Traded | Total | ||||||||||
| Designated as accounting hedges | ||||||||||||||
| Interest rate | $ | $ | $ | $ | ||||||||||
| Foreign exchange | ||||||||||||||
| Total | ||||||||||||||
| Not designated as accounting hedges | ||||||||||||||
| Economic hedges of loans | ||||||||||||||
| Credit | ||||||||||||||
| Other derivatives | ||||||||||||||
| Interest rate | ||||||||||||||
| Credit | ||||||||||||||
| Foreign exchange | ||||||||||||||
| Equity | ||||||||||||||
| Commodity and other | ||||||||||||||
| Total | ||||||||||||||
| Total gross derivatives | $ | $ | $ | $ | ||||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Fair value hedges—Recognized in Interest income | |||||||||||
| Interest rate contracts | $ | ( | $ | $ | ( | ||||||
| Investment Securities—AFS | ( | ||||||||||
| Fair value hedges—Recognized in Interest expense | |||||||||||
| Interest rate contracts | $ | $ | ( | $ | |||||||
| Deposits | ( | ( | ( | ||||||||
| Borrowings | ( | ( | |||||||||
| Net investment hedges—Foreign exchange contracts | |||||||||||
| Recognized in OCI | $ | ( | $ | $ | ( | ||||||
Forward points excluded from hedge effectiveness testing—Recognized in Interest income | |||||||||||
Cash flow hedges—Interest rate contracts1 | |||||||||||
| Recognized in OCI | $ | ( | $ | ( | $ | ||||||
Less: Realized gains (losses) (pre-tax) reclassified from AOCI to interest income | ( | ( | ( | ||||||||
| Net change in cash flow hedges included within AOCI | ( | ||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Investment securities—AFS | ||||||||
Amortized cost basis currently or previously hedged1 | $ | $ | ||||||
Basis adjustments included in amortized cost2 | $ | $ | ( | |||||
| Deposits | ||||||||
| Carrying amount currently or previously hedged | $ | $ | ||||||
Basis adjustments included in carrying amount2 | $ | $ | ||||||
| Borrowings | ||||||||
| Carrying amount currently or previously hedged | $ | $ | ||||||
| Basis adjustments included in carrying amount—Outstanding hedges | $ | ( | $ | ( | ||||
Basis adjustments included in carrying amount—Terminated hedges | $ | ( | $ | ( | ||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Recognized in Other revenues | |||||||||||
Credit contracts1 | ( | ( | ( | ||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Net derivative liabilities with credit risk-related contingent features | $ | $ | ||||||
| Collateral posted | ||||||||
| $ in millions | At December 31, 2025 | ||||
| One-notch downgrade | $ | ||||
| Two-notch downgrade | |||||
Bilateral downgrade agreements included in the amounts above1 | $ | ||||
109 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| Years to Maturity at December 31, 2025 | |||||||||||||||||
| $ in billions | < 1 | 1-3 | 3-5 | Over 5 | Total | ||||||||||||
| Single-name CDS | |||||||||||||||||
| Investment grade | $ | $ | $ | $ | $ | ||||||||||||
| Non-investment grade | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Index and basket CDS | |||||||||||||||||
| Investment grade | $ | $ | $ | $ | $ | ||||||||||||
| Non-investment grade | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Total CDS sold | $ | $ | $ | $ | $ | ||||||||||||
| Other credit contracts | |||||||||||||||||
| Total credit protection sold | $ | $ | $ | $ | $ | ||||||||||||
| CDS protection sold with identical protection purchased | $ | ||||||||||||||||
| Years to Maturity at December 31, 2024 | |||||||||||||||||
| $ in billions | < 1 | 1-3 | 3-5 | Over 5 | Total | ||||||||||||
| Single-name CDS | |||||||||||||||||
| Investment grade | $ | $ | $ | $ | $ | ||||||||||||
| Non-investment grade | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Index and basket CDS | |||||||||||||||||
| Investment grade | $ | $ | $ | $ | $ | ||||||||||||
| Non-investment grade | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Total CDS sold | $ | $ | $ | $ | $ | ||||||||||||
| Other credit contracts | |||||||||||||||||
| Total credit protection sold | $ | $ | $ | $ | $ | ||||||||||||
| CDS protection sold with identical protection purchased | $ | ||||||||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Single-name CDS | ||||||||
| Investment grade | $ | $ | ||||||
| Non-investment grade | ||||||||
| Total | $ | $ | ||||||
| Index and basket CDS | ||||||||
| Investment grade | $ | $ | ||||||
| Non-investment grade | ||||||||
| Total | $ | $ | ||||||
| Total CDS sold | $ | $ | ||||||
| Other credit contracts | ||||||||
| Total credit protection sold | $ | $ | ||||||
| Notional | ||||||||
| $ in billions | At December 31, 2025 | At December 31, 2024 | ||||||
| Single name | $ | $ | ||||||
| Index and basket | ||||||||
| Tranched index and basket | ||||||||
| Total | $ | $ | ||||||
| Fair Value Asset (Liability) | ||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Single name | $ | ( | $ | ( | ||||
| Index and basket | ( | ( | ||||||
| Tranched index and basket | ( | ( | ||||||
| Total | $ | ( | $ | ( | ||||
| December 2025 Form 10-K | 110 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | ||||||||||||||
| $ in millions | Amortized Cost1 | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||
| AFS securities | ||||||||||||||
| U.S. Treasury securities | $ | $ | $ | |||||||||||
U.S. agency securities2 | ||||||||||||||
| Agency CMBS | ||||||||||||||
| State and municipal securities | ||||||||||||||
FFELP student loan ABS3 | ||||||||||||||
Unallocated basis adjustment4 | — | — | ||||||||||||
| Total AFS securities | ||||||||||||||
| HTM securities | ||||||||||||||
| U.S. Treasury securities | ||||||||||||||
U.S. agency securities2 | ||||||||||||||
| Agency CMBS | ||||||||||||||
| Non-agency CMBS | ||||||||||||||
| Total HTM securities | ||||||||||||||
| Total investment securities | $ | $ | $ | $ | ||||||||||
| At December 31, 2024 | ||||||||||||||
| $ in millions | Amortized Cost1 | Gross Unrealized Gains | Gross Unrealized Losses | Fair Value | ||||||||||
| AFS securities | ||||||||||||||
| U.S. Treasury securities | $ | $ | $ | $ | ||||||||||
U.S. agency securities2 | ||||||||||||||
| Agency CMBS | ||||||||||||||
| State and municipal securities | ||||||||||||||
FFELP student loan ABS3 | ||||||||||||||
Unallocated basis adjustment4 | ( | — | — | |||||||||||
| Total AFS securities | ||||||||||||||
| HTM securities | ||||||||||||||
| U.S. Treasury securities | ||||||||||||||
U.S. agency securities2 | ||||||||||||||
| Agency CMBS | ||||||||||||||
| Non-agency CMBS | ||||||||||||||
| Total HTM securities | ||||||||||||||
| Total investment securities | $ | $ | $ | $ | ||||||||||
| At December 31, 2025 | At December 31, 2024 | |||||||||||||
| $ in millions | Fair Value | Gross Unrealized Losses | Fair Value | Gross Unrealized Losses | ||||||||||
| U.S. Treasury securities | ||||||||||||||
| Less than12 months | $ | $ | $ | $ | ||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| U.S. agency securities | ||||||||||||||
| Less than12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| Agency CMBS | ||||||||||||||
| Less than12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
State and municipal securities | ||||||||||||||
| Less than12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| FFELP student loan ABS | ||||||||||||||
| 12 months or longer | ||||||||||||||
| Total | ||||||||||||||
| Unallocated basis adjustment | — | — | — | |||||||||||
| Total AFS securities in an unrealized loss position | ||||||||||||||
| Less than12 months | ||||||||||||||
| 12 months or longer | ||||||||||||||
Unallocated basis adjustment | — | — | — | |||||||||||
| Total | $ | $ | $ | $ | ||||||||||
111 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | |||||||||||
| $ in millions | Amortized Cost1 | Fair Value | Annualized Average Yield2,3 | ||||||||
| AFS securities | |||||||||||
| U.S. Treasury securities: | |||||||||||
| Due within 1 year | $ | $ | % | ||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| Total | |||||||||||
| U.S. agency securities: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Agency CMBS: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| State and municipal securities: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| FFELP student loan ABS: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
Unallocated basis adjustment4: | — | — | |||||||||
| Total AFS securities | % | ||||||||||
| At December 31, 2025 | |||||||||||
| $ in millions | Amortized Cost1 | Fair Value | Annualized Average Yield2 | ||||||||
| HTM securities | |||||||||||
| U.S. Treasury securities: | |||||||||||
| Due within 1 year | $ | $ | % | ||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| U.S. agency securities: | |||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Agency CMBS: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Non-agency CMBS: | |||||||||||
| Due within 1 year | % | ||||||||||
| After 1 year through 5 years | % | ||||||||||
| After 5 years through 10 years | % | ||||||||||
| After 10 years | % | ||||||||||
| Total | |||||||||||
| Total HTM securities | % | ||||||||||
| Total investment securities | $ | $ | % | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Gross realized gains | $ | $ | $ | ||||||||
| Gross realized (losses) | ( | ( | |||||||||
Total1 | $ | $ | $ | ||||||||
| December 2025 Form 10-K | 112 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | |||||||||||||||||
| $ in millions | Gross Amounts | Amounts Offset | Balance Sheet Net Amounts | Amounts Not Offset1 | Net Amounts | ||||||||||||
| Assets | |||||||||||||||||
| Securities purchased under agreements to resell | $ | $ | ( | $ | $ | ( | $ | ||||||||||
| Securities borrowed | ( | ( | |||||||||||||||
| Liabilities | |||||||||||||||||
| Securities sold under agreements to repurchase | $ | $ | ( | $ | $ | ( | $ | ||||||||||
| Securities loaned | ( | ( | |||||||||||||||
Amounts for which master netting agreements are not in place or may not be legally enforceable, included in Net Amounts | |||||||||||||||||
| Securities purchased under agreements to resell | $ | ||||||||||||||||
| Securities borrowed | |||||||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||
| At December 31, 2024 | |||||||||||||||||
| $ in millions | Gross Amounts | Amounts Offset | Balance Sheet Net Amounts | Amounts Not Offset1 | Net Amounts | ||||||||||||
| Assets | |||||||||||||||||
| Securities purchased under agreements to resell | $ | $ | ( | $ | $ | ( | $ | ||||||||||
| Securities borrowed | ( | ( | |||||||||||||||
| Liabilities | |||||||||||||||||
| Securities sold under agreements to repurchase | $ | $ | ( | $ | $ | ( | $ | ||||||||||
| Securities loaned | ( | ( | |||||||||||||||
Amounts for which master netting agreements are not in place or may not be legally enforceable, included in Net Amounts | |||||||||||||||||
| Securities purchased under agreements to resell | $ | ||||||||||||||||
| Securities borrowed | |||||||||||||||||
| Securities sold under agreements to repurchase | |||||||||||||||||
| At December 31, 2025 | |||||||||||||||||
| $ in millions | Overnight and Open | Less than 30 Days | 30-90 Days | Over 90 Days | Total | ||||||||||||
| Securities sold under agreements to repurchase | $ | $ | $ | $ | $ | ||||||||||||
| Securities loaned | |||||||||||||||||
| Total included in the offsetting disclosure | $ | $ | $ | $ | $ | ||||||||||||
| Trading liabilities—Obligation to return securities received as collateral | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| At December 31, 2024 | |||||||||||||||||
| $ in millions | Overnight and Open | Less than 30 Days | 30-90 Days | Over 90 Days | Total | ||||||||||||
| Securities sold under agreements to repurchase | $ | $ | $ | $ | $ | ||||||||||||
| Securities loaned | |||||||||||||||||
| Total included in the offsetting disclosure | $ | $ | $ | $ | $ | ||||||||||||
| Trading liabilities—Obligation to return securities received as collateral | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Securities sold under agreements to repurchase | ||||||||
| U.S. Treasury and agency securities | $ | $ | ||||||
| Other sovereign government obligations | ||||||||
| Corporate equities | ||||||||
| Other | ||||||||
| Total | $ | $ | ||||||
| Securities loaned | ||||||||
| Other sovereign government obligations | $ | $ | ||||||
| Corporate equities | ||||||||
| Other | ||||||||
| Total | $ | $ | ||||||
| Total included in the offsetting disclosure | $ | $ | ||||||
| Trading liabilities—Obligation to return securities received as collateral | ||||||||
| Corporate equities | $ | $ | ||||||
| Other | ||||||||
| Total | $ | $ | ||||||
| Total | $ | $ | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Trading assets | $ | $ | ||||||
113 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Collateral received with right to sell or repledge | $ | $ | ||||||
Collateral that was sold or repledged1 | ||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
Segregated securities1 | $ | $ | ||||||
At December 31, 2025 | At December 31, 2024 | |||||||
| U.S. government and agency securities and other sovereign government obligations | ||||||||
Trading assets1 | % | % | ||||||
Off balance sheet—Collateral received2 | % | % | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Margin and other lending | $ | $ | ||||||
| December 2025 Form 10-K | 114 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | |||||||||||
| $ in millions | HFI Loans | HFS Loans | Total Loans | ||||||||
| Corporate | $ | $ | $ | ||||||||
| Secured lending facilities | |||||||||||
| Commercial real estate | |||||||||||
| Residential real estate | |||||||||||
Securities-based lending and Other | |||||||||||
| Total loans | |||||||||||
| ACL | ( | ( | |||||||||
| Total loans, net | $ | $ | $ | ||||||||
| Loans to non-U.S. borrowers, net | $ | $ | $ | ||||||||
| At December 31, 2024 | |||||||||||
| $ in millions | HFI Loans | HFS Loans | Total Loans | ||||||||
| Corporate | $ | $ | $ | ||||||||
| Secured lending facilities | |||||||||||
| Commercial real estate | |||||||||||
| Residential real estate | |||||||||||
Securities-based lending and Other | |||||||||||
| Total loans | |||||||||||
| ACL | ( | ( | |||||||||
| Total loans, net | $ | $ | $ | ||||||||
| Loans to non-U.S. borrowers, net | $ | $ | $ | ||||||||
| At December 31, 2025 | At December 31, 2024 | |||||||||||||
| $ in millions | Fixed Rate | Floating or Adjustable Rate | Fixed Rate | Floating or Adjustable Rate | ||||||||||
| Corporate | $ | $ | $ | $ | ||||||||||
| Secured lending facilities | ||||||||||||||
| Commercial real estate | ||||||||||||||
| Residential real estate | ||||||||||||||
Securities-based lending and Other | ||||||||||||||
| Total loans, before ACL | $ | $ | $ | $ | ||||||||||
115 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | At December 31, 2024 | |||||||||||||||||||
| Corporate | ||||||||||||||||||||
| $ in millions | IG | NIG | Total | IG | NIG | Total | ||||||||||||||
Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||
| 2025 | ||||||||||||||||||||
| 2024 | ||||||||||||||||||||
| 2023 | ||||||||||||||||||||
| 2022 | ||||||||||||||||||||
| 2021 | ||||||||||||||||||||
Prior | ||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||
| At December 31, 2025 | At December 31, 2024 | |||||||||||||||||||
| Secured Lending Facilities | ||||||||||||||||||||
| $ in millions | IG | NIG | Total | IG | NIG | Total | ||||||||||||||
Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||
| 2025 | ||||||||||||||||||||
| 2024 | ||||||||||||||||||||
| 2023 | ||||||||||||||||||||
| 2022 | ||||||||||||||||||||
| 2021 | ||||||||||||||||||||
Prior | ||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||
| At December 31, 2025 | At December 31, 2024 | |||||||||||||||||||
| Commercial Real Estate | ||||||||||||||||||||
| $ in millions | IG | NIG | Total | IG | NIG | Total | ||||||||||||||
| Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||
| 2025 | ||||||||||||||||||||
| 2024 | ||||||||||||||||||||
| 2023 | ||||||||||||||||||||
| 2022 | ||||||||||||||||||||
| 2021 | ||||||||||||||||||||
Prior | ||||||||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||
| At December 31, 2025 | ||||||||||||||||||||||||||
| Residential Real Estate | ||||||||||||||||||||||||||
| by FICO Scores | by LTV Ratio | Total | ||||||||||||||||||||||||
| $ in millions | ≥ 740 | 680-739 | ≤ 679 | ≤ 80% | > 80% | |||||||||||||||||||||
| Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| 2025 | ||||||||||||||||||||||||||
| 2024 | ||||||||||||||||||||||||||
| 2023 | ||||||||||||||||||||||||||
| 2022 | ||||||||||||||||||||||||||
| 2021 | ||||||||||||||||||||||||||
| Prior | ||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| At December 31, 2024 | ||||||||||||||||||||||||||
| Residential Real Estate | ||||||||||||||||||||||||||
| by FICO Scores | by LTV Ratio | Total | ||||||||||||||||||||||||
| $ in millions | ≥ 740 | 680-739 | ≤ 679 | ≤ 80% | > 80% | |||||||||||||||||||||
| Revolving | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| 2024 | ||||||||||||||||||||||||||
| 2023 | ||||||||||||||||||||||||||
| 2022 | ||||||||||||||||||||||||||
| 2021 | ||||||||||||||||||||||||||
| Prior | ||||||||||||||||||||||||||
| Total | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| At December 31, 2025 | ||||||||||||||
Securities-based lending1 | Other2 | |||||||||||||
| $ in millions | IG | NIG | Total | |||||||||||
Revolving | $ | $ | $ | $ | ||||||||||
| 2025 | ||||||||||||||
| 2024 | ||||||||||||||
| 2023 | ||||||||||||||
| 2022 | ||||||||||||||
| 2021 | ||||||||||||||
| Prior | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| At December 31, 2024 | ||||||||||||||
Securities-based lending1 | Other2 | |||||||||||||
| $ in millions | IG | NIG | Total | |||||||||||
| Revolving | $ | $ | $ | $ | ||||||||||
| 2024 | ||||||||||||||
| 2023 | ||||||||||||||
| 2022 | ||||||||||||||
| 2021 | ||||||||||||||
| Prior | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Commercial real estate | $ | $ | ||||||
| Residential real estate | ||||||||
Securities-based lending and Other | ||||||||
| Total | $ | $ | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Corporate | $ | $ | ||||||
| Secured lending facilities | ||||||||
| Commercial real estate | ||||||||
| Residential real estate | ||||||||
Securities-based lending and Other | ||||||||
Total | $ | $ | ||||||
| Nonaccrual loans without an ACL | $ | $ | ||||||
| December 2025 Form 10-K | 116 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| Year Ended December 31, | |||||||||||||||||
| 2025 | 2024 | ||||||||||||||||
| $ in millions | Amortized Cost | % of Total Loans2 | Amortized Cost | % of Total Loans2 | |||||||||||||
Term Extension | |||||||||||||||||
| Corporate | $ | % | $ | % | |||||||||||||
| Secured lending facilities | % | % | |||||||||||||||
| Commercial real estate | % | % | |||||||||||||||
| Residential real estate | % | % | |||||||||||||||
| Securities-based lending and Other | % | % | |||||||||||||||
| Total | $ | % | $ | % | |||||||||||||
| Other-than-insignificant Payment Delay | |||||||||||||||||
| Corporate | $ | % | $ | % | |||||||||||||
| Residential real estate | % | % | |||||||||||||||
| Securities-based lending and Other | % | % | |||||||||||||||
| Total | $ | % | $ | % | |||||||||||||
| Interest Rate Reduction | |||||||||||||||||
| Residential real estate | $ | % | $ | % | |||||||||||||
| Total | $ | % | $ | % | |||||||||||||
| Multiple Modifications - Term Extension and Interest Rate Reduction | |||||||||||||||||
| Commercial real estate | $ | % | $ | % | |||||||||||||
| Residential real estate | % | % | |||||||||||||||
| Total | $ | % | $ | % | |||||||||||||
| Total Modifications | $ | % | $ | % | |||||||||||||
Year Ended December 31, 20251 | ||||||||||||||
| Term Extension (Months) | Other-than-insignificant Payment Delay (Months) | Principal Forgiveness ($ millions) | Interest Rate Reduction (%) | |||||||||||
Single Modifications | ||||||||||||||
| Corporate | $ | % | ||||||||||||
| Secured lending facilities | 0 | % | ||||||||||||
| Commercial real estate | 0 | % | ||||||||||||
| Residential real estate | % | |||||||||||||
| Securities-based lending and Other | % | |||||||||||||
| Multiple Modifications - Term Extension and Interest Rate Reduction | ||||||||||||||
| Commercial real estate | 0 | % | ||||||||||||
| Residential real estate | 0 | % | ||||||||||||
Year Ended December 31, 20241 | ||||||||||||||
| Term Extension (Months) | Other-than-insignificant Payment Delay (Months) | Principal Forgiveness ($ millions) | Interest Rate Reduction (%) | |||||||||||
Single Modifications | ||||||||||||||
| Corporate | $ | % | ||||||||||||
| Secured lending facilities | % | |||||||||||||
| Commercial real estate | % | |||||||||||||
| Residential real estate | % | |||||||||||||
| Securities-based lending and Other | % | |||||||||||||
| Multiple Modifications - Term Extension and Interest Rate Reduction | ||||||||||||||
| Commercial real estate | % | |||||||||||||
| Residential real estate | % | |||||||||||||
| At December 31, 2025 | |||||||||||
| $ in millions | 30-89 Days Past Due | 90+ Days Past Due | Total | ||||||||
| Commercial real estate | $ | $ | $ | ||||||||
| At December 31, 2024 | |||||||||||
| $ in millions | 30-89 Days Past Due | 90+ days Past Due | Total | ||||||||
| Commercial real estate | $ | $ | $ | ||||||||
Year Ended December 31, 2025 | ||||||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
| ACL—Loans | ||||||||||||||||||||
Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Gross charge-offs | ( | ( | ( | ( | ||||||||||||||||
| Recoveries | ||||||||||||||||||||
Net (charge-offs)/recoveries | ( | ( | ( | ( | ||||||||||||||||
| Provision (release) | ||||||||||||||||||||
| Other | ||||||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Percent of loans to total loans1 | % | % | % | % | % | % | ||||||||||||||
ACL—Lending commitments | ||||||||||||||||||||
Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Provision (release) | ( | ( | ||||||||||||||||||
| Other | ||||||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Total ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
117 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| Year Ended December 31, 2024 | ||||||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
| ACL—Loans | ||||||||||||||||||||
Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Gross charge-offs | ( | ( | ( | ( | ( | |||||||||||||||
| Recoveries | ||||||||||||||||||||
Net (charge-offs)/recoveries | ( | ( | ( | ( | ( | |||||||||||||||
| Provision (release) | ( | |||||||||||||||||||
| Other | ( | ( | ( | ( | ( | |||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Percent of loans to total loans1 | % | % | % | % | % | % | ||||||||||||||
ACL—Lending commitments | ||||||||||||||||||||
Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Provision (release) | ( | |||||||||||||||||||
| Other | ( | ( | ( | ( | ||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Total ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Year Ended December 31, 2023 | ||||||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
| ACL—Loans | ||||||||||||||||||||
Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Gross charge-offs | ( | ( | ( | ( | ||||||||||||||||
| Recoveries | ||||||||||||||||||||
Net (charge-offs)/recoveries | ( | ( | ( | ( | ||||||||||||||||
| Provision (release) | ||||||||||||||||||||
| Other | ( | |||||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Percent of loans to total loans1 | % | % | % | % | % | % | ||||||||||||||
ACL—Lending commitments | ||||||||||||||||||||
Beginning balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Provision (release) | ( | |||||||||||||||||||
| Other | ( | |||||||||||||||||||
| Ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
Total ending balance | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Year Ended December 31, 2025 | ||||||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
Revolving | $ | ( | $ | $ | $ | $ | ( | $ | ( | |||||||||||
| 2025 | ( | ( | ||||||||||||||||||
| 2022 | ( | ( | ||||||||||||||||||
| 2021 | ( | ( | ( | |||||||||||||||||
Prior | ( | ( | ( | |||||||||||||||||
Total | $ | ( | $ | $ | ( | $ | $ | ( | $ | ( | ||||||||||
| Year Ended December 31, 2024 | ||||||||||||||||||||
| $ in millions | Corporate | Secured Lending Facilities | CRE | Residential Real Estate | SBL and Other | Total | ||||||||||||||
Revolving | $ | ( | $ | $ | $ | $ | $ | ( | ||||||||||||
| 2022 | ( | ( | ||||||||||||||||||
| 2021 | ( | ( | ( | |||||||||||||||||
| 2020 | ( | ( | ||||||||||||||||||
Prior | ( | ( | ( | |||||||||||||||||
Total | $ | ( | $ | ( | $ | ( | $ | $ | ( | $ | ( | |||||||||
| At December 31, 2025 | At December 31, 2024 | |||||||
| ACL for loans to total HFI loans | % | % | ||||||
Nonaccrual HFI loans to total HFI loans | % | % | ||||||
ACL for loans to nonaccrual HFI loans | % | % | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
Currently employed by the Firm1 | $ | $ | ||||||
No longer employed by the Firm2 | ||||||||
| Employee loans | $ | $ | ||||||
| ACL | ( | ( | ||||||
| Employee loans, net of ACL | $ | $ | ||||||
| Remaining repayment term, weighted average in years | ||||||||
| December 2025 Form 10-K | 118 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | IS | WM | IM | Total | ||||||||||
| At December 31, 2023¹ | $ | $ | $ | $ | ||||||||||
Foreign currency | ( | ( | ( | ( | ||||||||||
Acquired | ||||||||||||||
Disposals | ( | ( | ||||||||||||
| December 31, 2024 | ||||||||||||||
| Foreign currency | ||||||||||||||
| At December 31, 2025¹ | $ | $ | $ | $ | ||||||||||
Accumulated impairments2 | $ | $ | $ | $ | ||||||||||
| $ in millions | IS | WM | IM | Total | ||||||||||
| At December 31, 2023 | $ | $ | $ | $ | ||||||||||
Acquired | ||||||||||||||
| Disposals | ( | ( | ||||||||||||
| Amortization expense | ( | ( | ( | ( | ||||||||||
| Other | ( | ( | ( | ( | ||||||||||
| At December 31, 2024 | $ | $ | $ | $ | ||||||||||
| Acquired | ||||||||||||||
| Amortization expense | ( | ( | ( | ( | ||||||||||
| Other | ||||||||||||||
| At December 31, 2025 | $ | $ | $ | $ | ||||||||||
| Non-amortizable | Amortizable | ||||||||||
| $ in millions | Gross Carrying Amount | Gross Carrying Amount | Accumulated Amortization | ||||||||
| At December 31, 2025 | |||||||||||
| Management contracts | $ | $ | $ | ||||||||
| Customer relationships | |||||||||||
Trade names | |||||||||||
| Other | |||||||||||
| Total | $ | $ | $ | ||||||||
| At December 31, 2024 | |||||||||||
| Management contracts | |||||||||||
| Customer relationships | |||||||||||
Trade names | |||||||||||
| Other | |||||||||||
| Total | $ | $ | $ | ||||||||
| $ in millions | At December 31, 2025 | ||||
| 2026 | $ | ||||
| 2027 | |||||
| 2028 | |||||
| 2029 | |||||
| 2030 | |||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Investments | $ | $ | ||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Income (loss) | $ | $ | $ | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Income (loss) from investment in MUMSS | $ | $ | $ | ||||||||
119 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
Low-income housing | $ | $ | ||||||
Renewable energy and other | ||||||||
| $ | $ | |||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| $ | $ | $ | |||||||||
| ( | ( | ( | |||||||||
| Other income | — | — | |||||||||
| Net benefits | $ | $ | $ | ||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| $ | $ | |||||||
| Weighted average: | ||||||||
| Remaining lease term, in years | ||||||||
| Discount rate | % | % | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| 2025 | $ | |||||||
| 2026 | $ | |||||||
| 2027 | ||||||||
| 2028 | ||||||||
| 2029 | ||||||||
| 2030 | ||||||||
| Thereafter | ||||||||
| Total undiscounted cash flows | $ | $ | ||||||
| Imputed interest | ( | ( | ||||||
| Amount on balance sheet | $ | $ | ||||||
| Committed leases not yet commenced | $ | $ | ||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Fixed costs | $ | $ | $ | ||||||||
Variable costs1 | |||||||||||
| Less: Sublease income | ( | ( | ( | ||||||||
| Total lease cost, net | $ | $ | $ | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Cash outflows—Lease liabilities | $ | $ | $ | ||||||||
| Non-cash—ROU assets recorded for new and modified leases | |||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Savings and demand deposits | $ | $ | ||||||
| Time deposits | ||||||||
Total deposits | $ | $ | ||||||
| Deposits subject to FDIC insurance | $ | $ | ||||||
| Deposits not subject to FDIC insurance | $ | $ | ||||||
| $ in millions | At December 31, 2025 | ||||
| 2026 | $ | ||||
| 2027 | |||||
| 2028 | |||||
| 2029 | |||||
| 2030 | |||||
| Thereafter | |||||
| Total | $ | ||||
| December 2025 Form 10-K | 120 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | At December 31, 2025 | ||||
| Less than 3 months | $ | ||||
| 3 - 6 months | |||||
| 6 - 12 months | |||||
| Over 12 months | |||||
| Total | $ | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Deposits in U.S. bank subsidiaries from non-U.S. depositors | $ | $ | ||||||
| Parent Company | Subsidiaries | At December 31, 2025 | At December 31, 2024 | |||||||||||||||||
| $ in millions | Fixed Rate1 | Variable Rate2 | Fixed Rate1 | Variable Rate2 | ||||||||||||||||
| Original maturities of one year or less: | ||||||||||||||||||||
| Next 12 months | $ | $ | $ | $ | $ | $ | ||||||||||||||
| Original maturities greater than one year: | ||||||||||||||||||||
| 2025 | $ | |||||||||||||||||||
| 2026 | $ | $ | $ | $ | $ | |||||||||||||||
| 2027 | ||||||||||||||||||||
| 2028 | ||||||||||||||||||||
| 2029 | ||||||||||||||||||||
| 2030 | ||||||||||||||||||||
| Thereafter | ||||||||||||||||||||
| Total greater than one year | $ | $ | $ | $ | $ | $ | ||||||||||||||
Total | $ | $ | $ | $ | $ | $ | ||||||||||||||
Weighted average coupon at period end3 | % | % | % | % | % | % | ||||||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Senior | $ | $ | ||||||
| Subordinated | ||||||||
| Total | $ | $ | ||||||
| Weighted average stated maturity, in years | ||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Put options embedded in debt agreements | $ | $ | ||||||
Liquidity obligations1 | $ | $ | ||||||
| 2025 | 2024 | |||||||
| Contractual weighted average coupon | % | % | ||||||
| At December 31, | |||||||||||
| 2025 | 2024 | 2023 | |||||||||
Contractual weighted average coupon1 | % | % | % | ||||||||
| Weighted average coupon after hedging derivatives | % | % | % | ||||||||
121 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Original maturities: | ||||||||
| One year or less | $ | $ | ||||||
| Greater than one year | ||||||||
| Total | $ | $ | ||||||
| Transfers of assets accounted for as secured financings | ||||||||
| At December 31, 2025 | At December 31, 2024 | |||||||||||||
| $ in millions | Fixed Rate | Variable Rate2 | Total | |||||||||||
| Original maturities of one year or less: | ||||||||||||||
| Next 12 months | $ | $ | $ | $ | ||||||||||
| Original maturities greater than one year: | ||||||||||||||
| 2025 | $ | |||||||||||||
| 2026 | $ | $ | $ | |||||||||||
| 2027 | ||||||||||||||
| 2028 | ||||||||||||||
| 2029 | ||||||||||||||
| 2030 | ||||||||||||||
| Thereafter | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
Weighted average coupon at period-end3 | % | % | % | % | ||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| 2025 | $ | — | $ | |||||
| 2026 | ||||||||
| 2027 | ||||||||
| 2028 | ||||||||
| 2029 | ||||||||
| 2030 | ||||||||
| Thereafter | ||||||||
| Total | $ | $ | ||||||
| Years to Maturity at December 31, 2025 | |||||||||||||||||
| $ in millions | Less than 1 | 1-3 | 3-5 | Over 5 | Total | ||||||||||||
| Lending: | |||||||||||||||||
| Corporate | $ | $ | $ | $ | $ | ||||||||||||
| Secured lending facilities | |||||||||||||||||
| Commercial and Residential real estate | |||||||||||||||||
| Securities-based lending and Other | |||||||||||||||||
Forward-starting secured financing receivables1 | |||||||||||||||||
| Central counterparty | |||||||||||||||||
| Investment activities | |||||||||||||||||
| Letters of credit and other financial guarantees | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Lending commitments participated to third parties | $ | ||||||||||||||||
| December 2025 Form 10-K | 122 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | ||||||||||||||||||||
| Maximum Potential Payout/Notional of Obligations by Years to Maturity | Carrying Amount Asset (Liability) | |||||||||||||||||||
| $ in millions | Less than 1 | 1-3 | 3-5 | Over 5 | ||||||||||||||||
Non-credit derivatives1 | ( | |||||||||||||||||||
Standby letters of credit and other financial guarantees issued2,3 | ||||||||||||||||||||
| Liquidity facilities | ||||||||||||||||||||
| Whole loan sales guarantees | ||||||||||||||||||||
Securitization representations and warranties4 | ||||||||||||||||||||
| General partner guarantees | ( | |||||||||||||||||||
| Client clearing guarantees | ||||||||||||||||||||
123 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| December 2025 Form 10-K | 124 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
125 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Legal expenses | $ | $ | $ | ||||||||
| December 2025 Form 10-K | 126 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
127 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| December 2025 Form 10-K | 128 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | At December 31, 2024 | |||||||||||||
| $ in millions | VIE Assets | VIE Liabilities | VIE Assets | VIE Liabilities | ||||||||||
MABS1 | $ | $ | $ | $ | ||||||||||
Investment vehicles2 | ||||||||||||||
| MTOB | ||||||||||||||
| Other | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Assets | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Trading assets at fair value | ||||||||
| Investment securities | ||||||||
| Customer and other receivables | ||||||||
| Other assets | ||||||||
| Total | $ | $ | ||||||
| Liabilities | ||||||||
| Other secured financings | $ | $ | ||||||
| Other liabilities and accrued expenses | ||||||||
| Borrowings | ||||||||
| Total | $ | $ | ||||||
| Noncontrolling interests | $ | $ | ||||||
| At December 31, 2025 | |||||||||||||||||
| $ in millions | MABS1 | CDO | MTOB | OSF | Other2 | ||||||||||||
| VIE assets (UPB) | $ | $ | $ | $ | $ | ||||||||||||
Maximum exposure to loss3 | |||||||||||||||||
| Debt and equity interests | $ | $ | $ | $ | $ | ||||||||||||
| Derivative and other contracts | |||||||||||||||||
| Commitments, guarantees and other | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Carrying value of variable interests—Assets | |||||||||||||||||
| Debt and equity interests | $ | $ | $ | $ | $ | ||||||||||||
| Derivative and other contracts | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
Additional VIE assets owned4 | $ | ||||||||||||||||
| Carrying value of variable interests—Liabilities | |||||||||||||||||
| Derivative and other contracts | $ | $ | $ | $ | $ | ||||||||||||
| At December 31, 2024 | |||||||||||||||||
| $ in millions | MABS1 | CDO | MTOB | OSF | Other2 | ||||||||||||
| VIE assets (UPB) | $ | $ | $ | $ | $ | ||||||||||||
Maximum exposure to loss3 | |||||||||||||||||
| Debt and equity interests | $ | $ | $ | $ | $ | ||||||||||||
| Derivative and other contracts | |||||||||||||||||
| Commitments, guarantees and other | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
| Carrying value of variable interests—Assets | |||||||||||||||||
| Debt and equity interests | $ | $ | $ | $ | $ | ||||||||||||
| Derivative and other contracts | |||||||||||||||||
| Total | $ | $ | $ | $ | $ | ||||||||||||
Additional VIE assets owned4 | $ | ||||||||||||||||
| Carrying value of variable interests—Liabilities | |||||||||||||||||
| Derivative and other contracts | $ | $ | $ | $ | $ | ||||||||||||
129 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | At December 31, 2024 | |||||||||||||
| $ in millions | UPB | Debt and Equity Interests | UPB | Debt and Equity Interests | ||||||||||
| Residential mortgages | $ | $ | $ | $ | ||||||||||
| Commercial mortgages | ||||||||||||||
| U.S. agency collateralized mortgage obligations | ||||||||||||||
| Other consumer or commercial loans | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| December 2025 Form 10-K | 130 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | ||||||||||||||
| $ in millions | RML | CML | U.S. Agency CMO | CLN and Other1 | ||||||||||
SPE assets (UPB)2, 3 | $ | $ | $ | $ | ||||||||||
| Retained interests | ||||||||||||||
| Investment grade | $ | $ | $ | $ | ||||||||||
| Non-investment grade | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
Interests purchased in the secondary market3 | ||||||||||||||
| Investment grade | $ | $ | $ | $ | ||||||||||
| Non-investment grade | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| Derivative assets | $ | $ | $ | $ | ||||||||||
| Derivative liabilities | ||||||||||||||
| At December 31, 2024 | ||||||||||||||
| $ in millions | RML | CML | U.S. Agency CMO | CLN and Other1 | ||||||||||
SPE assets (UPB)2, 3 | $ | $ | $ | $ | ||||||||||
| Retained interests | ||||||||||||||
| Investment grade | $ | $ | $ | $ | ||||||||||
| Non-investment grade | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
Interests purchased in the secondary market3 | ||||||||||||||
| Investment grade | $ | $ | $ | $ | ||||||||||
| Non-investment grade | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| Derivative assets | $ | $ | $ | $ | ||||||||||
| Derivative liabilities | ||||||||||||||
| Fair Value at December 31, 2025 | |||||||||||
| $ in millions | Level 2 | Level 3 | Total | ||||||||
| Retained interests | |||||||||||
| Investment grade | $ | $ | $ | ||||||||
| Non-investment grade | |||||||||||
| Total | $ | $ | $ | ||||||||
Interests purchased in the secondary market3 | |||||||||||
| Investment grade | $ | $ | $ | ||||||||
| Non-investment grade | |||||||||||
| Total | $ | $ | $ | ||||||||
| Derivative assets | $ | $ | $ | ||||||||
| Derivative liabilities | |||||||||||
| Fair Value at December 31, 2024 | |||||||||||
| $ in millions | Level 2 | Level 3 | Total | ||||||||
| Retained interests | |||||||||||
| Investment grade | $ | $ | $ | ||||||||
| Non-investment grade | |||||||||||
| Total | $ | $ | $ | ||||||||
Interests purchased in the secondary market3 | |||||||||||
| Investment grade | $ | $ | $ | ||||||||
| Non-investment grade | |||||||||||
| Total | $ | $ | $ | ||||||||
| Derivative assets | $ | $ | $ | ||||||||
| Derivative liabilities | |||||||||||
131 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
New transactions1 | $ | $ | $ | ||||||||
| Retained interests | |||||||||||
Sales of corporate loans to CLO SPEs1, 2 | |||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
Gross cash proceeds from sale of assets1 | $ | $ | ||||||
| Fair value | ||||||||
| Assets sold | $ | $ | ||||||
| Derivative assets recognized in the balance sheet | ||||||||
| Derivative liabilities recognized in the balance sheet | ||||||||
| At December 31, 2025 | At December 31, 2024 | At December 31, 2025 and December 31, 2024 | |||||||||
| Standardized | Standardized | Advanced | |||||||||
| Capital buffers | |||||||||||
Fixed 2.5% buffer | —% | —% | |||||||||
| SCB | N/A | ||||||||||
| G-SIB capital surcharge | |||||||||||
CCyB1 | |||||||||||
Capital conservation buffer requirement | |||||||||||
| December 2025 Form 10-K | 132 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | At December 31, 2024 | At December 31, 2025 and December 31, 2024 | ||||||||||||
| Regulatory Minimum | ||||||||||||||
| Standardized | Standardized | Advanced | ||||||||||||
Required ratios1 | ||||||||||||||
CET1 capital ratio | % | |||||||||||||
| Tier 1 capital ratio | % | |||||||||||||
| Total capital ratio | % | |||||||||||||
| Standardized | ||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
Risk-based capital | ||||||||
| CET1 capital | $ | $ | ||||||
| Tier 1 capital | ||||||||
| Total capital | ||||||||
| Total RWA | ||||||||
| Risk-based capital ratio | ||||||||
| CET1 capital | % | % | ||||||
| Tier 1 capital | % | % | ||||||
| Total capital | % | % | ||||||
Required ratio1 | ||||||||
| CET1 capital | % | % | ||||||
| Tier 1 capital | % | % | ||||||
| Total capital | % | % | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
Leverage-based capital | ||||||||
Adjusted average assets1 | $ | $ | ||||||
Supplementary leverage exposure2 | ||||||||
Leverage-based capital ratio | ||||||||
| Tier 1 leverage | % | % | ||||||
| SLR | % | % | ||||||
Required ratio3 | ||||||||
| Tier 1 leverage | % | % | ||||||
| SLR | % | % | ||||||
133 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| Well-Capitalized Requirement | Required Ratio1 | At December 31, 2025 | At December 31, 2024 | |||||||||||||||||
| $ in millions | Amount | Ratio | Amount | Ratio | ||||||||||||||||
| Risk-based capital | ||||||||||||||||||||
CET1 capital | % | % | $ | % | $ | % | ||||||||||||||
| Tier 1 capital | % | % | % | % | ||||||||||||||||
| Total capital | % | % | % | % | ||||||||||||||||
| Leverage-based capital | ||||||||||||||||||||
| Tier 1 leverage | % | % | $ | % | $ | % | ||||||||||||||
| SLR | % | % | % | % | ||||||||||||||||
| Well-Capitalized Requirement | Required Ratio1 | At December 31, 2025 | At December 31, 2024 | |||||||||||||||||
| $ in millions | Amount | Ratio | Amount | Ratio | ||||||||||||||||
| Risk-based capital | ||||||||||||||||||||
| CET1 capital | % | % | $ | % | $ | % | ||||||||||||||
| Tier 1 capital | % | % | % | % | ||||||||||||||||
| Total capital | % | % | % | % | ||||||||||||||||
| Leverage-based capital | ||||||||||||||||||||
| Tier 1 leverage | % | % | $ | % | $ | % | ||||||||||||||
| SLR | % | % | % | % | ||||||||||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Net capital | $ | $ | ||||||
| Excess net capital | ||||||||
| December 2025 Form 10-K | 134 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Restricted net assets | $ | $ | ||||||
| Shares Outstanding | Carrying Value | |||||||||||||
| $ in millions, except per share data | At December 31, 2025 | Liquidation Preference per Share | At December 31, 2025 | At December 31, 2024 | ||||||||||
| Series | ||||||||||||||
| A | $ | $ | $ | |||||||||||
C1 | ||||||||||||||
| E | ||||||||||||||
| F | ||||||||||||||
| I | ||||||||||||||
| K | ||||||||||||||
| L | ||||||||||||||
| M | ||||||||||||||
| N | ||||||||||||||
| O | ||||||||||||||
| P | ||||||||||||||
Q | ||||||||||||||
| Total | $ | $ | ||||||||||||
| Shares authorized | ||||||||||||||
| Depositary Shares per Share | Redemption | ||||||||||||||||
Series1, 2 | Shares Issued | Price per Share3 | Earliest optional redemption date4 | ||||||||||||||
| A | $ | July 15, 2011 | |||||||||||||||
C5 | N/A | October 15, 2011 | |||||||||||||||
| E | October 15, 2023 | ||||||||||||||||
| F | January 15, 2024 | ||||||||||||||||
| I | October 15, 2024 | ||||||||||||||||
| K | April 15, 2027 | ||||||||||||||||
| L | January 15, 2025 | ||||||||||||||||
M | N/A | September 15, 2026 | |||||||||||||||
N | October 2, 2025 | ||||||||||||||||
O | January 15, 2027 | ||||||||||||||||
P | October 15, 2027 | ||||||||||||||||
Q | October 15, 2029 | ||||||||||||||||
| in millions | 2025 | 2024 | ||||||
| Shares outstanding at beginning of period | ||||||||
Treasury stock purchases1 | ( | ( | ||||||
Other2 | ||||||||
| Shares outstanding at end of period | ||||||||
| $ in millions | 2025 | 2024 | ||||||
Repurchases of common stock under the Firm’s Share Repurchase Program | $ | $ | ||||||
135 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| in millions | 2025 | 2024 | 2023 | ||||||||
| Weighted average common shares outstanding, basic | |||||||||||
| Effect of dilutive RSUs and PSUs | |||||||||||
| Weighted average common shares outstanding and common stock equivalents, diluted | |||||||||||
| Weighted average antidilutive common stock equivalents (excluded from the computation of diluted EPS) | |||||||||||
| $ in millions, except per share data | 2025 | 2024 | 2023 | |||||||||||||||||||||||
Per Share1 | Total | Per Share1 | Total | Per Share1 | Total | |||||||||||||||||||||
| Preferred Stock Series | ||||||||||||||||||||||||||
| A | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| C | ||||||||||||||||||||||||||
| E | ||||||||||||||||||||||||||
| F | ||||||||||||||||||||||||||
| I | ||||||||||||||||||||||||||
| K | ||||||||||||||||||||||||||
| L | ||||||||||||||||||||||||||
M2 | ||||||||||||||||||||||||||
N3 | ||||||||||||||||||||||||||
O | ||||||||||||||||||||||||||
| P | ||||||||||||||||||||||||||
Q | ||||||||||||||||||||||||||
| Total Preferred stock | $ | $ | $ | |||||||||||||||||||||||
| Common stock | $ | $ | $ | $ | $ | $ | ||||||||||||||||||||
| Year Ended December 31, 2025 | ||||||||||||||||||||
| $ in millions | CTA | AFS Securities | Pension and Other | DVA | Cash Flow Hedges | Total | ||||||||||||||
Beginning Balance | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||
OCI activity: | ||||||||||||||||||||
Pre-Tax Gain (Loss) | ( | ( | ( | |||||||||||||||||
Tax effect | ( | ( | ||||||||||||||||||
After-tax Gain (Loss) | ( | ( | ||||||||||||||||||
Non-Controlling Interests | ( | ( | ( | |||||||||||||||||
OCI Activity | ( | ( | ||||||||||||||||||
Reclassified to Earnings: | ||||||||||||||||||||
Pre-tax Reclass. | ( | |||||||||||||||||||
Tax effect | ( | ( | ( | ( | ||||||||||||||||
Reclass. After-tax | ( | |||||||||||||||||||
Net OCI Activity | ( | |||||||||||||||||||
Ending Balance | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | ( | |||||||||
| Year Ended December 31, 2024 | ||||||||||||||||||||
| $ in millions | CTA | AFS Securities | Pension and Other | DVA | Cash Flow Hedges | Total | ||||||||||||||
| Beginning Balance | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | ( | |||||||||
| OCI activity: | ||||||||||||||||||||
| Pre-Tax Gain (Loss) | ( | ( | ( | ( | ( | |||||||||||||||
| Tax effect | ( | ( | ( | |||||||||||||||||
| After-tax Gain (Loss) | ( | ( | ( | ( | ( | |||||||||||||||
| Non-Controlling Interests | ( | ( | ||||||||||||||||||
| OCI Activity | ( | ( | ( | ( | ( | |||||||||||||||
| Reclassified to Earnings: | ||||||||||||||||||||
Pre-tax Reclass | ( | |||||||||||||||||||
| Tax effect | ( | ( | ( | ( | ||||||||||||||||
Reclass. After-tax | ( | |||||||||||||||||||
| Net OCI Activity | ( | ( | ( | ( | ||||||||||||||||
| Ending Balance | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||
| Year Ended December 31, 2023 | ||||||||||||||||||||
| $ in millions | CTA | AFS Securities | Pension and Other | DVA | Cash Flow Hedges | Total | ||||||||||||||
| Beginning Balance | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | $ | ( | ||||||||
| OCI activity: | ||||||||||||||||||||
| Pre-Tax Gain (Loss) | ( | ( | ( | ( | ||||||||||||||||
| Tax effect | ( | ( | ||||||||||||||||||
| After-tax Gain (Loss) | ( | ( | ( | ( | ||||||||||||||||
| Non-Controlling Interests | ( | ( | ( | |||||||||||||||||
| OCI Activity | ( | ( | ( | |||||||||||||||||
| Reclassified to Earnings: | ||||||||||||||||||||
Pre-tax Reclass | ( | ( | ( | |||||||||||||||||
| Tax effect | ( | ( | ||||||||||||||||||
Reclass. After-tax | ( | ( | ( | |||||||||||||||||
| Net OCI Activity | ( | ( | ( | |||||||||||||||||
| Ending Balance | $ | ( | $ | ( | $ | ( | $ | ( | $ | $ | ( | |||||||||
| December 2025 Form 10-K | 136 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Associated with net investments in subsidiaries with a non-U.S. dollar functional currency | $ | ( | $ | ( | ||||
| Hedges, net of tax | ||||||||
| Total | $ | ( | $ | ( | ||||
| Carrying value of net investments in non-U.S. dollar functional currency subsidiaries subject to hedges | $ | $ | ||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Interest income | |||||||||||
Cash and cash equivalents1 | $ | $ | $ | ||||||||
| Investment securities | |||||||||||
| Loans | |||||||||||
Securities purchased under agreements to resell2 | |||||||||||
Securities borrowed3 | |||||||||||
| Trading assets, net of Trading liabilities | |||||||||||
Customer receivables and Other1 | |||||||||||
| Total interest income | $ | $ | $ | ||||||||
| Interest expense | |||||||||||
| Deposits | $ | $ | $ | ||||||||
| Borrowings | |||||||||||
Securities sold under agreements to repurchase4 | |||||||||||
Securities loaned5 | |||||||||||
Customer payables and Other | |||||||||||
| Total interest expense | $ | $ | $ | ||||||||
| Net interest | $ | $ | $ | ||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Customer and other receivables | $ | $ | ||||||
| Customer and other payables | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| RSUs | $ | $ | $ | ||||||||
| PSUs | |||||||||||
| ESPP | |||||||||||
| Total | $ | $ | $ | ||||||||
Retirement-eligible awards1 | $ | $ | $ | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
Tax benefit1 | $ | $ | $ | ||||||||
| $ in millions | At December 31, 20251 | ||||
| To be recognized in: | |||||
| 2026 | $ | ||||
| 2027 | |||||
| Thereafter | |||||
| Total | $ | ||||
137 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| in millions | At December 31, 2025 | ||||
| Shares | |||||
| 2025 | ||||||||||||||
Number of RSUs | Weighted Average Award Date Fair Value | |||||||||||||
shares in millions, $ per share | Unvested2 | Vested | Unvested | Vested | ||||||||||
Beginning balance | $ | $ | ||||||||||||
| Awarded | ||||||||||||||
| Conversions to common stock | — | ( | — | |||||||||||
| Forfeited | ( | |||||||||||||
Vested | ( | |||||||||||||
Ending balance1 | $ | $ | ||||||||||||
| Weighted average award date fair value | ||||||||||||||
| RSUs awarded in 2024 | $ | |||||||||||||
| RSUs awarded in 2023 | $ | |||||||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
Conversions to common stock | $ | $ | $ | ||||||||
| Vested | |||||||||||
| 2025 | 2024 | 2023 | |||||||||
Weighted average price on award date | $ | $ | $ | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Deferred cash-based awards | $ | $ | $ | ||||||||
| Return on referenced investments | |||||||||||
| Total | $ | $ | $ | ||||||||
Retirement-eligible awards1 | $ | $ | $ | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Expense | $ | $ | $ | ||||||||
| Pension Plans | |||||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Service cost, benefits earned during the period | $ | $ | $ | ||||||||
| Interest cost on projected benefit obligation | |||||||||||
| Expected return on plan assets | ( | ( | ( | ||||||||
| Net amortization of prior service cost | |||||||||||
Amortization of net (gains) losses | ( | ||||||||||
Plan settlements | |||||||||||
| Net periodic benefit expense | $ | $ | $ | ||||||||
| December 2025 Form 10-K | 138 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| Pension Plans | |||||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Beginning balance | $ | ( | $ | ( | $ | ( | |||||
| Net gain (loss) | ( | ( | |||||||||
| Amortization of prior service cost | |||||||||||
Amortization of net (gains) losses | ( | ||||||||||
Plan settlements, curtailments and amendments | ( | ||||||||||
| Changes recognized in OCI | ( | ||||||||||
| Ending balance | $ | ( | $ | ( | $ | ( | |||||
| Pension Plans | |||||||||||
| 2025 | 2024 | 2023 | |||||||||
| Discount rate | % | % | % | ||||||||
Expected long-term rate of return on plan assets | % | % | % | ||||||||
| Pension Plans | ||||||||
| $ in millions | 2025 | 2024 | ||||||
Projected benefit obligation | ||||||||
| Benefit obligation at beginning of year | $ | $ | ||||||
| Service cost | ||||||||
| Interest cost | ||||||||
Actuarial (gain) loss1 | ( | |||||||
| Plan amendments | ||||||||
| Plan settlements | ( | ( | ||||||
| Benefits paid | ( | ( | ||||||
Other2 | ( | |||||||
| Projected benefit obligation at end of year | $ | $ | ||||||
Fair value of plan assets | ||||||||
| Fair value of plan assets at beginning of year | $ | $ | ||||||
| Actual return on plan assets | ( | |||||||
| Employer contributions | ||||||||
| Benefits paid | ( | ( | ||||||
| Plan settlements | ( | ( | ||||||
Other2 | ( | |||||||
| Fair value of plan assets at end of year | $ | $ | ||||||
| Funded (unfunded) status | $ | ( | $ | ( | ||||
| Amounts recognized in the balance sheet | ||||||||
| Assets | $ | $ | ||||||
| Liabilities | ( | ( | ||||||
| Net amount recognized | $ | ( | $ | ( | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Pension plans | $ | $ | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Projected benefit obligation | $ | $ | ||||||
| Accumulated benefit obligation | ||||||||
| Fair value of plan assets | ||||||||
| Pension Plans | ||||||||
| At December 31, 2025 | At December 31, 2024 | |||||||
| Discount rate | % | % | ||||||
139 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | ||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Total | ||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | $ | $ | $ | ||||||||||
| U.S. government and agency securities | ||||||||||||||
| Other investments | ||||||||||||||
Other receivables1 | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| Assets Measured at NAV | ||||||||||||||
| Commingled trust funds: | ||||||||||||||
| Money market | ||||||||||||||
| Foreign funds: | ||||||||||||||
| Fixed income | ||||||||||||||
| Liquidity | ||||||||||||||
| Targeted cash flow | ||||||||||||||
| Total | $ | |||||||||||||
| Liabilities | ||||||||||||||
Other payables1 | ( | ( | ||||||||||||
| Total liabilities | $ | $ | ( | $ | $ | ( | ||||||||
| Fair value of plan assets | $ | |||||||||||||
| At December 31, 2024 | ||||||||||||||
| $ in millions | Level 1 | Level 2 | Level 3 | Total | ||||||||||
| Assets | ||||||||||||||
| Cash and cash equivalents | $ | $ | $ | $ | ||||||||||
| U.S. government and agency securities | ||||||||||||||
| Derivative contracts | ||||||||||||||
| Other investments | ||||||||||||||
Other receivables1 | ||||||||||||||
| Total | $ | $ | $ | $ | ||||||||||
| Assets Measured at NAV | ||||||||||||||
| Commingled trust funds: | ||||||||||||||
| Money market | ||||||||||||||
| Foreign funds: | ||||||||||||||
| Fixed income | ||||||||||||||
| Liquidity | ||||||||||||||
| Targeted cash flow | ||||||||||||||
| Total | $ | |||||||||||||
| Liabilities | ||||||||||||||
Other payables1 | ( | ( | ||||||||||||
| Total liabilities | $ | $ | ( | $ | $ | ( | ||||||||
| Fair value of plan assets | $ | |||||||||||||
| $ in millions | 2025 | 2024 | ||||||
| Balance at beginning of period | $ | $ | ||||||
| Realized and unrealized gains | ||||||||
Purchases, sales, settlements and exchange rate changes, net | ( | |||||||
| Balance at end of period | $ | $ | ||||||
| December 2025 Form 10-K | 140 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| At December 31, 2025 | |||||
| $ in millions | Pension Plans | ||||
| 2026 | $ | ||||
| 2027 | |||||
| 2028 | |||||
| 2029 | |||||
| 2030 | |||||
2031-2035 | |||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Expense | $ | $ | $ | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Expense | $ | $ | $ | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Current | |||||||||||
U.S. federal | $ | $ | $ | ||||||||
State and local | |||||||||||
Foreign | |||||||||||
| Total | $ | $ | $ | ||||||||
| Deferred | |||||||||||
U.S. federal | $ | $ | $ | ( | |||||||
State and local | ( | ( | |||||||||
Foreign | ( | ||||||||||
| Total | $ | $ | $ | ( | |||||||
| Provision for income taxes | $ | $ | $ | ||||||||
Year Ended December 31, | ||||||||||||||||||||||||||
$ in millions | 2025 | 2024 | 2023 | |||||||||||||||||||||||
| $ | % | $ | % | $ | % | |||||||||||||||||||||
| U.S. federal statutory tax | $ | % | $ | % | $ | % | ||||||||||||||||||||
State and local taxes1 | ||||||||||||||||||||||||||
| Foreign taxes | ||||||||||||||||||||||||||
India | ||||||||||||||||||||||||||
| Capital gains tax | ||||||||||||||||||||||||||
| Other | ||||||||||||||||||||||||||
Brazil | ||||||||||||||||||||||||||
| Capital gains tax | ||||||||||||||||||||||||||
| Other | ||||||||||||||||||||||||||
| Other jurisdictions | ||||||||||||||||||||||||||
| Changes in tax laws and rates | ||||||||||||||||||||||||||
Cross-border taxes | ||||||||||||||||||||||||||
| U.S. tax credits | ||||||||||||||||||||||||||
General business credits | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||
Foreign tax credit | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||
| Changes in valuation allowances | ( | |||||||||||||||||||||||||
| Nontaxable or nondeductible items | ||||||||||||||||||||||||||
Income/(loss) from affiliates | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||
Employee share-based compensation | ( | ( | ( | ( | ( | ( | ||||||||||||||||||||
| Other | ||||||||||||||||||||||||||
Unrecognized tax benefits | ||||||||||||||||||||||||||
Other | ||||||||||||||||||||||||||
Proportional amortization | ||||||||||||||||||||||||||
Effective tax | $ | % | $ | % | $ | % | ||||||||||||||||||||
141 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
$ in millions | 2025 | 2024 | 2023 | |||||||||||
U.S. federal | $ | $ | $ | |||||||||||
State and local | ||||||||||||||
New York State | * | * | ||||||||||||
New York City | * | * | ||||||||||||
Other | ||||||||||||||
Foreign | ||||||||||||||
U.K. | ||||||||||||||
India | ||||||||||||||
Brazil | * | |||||||||||||
Japan | * | * | ||||||||||||
Germany | * | * | ||||||||||||
Other | ||||||||||||||
Total | $ | $ | $ | |||||||||||
| $ in millions | At Dec 31, 2025 | At Dec 31, 2024 | ||||||
| Gross deferred tax assets | ||||||||
| Net operating loss and tax credit carryforwards | $ | $ | ||||||
| Employee compensation and benefit plans | ||||||||
| Allowance for credit losses and other reserves | ||||||||
| Valuation of net trading inventory, investments and receivables | ||||||||
| Other | ||||||||
| Total deferred tax assets | ||||||||
| Less: Deferred tax assets valuation allowance | ||||||||
| Deferred tax assets after valuation allowance | $ | $ | ||||||
| Gross deferred tax liabilities | ||||||||
| Fixed assets | ||||||||
| Intangibles and goodwill | ||||||||
| Total deferred tax liabilities | $ | $ | ||||||
| Net deferred tax assets | $ | $ | ||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Balance at beginning of period | $ | $ | $ | ||||||||
| Increases based on tax positions related to the current period | |||||||||||
| Increases based on tax positions related to prior periods | |||||||||||
| Decreases based on tax positions related to prior periods | ( | ( | ( | ||||||||
| Decreases related to settlements with taxing authorities | ( | ( | ( | ||||||||
| Decreases related to lapse of statute of limitations | ( | ( | ( | ||||||||
| Balance at end of period | $ | $ | $ | ||||||||
Net unrecognized tax benefits1 | $ | $ | $ | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Recognized in income statement | $ | $ | $ | ||||||||
| Accrued at end of period | |||||||||||
| Jurisdiction | Tax Year | ||||
| U.S. | 2017 | ||||
| New York State and New York City | 2010 | ||||
| U.K. | 2014 | ||||
| Japan | 2021 | ||||
| Hong Kong | 2018 | ||||
| December 2025 Form 10-K | 142 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| 2025 | |||||||||||||||||
| $ in millions | IS | WM | IM | I/E | Total | ||||||||||||
| Investment banking | $ | $ | $ | $ | ( | $ | |||||||||||
| Trading | ( | ||||||||||||||||
| Investments | |||||||||||||||||
Commissions and fees1 | ( | ||||||||||||||||
Asset management1, 2 | ( | ||||||||||||||||
| Other | ( | ||||||||||||||||
| Total non-interest revenues | ( | ||||||||||||||||
| Interest income | ( | ||||||||||||||||
| Interest expense | ( | ||||||||||||||||
| Net interest | ( | ||||||||||||||||
| Net revenues | $ | $ | $ | $ | ( | $ | |||||||||||
| Provision for credit losses | $ | $ | $ | $ | $ | ||||||||||||
Compensation and benefits3 | |||||||||||||||||
Non-compensation expenses3 | ( | ||||||||||||||||
| Total non-interest expenses | $ | $ | $ | $ | ( | $ | |||||||||||
| Income before provision for income taxes | $ | $ | $ | $ | ( | $ | |||||||||||
| Provision for income taxes | ( | ||||||||||||||||
| Net income | ( | ||||||||||||||||
| Net income applicable to noncontrolling interests | |||||||||||||||||
| Net income applicable to Morgan Stanley | $ | $ | $ | $ | ( | $ | |||||||||||
Pre-tax margin4 | % | % | % | N/M | % | ||||||||||||
| 2024 | |||||||||||||||||
| $ in millions | IS | WM | IM | I/E | Total | ||||||||||||
| Investment banking | $ | $ | $ | $ | ( | $ | |||||||||||
| Trading | |||||||||||||||||
| Investments | |||||||||||||||||
Commissions and fees1 | ( | ||||||||||||||||
Asset management1, 2 | ( | ||||||||||||||||
| Other | ( | ||||||||||||||||
| Total non-interest revenues | ( | ||||||||||||||||
Interest income | ( | ||||||||||||||||
Interest expense | ( | ||||||||||||||||
| Net interest | ( | ||||||||||||||||
| Net revenues | $ | $ | $ | $ | ( | $ | |||||||||||
| Provision for credit losses | $ | $ | $ | $ | $ | ||||||||||||
Compensation and benefits3 | |||||||||||||||||
Non-compensation expenses3 | ( | ||||||||||||||||
| Total non-interest expenses | $ | $ | $ | $ | ( | $ | |||||||||||
| Income before provision for income taxes | $ | $ | $ | $ | ( | $ | |||||||||||
| Provision for income taxes | ( | ||||||||||||||||
| Net income | ( | ||||||||||||||||
| Net income applicable to noncontrolling interests | |||||||||||||||||
| Net income applicable to Morgan Stanley | $ | $ | $ | $ | ( | $ | |||||||||||
Pre-tax margin4 | % | % | % | N/M | % | ||||||||||||
143 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| 2023 | |||||||||||||||||
| $ in millions | IS | WM | IM | I/E | Total | ||||||||||||
| Investment banking | $ | $ | $ | $ | ( | $ | |||||||||||
| Trading | ( | ||||||||||||||||
| Investments | |||||||||||||||||
Commissions and fees1 | ( | ||||||||||||||||
Asset management1,2 | ( | ||||||||||||||||
| Other | ( | ( | |||||||||||||||
| Total non-interest revenues | ( | ||||||||||||||||
Interest income | ( | ||||||||||||||||
Interest expense | ( | ||||||||||||||||
| Net interest | ( | ||||||||||||||||
| Net revenues | $ | $ | $ | $ | ( | $ | |||||||||||
| Provision for credit losses | $ | $ | $ | $ | $ | ||||||||||||
Compensation and benefits3 | |||||||||||||||||
Non-compensation expenses3 | ( | ||||||||||||||||
| Total non-interest expenses | $ | $ | $ | $ | ( | $ | |||||||||||
| Income before provision for income taxes | $ | $ | $ | $ | ( | $ | |||||||||||
| Provision for income taxes | ( | ||||||||||||||||
| Net income | ( | ||||||||||||||||
| Net income applicable to noncontrolling interests | |||||||||||||||||
| Net income applicable to Morgan Stanley | $ | $ | $ | $ | ( | $ | |||||||||||
Pre-tax margin4 | % | % | % | N/M | % | ||||||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Institutional Securities—Advisory | $ | $ | $ | ||||||||
| Institutional Securities—Underwriting | |||||||||||
| Firm Investment banking revenues from contracts with customers | % | % | % | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Interest rate | $ | $ | $ | ||||||||
| Foreign exchange | |||||||||||
Equity1 | |||||||||||
| Commodity and other | |||||||||||
| Credit | ( | ( | ( | ||||||||
| Total | $ | $ | $ | ||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Net cumulative unrealized performance-based fees at risk of reversing | $ | $ | ||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Fee waivers | $ | $ | $ | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Transaction taxes | $ | $ | $ | ||||||||
| December 2025 Form 10-K | 144 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Americas | $ | $ | $ | ||||||||
| EMEA | |||||||||||
| Asia | |||||||||||
| Total | $ | $ | $ | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| U.S. | $ | $ | $ | ||||||||
Non-U.S.1 | |||||||||||
| Total | $ | $ | $ | ||||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Non-interest revenues | $ | $ | $ | ||||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Customer and other receivables | $ | $ | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Institutional Securities | $ | $ | ||||||
| Wealth Management | ||||||||
| Investment Management | ||||||||
Total1 | $ | $ | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Americas | $ | |||||||
| EMEA | ||||||||
| Asia | ||||||||
| Total | $ | $ | ||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
| Revenues | |||||||||||
| Dividends from bank subsidiaries | $ | $ | $ | ||||||||
Dividends from BHC and non-bank subsidiaries | |||||||||||
| Total dividends from subsidiaries | |||||||||||
| Trading | ( | ( | ( | ||||||||
| Other | ( | ( | |||||||||
| Total non-interest revenues | |||||||||||
| Interest income | |||||||||||
| Interest expense | |||||||||||
| Net interest | ( | ||||||||||
| Net revenues | |||||||||||
| Non-interest expenses | |||||||||||
| Income before income taxes | |||||||||||
| Provision for (benefit from) income taxes | ( | ( | ( | ||||||||
| Net income before undistributed gain of subsidiaries | |||||||||||
Undistributed (loss) gain of subsidiaries | ( | ||||||||||
| Net income | |||||||||||
| Other comprehensive income (loss), net of tax: | |||||||||||
| Foreign currency translation adjustments | ( | ||||||||||
| Change in net unrealized gains (losses) on available-for-sale securities | |||||||||||
| Pensions and other | ( | ||||||||||
| Change in net debt valuation adjustment | ( | ( | ( | ||||||||
| Net change in cash flow hedges | ( | ||||||||||
| Comprehensive income | $ | $ | $ | ||||||||
| Net income | $ | $ | $ | ||||||||
| Preferred stock dividends and other | |||||||||||
Earnings applicable to Morgan Stanley common shareholders | $ | $ | $ | ||||||||
145 | December 2025 Form 10-K | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions, except share data | At December 31, 2025 | At December 31, 2024 | ||||||
| Assets | ||||||||
| Cash and cash equivalents | $ | $ | ||||||
| Trading assets at fair value | ||||||||
Investment securities: | ||||||||
Available-for-sale at fair value (amortized cost of $ | ||||||||
Held-to-maturity (fair value of $ | ||||||||
| Securities purchased under agreement to resell to affiliates | ||||||||
| Advances to subsidiaries: | ||||||||
| Bank and BHC | ||||||||
| Non-bank | ||||||||
| Equity investments in subsidiaries: | ||||||||
| Bank and BHC | ||||||||
| Non-bank | ||||||||
| Other assets | ||||||||
| Total assets | $ | $ | ||||||
| Liabilities | ||||||||
| Trading liabilities at fair value | $ | $ | ||||||
| Securities sold under agreements to repurchase from affiliates | ||||||||
| Payables to and advances from subsidiaries | ||||||||
| Other liabilities and accrued expenses | ||||||||
Borrowings (includes $ | ||||||||
| Total liabilities | ||||||||
| Commitments and contingent liabilities (see Note 14) | ||||||||
| Equity | ||||||||
| Preferred stock | ||||||||
Common stock, $ | ||||||||
Shares authorized: | ||||||||
| Additional paid-in capital | ||||||||
| Retained earnings | ||||||||
| Employee stock trusts | ||||||||
| Accumulated other comprehensive income (loss) | ( | ( | ||||||
Common stock held in treasury at cost, $ | ( | ( | ||||||
Common stock issued to employee stock trusts | ( | ( | ||||||
| Total shareholders’ equity | ||||||||
| Total liabilities and equity | $ | $ | ||||||
| $ in millions | 2025 | 2024 | 2023 | ||||||||
Net cash provided by (used for) operating activities | $ | $ | $ | ||||||||
| Cash flows from investing activities | |||||||||||
| Proceeds from (payments for): | |||||||||||
AFS securities: | |||||||||||
| Purchases | ( | ( | ( | ||||||||
| Proceeds from sales | |||||||||||
| Proceeds from paydowns and maturities | |||||||||||
HTM securities: | |||||||||||
| Purchases | ( | ||||||||||
| Proceeds from paydowns and maturities | |||||||||||
| Securities purchased under agreements to resell with affiliates | ( | ( | ( | ||||||||
| Securities sold under agreements to repurchase with affiliates | ( | ( | ( | ||||||||
| Advances to and investments in subsidiaries | ( | ( | ( | ||||||||
| Net cash provided by (used for) investing activities | ( | ( | ( | ||||||||
| Cash flows from financing activities | |||||||||||
| Proceeds from: | |||||||||||
| Issuance of preferred stock, net of issuance costs | |||||||||||
| Issuance of Borrowings | |||||||||||
| Payments for: | |||||||||||
| Borrowings | ( | ( | ( | ||||||||
| Repurchases of common stock and employee tax withholdings | ( | ( | ( | ||||||||
| Cash dividends | ( | ( | ( | ||||||||
| Net change in advances from subsidiaries | ( | ||||||||||
| Net cash provided by (used for) financing activities | ( | ||||||||||
| Effect of exchange rate changes on cash and cash equivalents | ( | ||||||||||
| Net increase (decrease) in cash and cash equivalents | ( | ||||||||||
| Cash and cash equivalents, at beginning of period | |||||||||||
| Cash and cash equivalents, at end of period | $ | $ | $ | ||||||||
| Cash and cash equivalents: | |||||||||||
| Cash and due from banks | $ | $ | $ | ||||||||
| Deposits with bank subsidiaries | |||||||||||
| Cash and cash equivalents, at end of period | $ | $ | $ | ||||||||
| Restricted cash | $ | $ | $ | ||||||||
| Supplemental Disclosure of Cash Flow Information | |||||||||||
| Cash payments for: | |||||||||||
| Interest | $ | $ | $ | ||||||||
Income taxes, net of refunds1 | |||||||||||
| December 2025 Form 10-K | 146 | |||||||
| Notes to Consolidated Financial Statements | ![]() | ||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Senior | $ | $ | ||||||
| Subordinated | ||||||||
| Total | $ | $ | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
| Aggregate balance | $ | $ | ||||||
| $ in millions | At December 31, 2025 | At December 31, 2024 | ||||||
Aggregate balance1 | $ | $ | ||||||
147 | December 2025 Form 10-K | |||||||
| Financial Data Supplement (Unaudited) | ![]() | ||||
| 2025 | 2024 | |||||||||||||||||||
| $ in millions | Average Daily Balance | Interest | Average Rate | Average Daily Balance | Interest | Average Rate | ||||||||||||||
Interest earning assets | ||||||||||||||||||||
Cash and cash equivalents: | ||||||||||||||||||||
| U.S. | $ | 54,637 | $ | 1,732 | 3.2 | % | $ | 47,751 | $ | 2,004 | 4.2 | % | ||||||||
| Non-U.S. | 45,666 | 834 | 1.8 | % | 43,406 | 1,064 | 2.5 | % | ||||||||||||
Investment securities2 | 162,840 | 5,328 | 3.3 | % | 156,920 | 5,161 | 3.3 | % | ||||||||||||
Loans2 | 257,513 | 13,995 | 5.4 | % | 226,454 | 13,771 | 6.1 | % | ||||||||||||
Securities purchased under agreements to resell3: | ||||||||||||||||||||
| U.S. | 72,438 | 9,919 | 13.7 | % | 65,222 | 7,332 | 11.2 | % | ||||||||||||
| Non-U.S. | 41,126 | 4,629 | 11.3 | % | 47,735 | 5,084 | 10.7 | % | ||||||||||||
Securities borrowed4: | ||||||||||||||||||||
| U.S. | 120,273 | 6,396 | 5.3 | % | 110,024 | 4,985 | 4.5 | % | ||||||||||||
| Non-U.S. | 18,854 | 227 | 1.2 | % | 18,224 | 406 | 2.2 | % | ||||||||||||
Trading assets, net of Trading liabilities: | ||||||||||||||||||||
U.S. | 114,215 | 5,259 | 4.6 | % | 106,063 | 5,016 | 4.7 | % | ||||||||||||
Non-U.S. | 24,088 | 983 | 4.1 | % | 14,385 | 908 | 6.3 | % | ||||||||||||
Customer receivables and Other: | ||||||||||||||||||||
U.S. | 66,830 | 7,630 | 11.4 | % | 52,510 | 6,223 | 11.9 | % | ||||||||||||
Non-U.S. | 18,891 | 2,131 | 11.3 | % | 15,889 | 2,181 | 13.7 | % | ||||||||||||
| Total | $ | 997,371 | $ | 59,063 | 5.9 | % | $ | 904,583 | $ | 54,135 | 6.0 | % | ||||||||
| Interest bearing liabilities | ||||||||||||||||||||
Deposits2 | $ | 384,412 | $ | 10,626 | 2.8 | % | $ | 350,487 | $ | 10,368 | 3.0 | % | ||||||||
Borrowings2,5 | 307,055 | 12,556 | 4.1 | % | 265,473 | 13,242 | 5.0 | % | ||||||||||||
Securities sold under agreements to repurchase6,8: | ||||||||||||||||||||
| U.S. | 20,260 | 7,784 | 38.4 | % | 18,442 | 5,336 | 28.9 | % | ||||||||||||
| Non-U.S. | 50,834 | 5,090 | 10.0 | % | 52,135 | 5,451 | 10.5 | % | ||||||||||||
Securities loaned7,8: | ||||||||||||||||||||
| U.S. | 9,844 | 2,152 | 21.9 | % | 9,499 | 108 | 1.1 | % | ||||||||||||
| Non-U.S. | 7,025 | 924 | 13.2 | % | 6,853 | 928 | 13.5 | % | ||||||||||||
Customer payables and Other: | ||||||||||||||||||||
| U.S. | 133,680 | 6,801 | 5.1 | % | 128,853 | 6,478 | 5.0 | % | ||||||||||||
| Non-U.S. | 65,411 | 3,084 | 4.7 | % | 61,237 | 3,613 | 5.9 | % | ||||||||||||
| Total | $ | 978,521 | $ | 49,017 | 5.0 | % | $ | 892,979 | $ | 45,524 | 5.1 | % | ||||||||
| Net interest income and net interest rate spread | $ | 10,046 | 0.9 | % | $ | 8,611 | 0.9 | % | ||||||||||||
2025 versus 2024 | |||||||||||
| Increase (Decrease) Due to Change in: | |||||||||||
| $ in millions | Volume | Rate | Net Change | ||||||||
| Interest earning assets | |||||||||||
Cash and cash equivalents: | |||||||||||
| U.S. | $ | 289 | $ | (561) | $ | (272) | |||||
| Non-U.S. | 55 | (285) | (230) | ||||||||
Investment securities2 | 195 | (28) | 167 | ||||||||
Loans2 | 1,889 | (1,665) | 224 | ||||||||
Securities purchased under agreements to resell3: | |||||||||||
| U.S. | 811 | 1,776 | 2,587 | ||||||||
| Non-U.S. | (704) | 249 | (455) | ||||||||
Securities borrowed4: | |||||||||||
| U.S. | 464 | 947 | 1,411 | ||||||||
| Non-U.S. | 14 | (193) | (179) | ||||||||
Trading assets, net of Trading liabilities: | |||||||||||
| U.S. | 386 | (143) | 243 | ||||||||
| Non-U.S. | 612 | (537) | 75 | ||||||||
Customer receivables and Other: | |||||||||||
| U.S. | 1,697 | (290) | 1,407 | ||||||||
| Non-U.S. | 412 | (462) | (50) | ||||||||
| Change in interest income | $ | 6,120 | $ | (1,192) | $ | 4,928 | |||||
| Interest bearing liabilities | |||||||||||
Deposits2 | $ | 1,004 | $ | (746) | $ | 258 | |||||
Borrowings2,5 | 2,074 | (2,760) | (686) | ||||||||
Securities sold under agreements to repurchase6,8: | |||||||||||
| U.S. | 526 | 1,922 | 2,448 | ||||||||
| Non-U.S. | (136) | (225) | (361) | ||||||||
Securities loaned7,8: | |||||||||||
| U.S. | 4 | 2,040 | 2,044 | ||||||||
| Non-U.S. | 23 | (27) | (4) | ||||||||
Customer payables and Other: | |||||||||||
| U.S. | 243 | 80 | 323 | ||||||||
| Non-U.S. | 246 | (775) | (529) | ||||||||
| Change in interest expense | $ | 3,984 | $ | (491) | $ | 3,493 | |||||
| Change in net interest income | $ | 2,136 | $ | (701) | $ | 1,435 | |||||
| December 2025 Form 10-K | 148 | |||||||
| Financial Data Supplement (Unaudited) | ![]() | ||||
| 2023 | |||||||||||
| $ in millions | Average Daily Balance | Interest | Average Rate | ||||||||
| Interest earning assets | |||||||||||
Cash and cash equivalents1: | |||||||||||
| U.S. | $ | 56,920 | $ | 2,386 | 4.2 | % | |||||
| Non-U.S. | 48,373 | 1,022 | 2.1 | % | |||||||
Investment securities2 | 153,307 | 3,992 | 2.6 | % | |||||||
Loans2 | 215,628 | 12,424 | 5.8 | % | |||||||
Securities purchased under agreements to resell3: | |||||||||||
| U.S. | 47,604 | 4,714 | 9.9 | % | |||||||
| Non-U.S. | 61,766 | 3,048 | 4.9 | % | |||||||
Securities borrowed4: | |||||||||||
| U.S. | 115,279 | 4,794 | 4.2 | % | |||||||
| Non-U.S. | 18,514 | 397 | 2.1 | % | |||||||
Trading assets, net of Trading liabilities: | |||||||||||
| U.S. | 93,409 | 3,792 | 4.1 | % | |||||||
| Non-U.S. | 12,788 | 696 | 5.4 | % | |||||||
Customer receivables and Other1: | |||||||||||
| U.S. | 45,815 | 6,314 | 13.8 | % | |||||||
| Non-U.S. | 14,485 | 2,270 | 15.7 | % | |||||||
| Total | $ | 883,888 | $ | 45,849 | 5.2 | % | |||||
| Interest bearing liabilities | |||||||||||
Deposits2 | $ | 342,583 | $ | 8,216 | 2.4 | % | |||||
Borrowings2,5 | 238,164 | 11,437 | 4.8 | % | |||||||
Securities sold under agreements to repurchase6,8: | |||||||||||
| U.S. | 22,718 | 3,591 | 15.8 | % | |||||||
| Non-U.S. | 46,392 | 3,146 | 6.8 | % | |||||||
Securities loaned7: | |||||||||||
| U.S. | 4,244 | 67 | 1.6 | % | |||||||
| Non-U.S. | 9,470 | 717 | 7.6 | % | |||||||
Customer payables and Other: | |||||||||||
| U.S. | 133,069 | 6,954 | 5.2 | % | |||||||
| Non-U.S. | 63,916 | 3,491 | 5.5 | % | |||||||
| Total | $ | 860,556 | $ | 37,619 | 4.4 | % | |||||
| Net interest income and net interest rate spread | $ | 8,230 | 0.8 | % | |||||||
2024 versus 2023 | |||||||||||
| Increase (Decrease) Due to Change in: | |||||||||||
| $ in millions | Volume | Rate | Net Change | ||||||||
| Interest earning assets | |||||||||||
Cash and cash equivalents1: | |||||||||||
| U.S. | $ | (384) | $ | 2 | $ | (382) | |||||
| Non-U.S. | (105) | 147 | 42 | ||||||||
Investment securities2 | 94 | 1,075 | 1,169 | ||||||||
Loans2 | 624 | 723 | 1,347 | ||||||||
Securities purchased under agreements to resell3: | |||||||||||
| U.S. | 1,745 | 873 | 2,618 | ||||||||
| Non-U.S. | (692) | 2,728 | 2,036 | ||||||||
Securities borrowed4: | |||||||||||
| U.S. | (219) | 410 | 191 | ||||||||
| Non-U.S. | (6) | 15 | 9 | ||||||||
Trading assets, net of Trading liabilities: | |||||||||||
| U.S. | 514 | 710 | 1,224 | ||||||||
| Non-U.S. | 87 | 125 | 212 | ||||||||
Customer receivables and Other1: | |||||||||||
| U.S. | 923 | (1,014) | (91) | ||||||||
| Non-U.S. | 220 | (309) | (89) | ||||||||
| Change in interest income | $ | 2,801 | $ | 5,485 | $ | 8,286 | |||||
| Interest bearing liabilities | |||||||||||
Deposits2 | $ | 190 | $ | 1,962 | $ | 2,152 | |||||
Borrowings2,5 | 1,311 | 494 | 1,805 | ||||||||
Securities sold under agreements to repurchase6,8: | |||||||||||
| U.S. | (676) | 2,421 | 1,745 | ||||||||
| Non-U.S. | 389 | 1,916 | 2,305 | ||||||||
Securities loaned7: | |||||||||||
| U.S. | 83 | (42) | 41 | ||||||||
| Non-U.S. | (198) | 409 | 211 | ||||||||
Customer payables and Other: | |||||||||||
| U.S. | (220) | (256) | (476) | ||||||||
| Non-U.S. | (146) | 268 | 122 | ||||||||
| Change in interest expense | $ | 733 | $ | 7,172 | $ | 7,905 | |||||
| Change in net interest income | $ | 2,068 | $ | (1,687) | $ | 381 | |||||
149 | December 2025 Form 10-K | |||||||
| Financial Data Supplement (Unaudited) | ![]() | ||||
| Average Daily Deposits | ||||||||||||||||||||
| 2025 | 2024 | 2023 | ||||||||||||||||||
| $ in millions | Average Amount | Average Rate | Average Amount | Average Rate | Average Amount | Average Rate | ||||||||||||||
Deposits1: | ||||||||||||||||||||
Savings and demand | $ | 296,827 | 2.2 | % | $ | 280,926 | 2.5 | % | $ | 286,513 | 2.0 | % | ||||||||
| Time | 87,584 | 4.6 | % | 69,561 | 4.8 | % | 56,070 | 4.3 | % | |||||||||||
| Total | $ | 384,411 | 2.8 | % | $ | 350,487 | 3.0 | % | $ | 342,583 | 2.4 | % | ||||||||
| December 2025 Form 10-K | 150 | |||||||
| Glossary of Common Terms and Acronyms | ![]() | ||||
| ABS | Asset-backed securities | ||||
| ACL | Allowance for credit losses | ||||
| AFS | Available-for-sale | ||||
| AML | Anti-money laundering | ||||
| AOCI | Accumulated other comprehensive income (loss) | ||||
| AUM | Assets under management or supervision | ||||
| Balance sheet | Consolidated balance sheet | ||||
| BHC | Bank holding company | ||||
| bps | Basis points; one basis point equals 1/100th of 1% | ||||
| Cash flow statement | Consolidated cash flow statement | ||||
| CCAR | Comprehensive Capital Analysis and Review | ||||
| CCyB | Countercyclical capital buffer | ||||
| CDO | Collateralized debt obligation(s), including Collateralized loan obligation(s) | ||||
| CDS | Credit default swaps | ||||
| CECL | Current Expected Credit Losses, as calculated under the Financial Instruments—Credit Losses accounting update | ||||
CEO | Chief Executive Officer | ||||
CET1 | Common Equity Tier 1 | ||||
| CFTC | U.S. Commodity Futures Trading Commission | ||||
| CLN | Credit-linked note(s) | ||||
| CLO | Collateralized loan obligation(s) | ||||
| CMBS | Commercial mortgage-backed securities | ||||
| CMO | Collateralized mortgage obligation(s) | ||||
CRE | Commercial real estate | ||||
| CRM | Credit Risk Management Department | ||||
| CTA | Cumulative foreign currency translation adjustments | ||||
| CVA | Credit valuation adjustment | ||||
| DCP | Employee deferred cash-based compensation plans linked to investment performance | ||||
| DCP investments | Investments associated with certain DCP | ||||
| DVA | Debt valuation adjustment | ||||
| EBITDA | Earnings before interest, taxes, depreciation and amortization | ||||
| ELN | Equity-linked note(s) | ||||
| EMEA | Europe, Middle East and Africa | ||||
| EPS | Earnings per common share | ||||
| E.U. | European Union | ||||
| FDIC | Federal Deposit Insurance Corporation | ||||
| FFELP | Federal Family Education Loan Program | ||||
| FHC | Financial holding company | ||||
| FICC | Fixed Income Clearing Corporation | ||||
| FICO | Fair Isaac Corporation | ||||
| Financial statements | Consolidated financial statements | ||||
| FVA | Funding valuation adjustment | ||||
| FVO | Fair value option | ||||
| G-SIB | Global systemically important bank | ||||
| HELOC | Home Equity Line of Credit | ||||
| HFI | Held-for-investment | ||||
| HFS | Held-for-sale | ||||
| HQLA | High-quality liquid assets | ||||
| HTM | Held-to-maturity | ||||
| I/E | Intersegment eliminations | ||||
| IHC | Intermediate holding company | ||||
| IM | Investment Management | ||||
| Income statement | Consolidated income statement | ||||
| IRS | Internal Revenue Service | ||||
| IS | Institutional Securities | ||||
| LCR | Liquidity coverage ratio, as adopted by the U.S. banking agencies | ||||
| LTV | Loan-to-value | ||||
| M&A | Merger, acquisition and restructuring transaction | ||||
| MSBNA | Morgan Stanley Bank, N.A. | ||||
| MS&Co. | Morgan Stanley & Co. LLC | ||||
| MSCG | Morgan Stanley Capital Group Inc. | ||||
| MSCS | Morgan Stanley Capital Services LLC | ||||
| MSESE | Morgan Stanley Europe SE | ||||
| MSIP | Morgan Stanley & Co. International plc | ||||
| MSMS | Morgan Stanley MUFG Securities Co., Ltd. | ||||
| MSPBNA | Morgan Stanley Private Bank, National Association | ||||
| MSSB | Morgan Stanley Smith Barney LLC | ||||
| MUFG | Mitsubishi UFJ Financial Group, Inc. | ||||
| MUMSS | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | ||||
| MWh | Megawatt hour | ||||
| N/A | Not Applicable | ||||
| N/M | Not Meaningful | ||||
| NAV | Net asset value | ||||
| Non-GAAP | Non-generally accepted accounting principles in the U.S. | ||||
| NSFR | Net stable funding ratio, as adopted by the U.S. banking agencies | ||||
| OCC | Office of the Comptroller of the Currency | ||||
| OCI | Other comprehensive income (loss) | ||||
| OIS | Overnight index swap | ||||
| OTC | Over-the-counter | ||||
| PRA | Prudential Regulation Authority | ||||
| PSU | Performance-based stock unit | ||||
| RMBS | Residential mortgage-backed securities | ||||
| ROE | Return on average common equity | ||||
| ROTCE | Return on average tangible common equity | ||||
| ROU | Right-of-use | ||||
| RSU | Restricted stock unit | ||||
| RWA | Risk-weighted assets | ||||
| SCB | Stress capital buffer | ||||
| SEC | U.S. Securities and Exchange Commission | ||||
| SLR | Supplementary leverage ratio | ||||
| SOFR | Secured Overnight Financing Rate | ||||
| S&P | Standard & Poor’s | ||||
| SPE | Special purpose entity | ||||
| SPOE | Single point of entry | ||||
| TLAC | Total loss-absorbing capacity | ||||
| U.K. | United Kingdom | ||||
| UPB | Unpaid principal balance | ||||
| U.S. | United States of America | ||||
| U.S. Bank Subsidiaries | MSBNA and MSPBNA | ||||
| U.S. GAAP | Accounting principles generally accepted in the U.S. | ||||
| VaR | Value-at-Risk | ||||
| VIE | Variable interest entity | ||||
| WACC | Implied weighted average cost of capital | ||||
| WM | Wealth Management | ||||
151 | December 2025 Form 10-K | |||||||
| December 2025 Form 10-K | 152 | |||||||
153 | December 2025 Form 10-K | |||||||
| $ in millions, except per share data | Total Number of Shares Purchased1 | Average Price Paid per Share2 | Total Shares Purchased as Part of Share Repurchase Program3, 4 | Dollar Value of Remaining Authorized Repurchase | ||||||||||
| October | 2,132,433 | $ | 162.41 | 2,115,400 | $ | 18,572 | ||||||||
| November | 3,648,051 | $ | 163.81 | 3,624,300 | $ | 17,978 | ||||||||
| December | 3,327,625 | $ | 175.96 | 3,199,009 | $ | 17,415 | ||||||||
Three Months Ended December 31, 2025 | 9,108,109 | $ | 167.92 | 8,938,709 | ||||||||||
| December 2025 Form 10-K | 154 | |||||||

| At December 31, | ||||||||||||||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |||||||||||||||
| Morgan Stanley | $ | 100.00 | $ | 146.61 | $ | 131.36 | $ | 149.63 | $ | 209.06 | $ | 303.51 | ||||||||
S&P 500 Stock Index | 100.00 | 128.68 | 105.35 | 133.02 | 166.27 | 195.96 | ||||||||||||||
S&P 500 Financials Sector Index | 100.00 | 134.87 | 120.61 | 135.21 | 176.45 | 202.86 | ||||||||||||||
155 | December 2025 Form 10-K | |||||||
| At December 31, 2025 | ||||||||||||||
| (a) | (b) | (c) | ||||||||||||
| plan category | Number of securities to be issued upon exercise of outstanding options, warrants and rights1 | Weighted-average exercise price of outstanding options, warrants and rights | Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a)) | |||||||||||
Equity compensation plans approved by security holders | 53,389,903 | $ | — | 135,952,970 | 2 | |||||||||
Equity compensation plans not approved by security holders | — | — | — | |||||||||||
| Total | 53,389,903 | $ | — | 135,952,970 | ||||||||||
| Exhibit No. | Description | ||||
| 3.1 | Amended and Restated Certificate of Incorporation of Morgan Stanley, as amended to date (Exhibit 3.1 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended June 30, 2024). | ||||
| 3.2 | Amended and Restated Bylaws of Morgan Stanley, as amended to date (Exhibit 3.1 to Morgan Stanley’s current report on Form 8-K dated December 8, 2023). | ||||
| 4.1* | |||||
| 4.2 | Amended and Restated Senior Indenture dated as of May 1, 1999 between Morgan Stanley and The Bank of New York, as trustee (Exhibit 4e to Morgan Stanley’s Registration Statement on Form S-3/A (No. 333-75289) as amended by Fourth Supplemental Senior Indenture dated as of October 8, 2007 (Exhibit 4.3 to Morgan Stanley’s annual report on Form 10-K for the fiscal year ended November 30, 2007). | ||||
| December 2025 Form 10-K | 156 | |||||||
| Exhibit No. | Description | ||||
| 4.3 | Senior Indenture dated as of November 1, 2004 between Morgan Stanley and The Bank of New York, as trustee (Exhibit 4-f to Morgan Stanley’s Registration Statement on Form S-3/A (No. 333-117752), as amended by First Supplemental Senior Indenture dated as of September 4, 2007 (Exhibit 4.5 to Morgan Stanley’s annual report on Form 10-K for the fiscal year ended November 30, 2007), Second Supplemental Senior Indenture dated as of January 4, 2008 (Exhibit 4.1 to Morgan Stanley’s current report on Form 8-K dated January 4, 2008), Third Supplemental Senior Indenture dated as of September 10, 2008 (Exhibit 4 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended August 31, 2008), Fourth Supplemental Senior Indenture dated as of December 1, 2008 (Exhibit 4.1 to Morgan Stanley’s current report on Form 8-K dated December 1, 2008), Fifth Supplemental Senior Indenture dated as of April 1, 2009 (Exhibit 4 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended March 31, 2009), Sixth Supplemental Senior Indenture dated as of September 16, 2011 (Exhibit 4.1 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended September 30, 2011), Seventh Supplemental Senior Indenture dated as of November 21, 2011 (Exhibit 4.4 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2011), Eighth Supplemental Senior Indenture dated as of May 4, 2012 (Exhibit 4.1 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended June 30, 2012), Ninth Supplemental Senior Indenture dated as of March 10, 2014 (Exhibit 4.1 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended March 31, 2014), Tenth Supplemental Senior Indenture dated as of January 11, 2017 (Exhibit 4.1 to Morgan Stanley’s current report on Form 8-K dated January 11, 2017) and Eleventh Supplemental Senior Indenture dated as of March 24, 2021 (Exhibit 4.4 to Morgan Stanley's annual report on Form 10-K for the year ended December 31, 2021). | ||||
| 4.4 | The Unit Agreement Without Holders’ Obligations, dated as of August 29, 2008, between Morgan Stanley and The Bank of New York Mellon, as Unit Agent, as Trustee and Paying Agent under the Senior Indenture referred to therein and as Warrant Agent under the Warrant Agreement referred to therein (Exhibit 4.1 to Morgan Stanley’s current report on Form 8-K dated August 29, 2008). | ||||
| 4.5 | Subordinated Indenture dated as of October 1, 2004 between Morgan Stanley and The Bank of New York, as trustee (Exhibit 4-g to Morgan Stanley’s Registration Statement on Form S-3/A (No. 333-117752)). | ||||
| 4.6 | Junior Subordinated Indenture dated as of October 12, 2006 between Morgan Stanley and The Bank of New York, as trustee (Exhibit 4.1 to Morgan Stanley’s current report on Form 8-K dated October 12, 2006). | ||||
| 4.7 | Deposit Agreement dated as of July 6, 2006 among Morgan Stanley, JPMorgan Chase Bank, N.A. and the holders from time to time of the depositary receipts described therein (Exhibit 4.3 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended May 31, 2006). | ||||
| Exhibit No. | Description | ||||
| 4.8 | Form of Deposit Agreement among Morgan Stanley, JPMorgan Chase Bank, N.A. and the holders from time to time of the depositary receipts representing interests in the Series A Preferred Stock described therein (Exhibit 2.4 to Morgan Stanley’s Registration Statement on Form 8-A dated July 5, 2006). | ||||
| 4.9 | Depositary Receipt for Depositary Shares, representing Floating Rate Non-Cumulative Preferred Stock, Series A (included in Exhibit 4.8 hereto). | ||||
| 4.10 | Form of Deposit Agreement among Morgan Stanley, The Bank of New York Mellon and the holders from time to time of the depositary receipts representing interests in the Series E Preferred Stock described therein (Exhibit 2.6 to Morgan Stanley’s Registration Statement on Form 8-A dated September 27, 2013). | ||||
| 4.11 | Depositary Receipt for Depositary Shares, representing Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series E (included in Exhibit 4.10 hereto). | ||||
| 4.12 | Form of Deposit Agreement among Morgan Stanley, The Bank of New York Mellon and the holders from time to time of the depositary receipts representing interests in the Series F Preferred stock described therein (Exhibit 2.4 to Morgan Stanley’s Registration Statement on Form 8-A dated December 9, 2013). | ||||
| 4.13 | |||||
| 4.14 | Form of Deposit Agreement among Morgan Stanley, The Bank of New York Mellon and the holders from time to time of the depositary receipts representing interests in the Series I Preferred stock described therein (Exhibit 2.4 to Morgan Stanley’s Registration Statement on Form 8-A dated September 17, 2014). | ||||
| 4.15 | Depositary Receipt for Depositary Shares, representing Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series I (included in Exhibit 4.14 hereto). | ||||
| 4.16 | Form of Deposit Agreement among Morgan Stanley, The Bank of New York Mellon and the holders from time to time of the depositary receipts representing interests in the Series K Preferred Stock described therein (Exhibit 2.4 to Morgan Stanley’s Registration Statement on Form 8-A dated January 30, 2017). | ||||
| 4.17 | Depositary Receipt for Depositary Shares, representing Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series K (included in Exhibit 4.16 hereto). | ||||
| 4.18 | Form of Deposit Agreement among Morgan Stanley, The Bank of New York Mellon and the holders from time to time of the depositary receipts representing interests in the Series L Preferred Stock described therein (Exhibit 2.4 to Morgan Stanley’s Registration Statement on Form 8-A dated November 22, 2019). | ||||
157 | December 2025 Form 10-K | |||||||
| Exhibit No. | Description | ||||
| 4.19 | Depositary Receipt for Depositary Shares, representing 4.875% Non-Cumulative Preferred Stock, Series L (included in Exhibit 4.18 hereto). | ||||
| 4.20 | Form of Deposit Agreement among Morgan Stanley, The Bank of New York Mellon and the holders from time to time of the depositary receipts representing interests in the Series N Preferred Stock described therein (Exhibit 4.5 to Morgan Stanley’s current report on Form 8-K dated October 2, 2020). | ||||
| 4.21 | Depositary Receipt for Depositary Shares, representing Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series N (included in Exhibit 4.20 hereto). | ||||
| 4.22 | Form of Deposit Agreement among Morgan Stanley, The Bank of New York Mellon and the holders from time to time of the depositary receipts representing interests in the Series O Preferred Stock described therein (Exhibit 2.4 to Morgan Stanley’s Registration Statement on Form 8-A dated October 22, 2021). | ||||
| 4.23 | Depositary Receipt for Depositary Shares, representing 4.250% Non-Cumulative Preferred Stock, Series O (included in Exhibit 4.22 hereto). | ||||
| 4.24 | Form of Deposit Agreement among Morgan Stanley, The Bank of New York Mellon and the holders from time to time of the depositary receipts representing interests in the Series P Preferred Stock described therein (Exhibit 2.4 to Morgan Stanley’s Registration Statement on Form 8-A dated August 1, 2022). | ||||
| 4.25 | Depositary Receipt for Depositary Shares, representing 6.500% Non-Cumulative Preferred Stock, Series P (included in Exhibit 4.24 hereto). | ||||
| 4.26 | Form of Deposit Agreement among Morgan Stanley, The Bank of New York Mellon and the holders from time to time of the depositary receipts representing interests in the Series Q Preferred Stock described therein (Exhibit 2.4 to Morgan Stanley’s Registration Statement on Form 8-A dated July 29, 2024). | ||||
| 4.27 | Depositary Receipt for Depositary Shares, representing 6.625% Non-Cumulative Preferred Stock, Series Q (included in Exhibit 4.26 hereto). | ||||
| 10.1 | Amended and Restated Trust Agreement dated as of January 1, 2018 by and between Morgan Stanley and State Street Bank and Trust Company (Exhibit 10.1 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended March 31, 2018). | ||||
| Exhibit No. | Description | ||||
| 10.2 | Amended and Restated Investor Agreement dated as of June 30, 2011 by and between Morgan Stanley and Mitsubishi UFJ Financial Group, Inc. (Exhibit 10.1 to Morgan Stanley’s current report on Form 8-K dated June 30, 2011), as amended by Third Amendment, dated October 3, 2013 (Exhibit 10.1 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended September 30, 2013), Fourth Amendment, dated April 6, 2016 (Exhibit 10.1 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended March 31, 2016), Fifth Amendment, dated October 4, 2018 (Exhibit 10.3 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2020), Sixth Amendment, dated April 13, 2021 (Exhibit 10.1 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended June 30, 2021) and Seventh Amendment, dated October 13, 2023 (Exhibit 10.1 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended September 30, 2023). | ||||
| 10.3† | Morgan Stanley 401(k) Plan, amended and restated as of January 1, 2018 (Exhibit 10.4 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2018), as amended by Amendment (Exhibit 10.4 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2019), Amendment (Exhibit 10.6 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2020), Amendment (Exhibit 10.4 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2021), Amendment (Exhibit 10.4 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2022), Amendment (Exhibit 10.4 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2023) and Amendment (Exhibit 10.4 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2024). | ||||
| 10.4†* | |||||
| 10.5† | Tax Deferred Equity Participation Plan as amended and restated as of November 26, 2007, terminated effective March 31, 2025 (Exhibit 10.9 to Morgan Stanley’s annual report on Form 10-K for the fiscal year ended November 30, 2007). | ||||
10.6† | Directors’ Equity Capital Accumulation Plan as amended and restated as of November 1, 2024 (Exhibit 10.6 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2024). | ||||
| 10.7† | Employees’ Equity Accumulation Plan as amended and restated as of November 26, 2007, terminated effective March 31, 2025 (Exhibit 10.12 to Morgan Stanley’s annual report on Form 10-K for the fiscal year ended November 30, 2007). | ||||
| 10.8† | Employee Stock Purchase Plan as amended and restated as of August 1, 2022 (Exhibit 10.8 to Morgan Stanley's annual report on Form 10-K for the year ended December 31, 2022). | ||||
| December 2025 Form 10-K | 158 | |||||||
| Exhibit No. | Description | ||||
| 10.9† | Morgan Stanley Supplemental Executive Retirement and Excess Plan, amended and restated effective December 31, 2008 (Exhibit 10.2 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended March 31, 2009) as amended by Amendment (Exhibit 10.5 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended June 30, 2009), Amendment (Exhibit 10.19 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2010), Amendment (Exhibit 10.3 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended June 30, 2011) and Amendment (Exhibit 10.1 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended September 30, 2014). | ||||
| 10.10† | Form of Deferred Compensation Agreement under the Pre-Tax Incentive Program 2 (Exhibit 10.12 to MSG’s annual report for the fiscal year ended November 30, 1996). | ||||
| 10.11† | Morgan Stanley UK Share Ownership Plan (Exhibit 4.1 to Morgan Stanley’s Registration Statement on Form S-8 (No. 333-146954)). | ||||
| 10.12† | Supplementary Deed of Participation for the Morgan Stanley UK Share Ownership Plan, dated as of November 5, 2009 (Exhibit 10.36 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2009). | ||||
10.13† | Form of Restrictive Covenant Agreement (Exhibit 10 to Morgan Stanley’s current report on Form 8-K dated November 22, 2005). | ||||
10.14† | Morgan Stanley Equity Incentive Compensation Plan, as amended and restated as of March 31, 2025 (Exhibit 10.1 to Morgan Stanley's current report on Form 8-K dated May 15, 2025). | ||||
10.15† | Morgan Stanley Compensation Incentive Plan, as amended and restated as of December 16, 2024 (Exhibit 10.17 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2024). | ||||
10.16† | Morgan Stanley Schedule of Non-Employee Directors Annual Compensation, effective as of November 1, 2024 (Exhibit 10.18 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2024). | ||||
10.17† | Description of Executive Health Coverage (Exhibit 10.19 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2024). | ||||
10.18† | Form of Award Certificate for Discretionary Retention Awards of Stock Units (Exhibit 10.20 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2023). | ||||
10.19† | Form of Award Certificate for Discretionary Retention Awards under the Morgan Stanley Compensation Incentive Plan (Exhibit 10.21 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2023). | ||||
10.20† | |||||
10.21† | Form of Aircraft Time-Sharing Agreement (Exhibit 10.1 to Morgan Stanley’s quarterly report on Form 10-Q for the quarter ended September 30, 2020). | ||||
| Exhibit No. | Description | ||||
| 19 | |||||
| 21* | |||||
| 22* | |||||
| 23.1* | |||||
| 24 | |||||
| 31.1* | |||||
| 31.2* | |||||
| 32.1** | |||||
| 32.2** | |||||
| 97 | Morgan Stanley Compensation Recoupment Policy (Exhibit 97 to Morgan Stanley’s annual report on Form 10-K for the year ended December 31, 2023). | ||||
| 101 | Interactive Data Files pursuant to Rule 405 of Regulation S-T formatted in Inline eXtensible Business Reporting Language (“Inline XBRL”). | ||||
| 104 | Cover Page Interactive Data File (formatted in Inline XBRL and contained in Exhibit 101). | ||||
| * | Filed herewith. | ||||
| ** | Furnished herewith. | ||||
| † | Management contract or compensatory plan or arrangement required to be filed as an exhibit to this Form 10-K pursuant to Item 15(b). | ||||
159 | December 2025 Form 10-K | |||||||
MORGAN STANLEY (REGISTRANT) | |||||
| By: | /s/ EDWARD PICK | ||||
(Edward Pick) | |||||
Chairman of the Board and Chief Executive Officer | |||||
| Signature | Title | ||||
/s/ EDWARD PICK | Chairman of the Board and Chief Executive Officer | ||||
(Edward Pick) | (Principal Executive Officer) | ||||
/s/ SHARON YESHAYA | Executive Vice President and Chief Financial Officer | ||||
| (Sharon Yeshaya) | (Principal Financial Officer) | ||||
/s/ VICTORIA WORSTER | Chief Accounting Officer and Controller | ||||
(Victoria Worster) | (Principal Accounting Officer) | ||||
/s/ MEGAN BUTLER | Director | ||||
(Megan Butler) | |||||
/s/ THOMAS H. GLOCER | Director | ||||
| (Thomas H. Glocer) | |||||
/s/ LYNN J. GOOD | Director | ||||
| (Lynn J. Good) | |||||
| Signature | Title | ||||
/s/ ROBERT H. HERZ | Director | ||||
| (Robert H. Herz) | |||||
/s/ ERIKA H. JAMES | Director | ||||
| (Erika H. James) | |||||
/s/ HIRONORI KAMEZAWA | Director | ||||
| (Hironori Kamezawa) | |||||
/s/ SHELLEY B. LEIBOWITZ | Director | ||||
| (Shelley B. Leibowitz) | |||||
/s/ JAMI MISCIK | Director | ||||
| (Jami Miscik) | |||||
/s/ MASATO MIYACHI | Director | ||||
| (Masato Miyachi) | |||||
/s/ DENNIS M. NALLY | Director | ||||
| (Dennis M. Nally) | |||||
/s/ DOUGLAS L. PETERSON | Director | ||||
| (Douglas L. Peterson) | |||||
/s/ MARY L. SCHAPIRO | Director | ||||
| (Mary L. Schapiro) | |||||
/s/ PERRY M. TRAQUINA | Director | ||||
| (Perry M. Traquina) | |||||
/s/ RAYFORD WILKINS, JR. | Director | ||||
| (Rayford Wilkins, Jr.) | |||||
| December 2025 Form 10-K | 160 | |||||||

| Company | Jurisdiction of Incorporation or Formation | ||||
| Morgan Stanley | United States | ||||
| Morgan Stanley Capital Management, LLC | United States | ||||
| Morgan Stanley & Co. LLC | United States | ||||
| Morgan Stanley Bank, N.A. | United States | ||||
| Morgan Stanley Domestic Holdings, LLC | United States | ||||
| Morgan Stanley Capital Group Inc. | United States | ||||
| Morgan Stanley Capital Services LLC | United States | ||||
| Morgan Stanley Investment Management Inc. | United States | ||||
| Morgan Stanley Private Bank, National Association | United States | ||||
| Morgan Stanley Smith Barney LLC | United States | ||||
| Morgan Stanley Finance LLC | United States | ||||
| Morgan Stanley Holdings LLC | United States | ||||
| Morgan Stanley International Holdings Inc. | United States | ||||
| Morgan Stanley Japan Holdings Co., Ltd. | Japan | ||||
| Morgan Stanley MUFG Securities Co., Ltd. | Japan | ||||
| Morgan Stanley International Limited | United Kingdom | ||||
| Morgan Stanley Europe SE | Germany | ||||
| Morgan Stanley Bank AG | Germany | ||||
| Morgan Stanley Investments (UK) | United Kingdom | ||||
| Morgan Stanley & Co. International plc | United Kingdom | ||||
| Morgan Stanley Investment Management Limited | United Kingdom | ||||
Securities | Guarantor | ||||
Morgan Stanley Finance LLC (“MSFL”) issues, from time to time, its Series A senior debt securities under the MSFL Senior Debt Indenture dated February 16, 2016 that are each fully and unconditionally guaranteed by Morgan Stanley. Of those issuances, the Global Medium-Term Notes, Series A, Fixed Rate Step-Up Senior Notes Due 2026 and the Global Medium-Term Notes, Series A, Floating Rate Notes Due 2029 are currently listed on the New York Stock Exchange. | Morgan Stanley | ||||
| Filed on Form S-3: | ||
Registration Statement No. 333-253728 | ||
Registration Statement No. 333-275587 | ||
Registration Statement No. 333-275587-01 | ||
| Filed on Form S-8: | ||
| Registration Statement No. 33-63024 | ||
| Registration Statement No. 33-63026 | ||
| Registration Statement No. 33-78038 | ||
| Registration Statement No. 33-79516 | ||
| Registration Statement No. 33-82240 | ||
| Registration Statement No. 33-82242 | ||
| Registration Statement No. 33-82244 | ||
| Registration Statement No. 333-04212 | ||
| Registration Statement No. 333-28141 | ||
| Registration Statement No. 333-28263 | ||
| Registration Statement No. 333-62869 | ||
| Registration Statement No. 333-78081 | ||
| Registration Statement No. 333-95303 | ||
| Registration Statement No. 333-55972 | ||
| Registration Statement No. 333-85148 | ||
| Filed on Form S-8: | ||
| Registration Statement No. 333-85150 | ||
| Registration Statement No. 333-108223 | ||
| Registration Statement No. 333-142874 | ||
| Registration Statement No. 333-146954 | ||
| Registration Statement No. 333-159503 | ||
| Registration Statement No. 333-159504 | ||
| Registration Statement No. 333-159505 | ||
| Registration Statement No. 333-168278 | ||
| Registration Statement No. 333-172634 | ||
| Registration Statement No. 333-177454 | ||
| Registration Statement No. 333-183595 | ||
| Registration Statement No. 333-188649 | ||
| Registration Statement No. 333-192448 | ||
| Registration Statement No. 333-204504 | ||
| Registration Statement No. 333-211723 | ||
| Registration Statement No. 333-218377 | ||
| Registration Statement No. 333-231913 | ||
| Registration Statement No. 333-256493 | ||
| Registration Statement No. 333-266612 | ||
Registration Statement No. 333-287621 | ||
/s/ Deloitte & Touche LLP | ||
| New York, New York | ||
| February 19, 2026 | ||
/s/ EDWARD PICK | ||
| Edward Pick | ||
| Chairman of the Board and Chief Executive Officer | ||
/s/ SHARON YESHAYA | ||
| Sharon Yeshaya | ||
| Executive Vice President and Chief Financial Officer | ||
/s/ EDWARD PICK | ||
| Edward Pick | ||
| Chairman of the Board and Chief Executive Officer | ||
/s/ SHARON YESHAYA | ||
| Sharon Yeshaya | ||
| Executive Vice President and | ||
| Chief Financial Officer | ||